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ABSTRACT 
The obesity epidemic is a major health and economic burden in the United States with 
approximately 35% of the population classified as overweight or obese, and annual medical costs 
for obese persons is approximately 150% more relative to lean persons.  Obesity can develop 
when energy intake exceeds energy expenditure, and the stomach-derived orexigenic hormone 
ghrelin has emerged as a key mediator of this balance in humans due to its increased circulating 
concentrations in obese persons and involvement in regulating ingestive behaviors and numerous 
metabolic processes.  We and others have previously shown ghrelin is sufficient to drive both 
appetitive (i.e. the searching for and storage of food) and consummatory (i.e. the consumption of 
food) ingestive behaviors and metabolic processes such as gut motility, nutrient partitioning, 
glycemia, and body temperature.  The ghrelin receptor, growth hormone secretagogue receptor 
1a (GHSR), is widely expressed in the brain and on gastrointestinal vagal sensory neurons, and 
neuronal GHSR knockout affords protection against diet-induced obesity and glycemic 
dysregulation.  Hence, the absence of ghrelin signaling results in a profoundly beneficial 
metabolic profile and elucidating the mechanisms through which ghrelin mediates ingestive 
behaviors and metabolic processes may provide novel obesity treatment options.  Targeted 
central/peripheral ghrelin injections or neuronal-specific GHSR restoration in otherwise GHSR-
null mice has provided mounting evidence for discrete neuroanatomical mechanisms regulating 
ghrelin’s behavioral and metabolic effects, yet a thorough interrogation of these distributed 
signaling pathways in the context of ghrelin-mediated ingestive behaviors or metabolism has yet 
to be conducted.  Here, we utilize two rodent models (Siberian hamsters and mice) to examine 
the mechanisms through which ghrelin regulates ingestive behaviors and overall metabolic 
homeostasis.  We find that central ghrelin signaling is necessary and sufficient to drive appetitive 
and consummatory ingestive behaviors and that hypothalamic agouti-related peptide is critical 
for ghrelin-induced appetitive, but not consummatory, behaviors.  In addition, we identify a 
novel, peripheral sensory neuron ghrelin signaling pathway that is critical for regulating energy 
expenditure and metabolic homeostasis.  Thus, this dissertation provides a significant step 
forward for our understanding of ghrelin signaling and the discrete mechanisms through which it 
mediates behaviors and metabolic processes.   
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1 INTRODUCTION  
 
1.1 Global rise of the Obesity Epidemic 
Over 1.4 billion people worldwide are classified as overweight or obese with the number 
of affected persons nearly doubling in developed countries and tripling in developing countries 
since 1980 [1].  As obesity is closely associated with a myriad of secondary health consequences 
including diabetes, stroke, and some types of cancers, the resulting annual medical costs for 
obese persons is approximately 42% higher than lean persons [2].  The dramatic increase in 
obesity rates and resultant economic impact is due, in part, to an increasingly sedentary lifestyle 
coupled with the prevalence of inexpensive, calorically dense foods with long shelf lives.  To 
this end, obesity can develop when energy intake exceeds energy expenditure, and there are 
multiple behavioral and metabolic factors that contribute to this imbalance and can compound 
the effects of consuming energy rich foods and a sedentary lifestyle.  Daily fluctuations in 
orexigenic (e.g. the stomach derived hormone ghrelin [3]) or satiety hormones (e.g. leptin [4]) 
correspond with physiological changes that mediate the searching for and storage of food, energy 
conservation, or the liberation of energy stores [5-11].  Hence, a comprehensive interrogation of 
the ethological, genetic, and neuroanatomical mechanism through which animals (including 
humans) regulate energy homeostasis is critical for stopping the obesity epidemic.   
Previous work on the neuroendocrine control of energy homeostasis has largely focused 
on uncovering the central (i.e. brain) mechanisms regulating food intake and peripheral 
metabolism and, in the process, identified a detailed neuroanatomical framework regulating these 
outputs.  However, both central and peripheral endocrine signaling is critical for metabolic 
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control, and uncovering the distributed systems regulating excessive weight gain through 
behavioral and non-behavioral mechanisms will inevitably lead to better treatment options to 
reduce the obesity epidemic.  Therefore, the overall goal of this dissertation is to investigate how 
discrete central and peripheral neuroendocrine signaling regulates behavior and metabolism, with 
a focus on the orexigenic hormone ghrelin which has been identified as a key mediator of energy 
homeostasis. 
1.2 Ethological and Neuroendocrine Control of Body Mass 
Obese and lean animals, including humans, have clear differences in the physiological 
mechanisms regulating metabolism and ingestive behaviors [12, 13], yet previous studies 
examining the neuroendocrine control of energy homeostasis have primarily focused on food 
intake and largely ignored the appetitive behaviors that bring animals into contact with food.  To 
this end, humans invariably search (forage) for food (e.g. at grocery stores and restaurants) prior 
to consumption, and numerous studies have suggested overweight and obese persons purchase 
more calorically dense foods and store these foods (hoard) for longer periods of time compared 
with lean persons (e.g. in cupboards and refrigerators) [14-17].  In an evolutionary context, an 
adaptive response to energetic challenges in which animals increase food hoarding, rather than 
overeat, upon locating food would prove beneficial for two reasons: first, a surplus of stored food 
would allow an animal to expend minimal energy to acquire the next meal and thus expedite the 
replenishment of lost calories; second, the long-term storage of food would mitigate the potential 
for future negative energy balances.  Caloric restriction is the most potent stimulator of food 
foraging and food hoarding in humans and laboratory rodents, and it elicits a profoundly 
negative valence signal mediated, in part, through neuroendocrine signaling that drives energy 
conservation and food seeking behaviors to prevent starvation and replenish energy stores [18, 
3 
19].  These energy stores are maintained through a tightly regulated network involving the brain 
and periphery, and peripheral organs such as the stomach and adipose tissue can communicate 
with central nuclei through neuronal and/or endocrine signaling mechanisms [11, 20, 21].  
Indeed, we and others have previously identified numerous peripheral endocrine signals, whose 
circulating concentrations are dependent on caloric state, that are sufficient to modulate ingestive 
behaviors, adipose tissue metabolism, and energy expenditure through activation of brain nuclei 
[22-26].  This behavioral and metabolic response to caloric deficiency would increase the 
survival probability of ancestral humans, but when coupled with the advent of calorically dense 
foods with long shelf-lives it directly contributes to the obesity epidemic in contemporary 
society.  
As the behavioral and metabolic parameters regulating energy homeostasis are often 
mediated by the same neuroendocrine mechanisms, it is logical to classify the concomitant 
responses to caloric imbalance as either behavioral or metabolic.  At the most basic level, 
maintaining energy homeostasis necessitates central and peripheral mechanisms that relay 
nutrient state to avoid overeating or starvation.  For instance, ghrelin promotes caloric intake and 
adiposity through a marked increase in food foraging, food hoarding, and food intake (i.e. a 
behavioral response) while simultaneously decreasing fatty acid utilization and liberation (i.e. a 
metabolic response) [22, 27-31].  In the context of adipose tissue metabolism and energy 
expenditure, this ghrelin signal → central/peripheral nuclei → adipose metabolic response can 
manifest through altered sympathetic nervous system (SNS) outflow [32-36].  The SNS is the 
primary driver of lipolysis, and changes to SNS outflow is sufficient to modulate whole body 
energy expenditure [33, 37-43].  Indeed, central ghrelin injections that circumvent peripheral 
receptors are sufficient to mediate both ingestive behaviors and sympathetic outflow [35, 44-47], 
4 
yet emerging evidence suggests these responses are mediated by a complex, distributed ghrelin 
signaling network.  Direct brain activation can occur directly through humoral circulating [48-
51], and numerous central nuclei critical for metabolic control are circumventricular organs 
exposed to circulating ghrelin [51-55].  By contrast, ghrelin responsive enteric sensory neurons 
emanating from the vagus nerve and dorsal root ganglia (DRGs) can facilitate rapid crosstalk 
with the brain [56-59], and previous work has demonstrated ghrelin activation of hindbrain or 
vagal sensory neurons is sufficient to mediate food intake, energy expenditure, and adipose 
tissue metabolism [60-62].  These vagal and DRG sensory neurons can synapse with hindbrain 
nuclei that project to, and receive projections from, numerous hypothalamic nuclei critical for 
both ingestive behaviors and metabolic control [63-66], and presence of multiple pathways 
regulating energy homeostasis may provide the basis through which peripheral endocrine signals 
drive behaviors and/or metabolic processes.  In support of this, ghrelin microinjections into 
hypothalamic nuclei is sufficient to drive a rapid, robust increase in ingestive behaviors, whereas 
microinjections into the hindbrain can decrease SNS outflow and energy expenditure 
independent of food intake effects [47, 67-72].  As previous work has predominantly focused on 
a single experimental outcome (i.e. food intake or augmented metabolic processes), an approach 
that examines both behavioral and non-behavioral control of whole-body energy homeostasis 
represents a novel paradigm to combat the obesity epidemic. 
1.2.1 Siberian hamsters as a model to study ingestive behaviors 
Animal models used to study obesity have largely consisted of mice and rats, and the 
advent of genetic modification in these animals has provided a paradigm shift in how we can 
interrogate the neuroendocrine mechanisms regulating metabolism.  However, genetic mutations 
account for less than 5% of obesity cases in people [73], and mice and rats have limited use for 
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obesity related behavioral studies because they do not naturally hoard food.  By contrast, 
Siberian hamsters (Phodopus sungorus), like humans, are natural and prodigious food hoarders 
[74-76].  Siberian hamsters housed in short day photoperiod (8 hours light) accumulate up to 
50% body mass (a state that would be considered morbidly obese in humans) and simultaneously 
increase the amount of food hoarded [74, 76-78].  Hence, these animals provide an ideal model 
to study ingestive behaviors in the context of obesity as they display similar changes in food 
intake, food foraging, and food hoarding as obese humans.   
Interrogating the mechanisms regulating appetitive and consummatory behaviors 
necessitates the use of a unique experimental set up in which food foraging, food hoarding, and 
food intake can be delineated.  To accomplish this, we have previously developed a novel 
foraging/hoarding apparatus consisting of a transparent foraging cage, in which food is earned 
through wheel running, and an opaque hoarding cage in which the animal sleeps and stores food 
(Fig. 1.1) [79].  In brief, a 
running wheel present in the 
top, foraging cage is fitted 
with a magnet and a magnet 
detector connected to a 
computer is placed on the 
metal cage lid.  For every 10-
wheel revolutions, a food 
pellet is dispensed and the 
animal can either 1) 
immediately consume the 
Fig. 1.1 Diagram of foraging and hoarding apparatus. 
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pellet, 2) leave the pellet in the foraging cage, or 3) take the pellet from the foraging cage 
through PVC tubing down to the bottom, hoarding cage for storage.  Wheel revolutions 
(foraging), food intake, and food hoarding is then measured daily for all animals.  Using Siberian 
hamsters and our unique foraging/hoarding apparatus, we have begun to identify a detailed 
neuroendocrine framework driving appetitive and consummatory ingestive behaviors [76-78]. 
1.3 Ghrelin Regulates Ingestive Behaviors and Metabolism 
Ghrelin is a peptide hormone released by X/A-like stomach cells, and has received 
considerable attention for its role in obesity development as it is the only known peripheral 
orexigenic signal [3, 80, 81].  Pre-pro-ghrelin is modified into its active, acylated form acyl-
ghrelin (henceforth referred to as ghrelin) by the protein ghrelin O-acyl-transferase (GOAT) [3, 
82].  Unacylated ghrelin, des-acyl-ghrelin, has limited biological functionality in the context of 
ingestive behaviors and appears to signal through an alternate mechanism than acylated ghrelin 
(for review see [83]).  Circulating ghrelin levels rise pre-prandially (i.e. during fasting) and 
decrease post-prandially, and the rise and fall of ghrelin concentrations is suggested as a 
contributor to normal energy homeostasis and overall metabolic health [84, 85].  Elevated 
ghrelin levels underlie pathologies including Prader-Willi Syndrome that are characterized by 
obesity, unrestrained feeding and hoarding of food and food-related objects indicating an 
important link between obesity and atypical ingestive behaviors [86, 87].  The marked increase 
in appetitive and consummatory behaviors following fasting corresponds with elevated plasma 
ghrelin concentrations [84, 88], and we have previously demonstrated an exogenous ghrelin 
challenge drives food foraging, hoarding, and intake in Siberian hamsters [22].  Fasting or an 
exogenous ghrelin challenge acutely increases food intake, but results in a rapid and prolonged 
increase in food hoarding behavior (5-7 days) [22].  This long-term behavioral adaptation to 
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caloric deficiency is of particular importance as it, in part, underlies the frequent weight regain 
following caloric restriction (e.g. during a diet), and understanding the mechanism through 
which long-term behavioral responses are regulated is critical for sustained weight loss.  To this 
end, there are presently several pharmacological treatments aimed at blocking either the ghrelin 
peptide directly or GOAT, the enzyme responsible for the conversion into its active, acylated 
form [82, 89].  Ghrelin blockade with a single anti-ghrelin Spiegelmer injection blocks acute 
fasting-induced ingestive behaviors but has no effect on food foraging and hoarding past 48 
hours due to compensatory increases in circulating ghrelin [90].  By contrast, blockade of ghrelin 
acylation by GO-CoA-Tat-mediated GOAT inhibition significantly decreases food intake and the 
long-term (2-3 day) increase in food hoarding following an overnight fast [91].  This sustained 
attenuation of food hoarding is notable in that GOAT inhibition persists for only 6 hours [92], 
suggesting an initial blockade of ghrelin signaling is sufficient to inhibit the chronic increases in 
appetitive behaviors following energetic challenges. 
In addition to driving ingestive behaviors, ghrelin markedly increases adiposity through 
its effects on numerous metabolic processes.  Central ghrelin administration activates key 
enzymes promoting fatty acid storage while simultaneously inhibiting fat oxidation in an SNS 
dependent manner, independent of food intake or energy expenditure [93].  Moreover, central 
ghrelin infusion inhibits glucose-stimulated insulin secretion and impairs glucose tolerance in 
healthy humans, and the ghrelin system has in turn been proposed as a possible target for 
diabetes treatment [70, 94].  The dual role of ghrelin in driving appetitive behaviors, which 
require energy expenditure, and promoting energy conservation must therefore be balanced.  A 
possible mechanism underlying this balance is the presence of multiple signaling pathways that 
mediate the discrete ingestive and metabolic effects of ghrelin.  Although this hypothesis has not 
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been directly tested, several independent studies strongly point to discrete systems regulating 
ghrelin’s effects on ingestive behaviors and metabolic processes.  Ghrelin microinjections into 
several hypothalamic nuclei including the hypothalamic arcuate nucleus (Arc) or paraventricular 
hypothalamus (PVH) are sufficient to drive food intake and decrease energy expenditure whereas 
hindbrain microinjections into the caudal brainstem are sufficient to regulate energy expenditure 
and, to a lesser extent, food intake [68, 69].  It should be noted that within the Arc, ghrelin 
activates neurons that broadly project to hindbrain nuclei and may therefore mediate energy 
expenditure through these pathways and food intake through separate projections [95].  Indeed, 
only a subset of Arc, ghrelin sensitive neuronal projections is sufficient to drive food intake, but 
the function of the remaining projections remains unclear [95]. 
1.3.1 The ghrelin receptor 
In addition to circulating ghrelin levels, fasting markedly increases expression of its 
receptor, growth hormone secretagogue receptor 1a (GHSR) [96, 97].  GHSRs are broadly 
expressed in the brain and on gastrointestinal vagal sensory neurons [98, 99], and the orexigenic 
effects of ghrelin are entirely mediated through GHSRs as exogenous ghrelin fails to induce food 
intake in rodents lacking this receptor [100, 101].  Moreover, pharmacologic activation of 
GHSRs, independent of ghrelin manipulation, markedly increase ingestive behaviors indicating 
GHSR signaling is sufficient to mediate appetitive and consummatory feeding behaviors [102].  
In line with the pharmacological approaches targeting the ghrelin peptide directly, several GHSR 
antagonists have been developed including MK-0677, L692,585, and [d-Lys3]-growth hormone-
releasing peptide-6 (Dlys), JMV2959, and [d-Arg(1),d-Phe(5),d-Trp(7, 9),Leu(11)]-substance P 
(SP-analog) [103].  Of these GHSR antagonists, JMV2959 is highly selective and has proven 
effective at reducing ghrelin- and food deprivation-induced food intake in rodents as well as 
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food-based reward behaviors [103-106].  Although GHSR antagonism is sufficient to acutely 
reduce food intake, the long-term effects of GHSR antagonist administration, the specific 
mechanisms through which this antagonism mediates its effects, and it’s potential to inhibit or 
attenuate ghrelin- or food deprivation-induced food foraging and food hoarding remains unclear. 
1.3.2 Metabolic effects of ghrelin or GHSR knockout 
Following the discovery of ghrelin by Kojima et al., several ghrelin-deficient rodent 
models have been developed.  Whole body ghrelin or ghsr deletion imparts a profoundly 
beneficial metabolic phenotype in high-fat-diet fed mice [100, 107].  As ghrelin was initially 
identified as an appetite stimulating hormone, it would be logical that ghrelin or ghsr knockout 
models would resist obesity development through decreased food intake.  However, these 
knockout mice have comparable food intake with wild type littermates, yet they have markedly 
reduced body mass on high fat diet due to increased energy expenditure and a shift toward higher 
lipid utilization [108, 109].  In addition, these mice have improved glucose disposal and insulin 
sensitivity compared with high-fat-diet fed wild type controls suggesting the absence of ghrelin 
protects against Type 2 Diabetes development [108].  The comparable food intake of ghrelin or 
ghsr deficient and wild type mice strongly suggests ghrelin is not an essential meal initiation 
hormone and supports the presence of multiple mechanisms through which ghrelin can regulate 
caloric intake and metabolic processes.  To this end, numerous central and peripheral ghrelin 
signaling pathways have been identified (see below), and deconstructing these discrete pathways 
has revealed a complex network regulating ghrelin’s effects.  Selective Arc ghsr restoration in 
otherwise ghsr-null mice restores ghrelin-induced food intake and partially regulates glycemic 
dysregulation, yet selective restoration in hindbrain Phox2b neurons is sufficient to restore 
glycemic control only [70, 110].  The sufficiency of hindbrain ghsr restoration to mediate 
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glycemic control is notable as Phox2b neurons are present in the periphery therefore suggests 
peripheral ghrelin signaling is involved in glycemic control whereas Arc signaling drives food 
intake [111, 112].  Moreover, the authors did not examine the mechanisms through which Arc 
ghrelin signaling regulates glycemia, but emerging evidence suggests these neurons act through 
downstream nuclei in the hindbrain.  In particular, the nucleus tractus solitarius (NTS) and dorsal 
motor vagus (DMV) have been recognized for their role in ghrelin-mediated energy homeostasis 
[55, 113].  These studies collectively indicate clear physiological roles for ghrelin in regulating 
body mass and adiposity, and it is increasingly evident that ghrelin’s diverse metabolic effects 
are mediated through a complex, distributed system that remains to be fully elucidated. 
1.4 Ghrelin Signals Through Discrete Central and Peripheral Pathways 
The broad central and peripheral GHSR expression evident in laboratory rodents strongly 
suggests the diverse effects of ghrelin are mediated through discrete tissues and signaling 
pathways.  In the context of obesity, neuronal ghrelin signaling is necessary for obesity 
development and glycemic dysregulation during high fat diet feeding [107].  Initial GHSR 
characterization identified the vagus nerve, which densely innervates the gastrointestinal system, 
as the primary ghrelin signaling pathway and critical for ghrelin’s metabolic effects [57, 114, 
115].  However, further studies found that a subdiaphragmatic vagotomy has no effect on 
ghrelin-induced food intake or gastric motility suggesting that either brain GHSRs or non-vagal 
sensory neurons are sufficient to mediate ghrelin’s effects independent of the vagus nerve [116, 
117 , 118, 119].  To this end, central GHSR expressing neurons have been identified in diverse 
areas including the hippocampus, ventral tegmental area, hypothalamus, and dorsal motor vagus 
(DMV), and several studies have identified non-vagal sensory neurons within the gut, likely 
emanating from DRGs, as ghrelin responsive [117, 120].  Although these studies have begun to 
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elucidate the separate and shared mechanisms through which central and peripheral GHSR 
signaling regulates energy homeostasis, it remains unclear whether sensory neurons (i.e. both 
vagal and non-vagal) are necessary for ghrelin’s effects, whether central GHSR activation is 
necessary for appetitive behaviors in addition to consummatory behaviors, and the 
central/peripheral mechanisms through which ghrelin drives acute and chronic changes in 
ingestive behaviors and peripheral metabolic processes. 
1.4.1 Ghrelin signaling in the brain 
1.4.1.1 Hypothalamic arcuate nucleus 
Numerous studies have implicated the Arc as a key regulator of metabolism and food 
intake [11, 27, 121, 122].  The Arc contains more than 50 unique neuronal populations, many of 
which are critical for food intake regulation [123-125], and it has been hypothesized as a key link 
between central and peripheral endocrine signaling due to the absence of a normal blood brain 
barrier [126].  Within the Arc, GHSRs are most strongly expressed on neurons that co-release the 
neurotransmitters agouti-related protein (AgRP) and neuropeptide Y (NPY)- AgRP neurons 
[110].  Arc ablation in adult animals blocks the orexigenic action of a peripheral ghrelin 
challenge and results in profound hypophagia leading to death [127, 128].  In the context of 
appetitive behaviors, neonatal Arc destruction in Siberian hamsters has no effect on baseline 
food foraging or food hoarding [129], yet food deprivation in these animals markedly increases 
food hoarding upon refeeding suggesting compensatory mechanisms are sufficient to maintain 
basal appetitive behaviors independent of the Arc [129].  However, it should be noted that Arc 
destruction following NPY-saporin or monosodium glutamate treatment is unable to completely 
ablate all Arc neurons [129], and recent work has demonstrated as few as 400 AgRP neurons are 
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sufficient to drive food intake in mice [95].  Therefore, even in the absence of compensatory 
mechanisms, the intact AgRP/NPY neurons not destroyed by saporin or monosodium glutamate 
may be sufficient to regulate appetitive behaviors. 
Exogenous ghrelin markedly increases AgRP/NPY expression and AgRP neuron c-Fos-
immunoreactivity (-ir), a marker of neuronal activation [122, 130], and central administration of 
AgRP and NPY significantly increases both appetitive and consummatory ingestive behaviors in 
Siberian hamsters [131-133].  The integral role of Arc AgRP ghrelin signaling is further 
supported by the findings that 1) pharmacogenetic or optogenetic AgRP neuron activation drives 
a rapid and robust food intake response [134, 135], 2) mice lacking AgRP/NPY do not increase 
food intake in response to an exogenous ghrelin challenge [136], and 3) selective reexpression of 
GHSRs on AgRP neurons in otherwise ghsr-null mice restores ghrelin’s orexigenic effects [110].  
These results collectively indicate the Arc is the primary regulator of ghrelin-induced appetitive 
and consummatory ingestive behaviors, and AgRP neurons are necessary for ghrelin’s orexigenic 
actions in adult animals.  Recent advances in neuron-specific circuit mapping has elucidated 
numerous downstream nuclei that control AgRP-induced ingestive behaviors.  Discrete 
activation of AgRP→anterior bed nucleus of the stria terminalis, AgRP→PVH, or 
AgRP→lateral hypothalamus neurons drive food intake comparable to total Arc AgRP activation 
indicating the presence of parallel pathways mediating, at the very least, food intake [95, 134].  
By contrast, AgRP→parabrachial nucleus, periaqueductal gray, or central amygdala projections 
have no effect on food intake, and may therefore regulate energy expenditure rather than food 
intake [95].   This hypothesis is supported by the findings that many of these hindbrain nuclei 
also express the GHSRs and are involved in sympathetic outflow to adipose tissues [120, 137].  
While the role of these parallel pathways in the context of energy expenditure and food foraging 
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and food hoarding remains relatively unstudied, AgRP→PVH projections have received 
considerable attention for their role in driving appetitive behaviors [28, 138-141].  Indeed, we 
have previously demonstrated the PVH is integral in regulating food foraging, food hoarding, 
and food intake in Siberian hamsters [28], and the discrete mechanism through which the PVH 
regulates these behaviors is actively being investigated. 
Although AgRP neuron activation rapidly drives food intake in satiated animals, NPY 
and AgRP peptide signaling appears to mediate ingestive behaviors through discrete temporal 
mechanisms.  Studies in mice have demonstrated that NPY promotes rapid, but transient 
increases in food intake while AgRP drives food intake in a delayed, but prolonged, manner 
[134, 142].  In Siberian hamsters, intracerebroventricular NPY results in a pronounced (~500%-
1000%), but transient (<48h), increase in ingestive behaviors whereas AgRP drives long-term 
(~7D) food hoarding to a greater extent than food intake.  The robust, delayed effects on food 
hoarding following a central AgRP challenge closely mimics the timeframe in which the 
maximal increase in food hoarding is seen following exogenous ghrelin or food deprivation [22, 
28].  It is thus likely that the long-term increases in food hoarding following food deprivation or 
a peripheral ghrelin challenge are due to AgRP signaling, and the acute increases in food intake, 
food foraging, and food hoarding are regulated by NPY.  In addition, recently developed mouse 
models allowing for real-time neuronal recording have demonstrated Arc AgRP neurons are 
rapidly modulated by sensory detection of food independent of caloric intake [143].  In a 
calorically depleted state, in which AgRP neuron activity is markedly increased relative to a 
satiated state, sensory detection of food rapidly inhibits AgRP activity (within seconds) prior to 
caloric intake [143].  This inhibition is reversed if food is removed prior to consumption 
suggesting the modulation of AgRP neurons following food presentation is a mechanism to stop 
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foraging and promote feeding.  Moreover, as hunger (and, hence, increased AgRP neuron 
activity) imparts a profoundly negative valence teaching signal [18], inhibiting AgRP neurons 
upon food discovery may be due to a learned correlation between finding food and consuming or 
storing the food for future  meals.   
1.4.1.2 Midbrain nuclei 
In addition to forebrain Arc AgRP neurons, GHSRs are strongly expressed in midbrain 
[98].  The midbrain ventral tegmental area (VTA) is recognized as a key regulator of the reward 
system and is characterized by its dense dopaminergic neuron population [144, 145].  Many of 
these dopaminergic neurons express GHSRs, and ghrelin has been proposed as a mediator of 
food-related reward and motivation [106, 146, 147].  Indeed, ghrelin microinjections into the 
VTA markedly increase sucrose self-administration and food intake [105, 148], and ablating 
VTA dopaminergic neurons blocks ghrelin's ability to elicit food-reinforced behavior [149].  In 
an evolutionary context, it is logical for ghrelin to increase the motivation to find food (i.e. 
foraging behavior) and mediate the subsequent reward signals once the food is found.  Caloric 
depletion is an inherently negative valence signal that drives an animal to search for food (see 
above), and concomitant reward circuitry activation by ghrelin would help ensure an animal 
continues to forage for food to prevent starvation.  It is notable that the VTA, unlike the Arc, is 
not recognized as a circumventricular organ exposed to circulating nutrients or endocrine signals, 
and it is therefore unclear how endogenous ghrelin activates these neurons.  To this end, ghrelin 
mRNA has been localized to periventricular neurons adjacent to the Arc that project to AgRP 
neurons [29], but whether the VTA is a downstream target of these neurons was not investigated.  
Future studies are clearly needed to elucidate the mechanism through which ghrelin activates 
VTA neurons and would provide further insight into ghrelin’s effects on the reward system. 
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1.4.1.3 Hindbrain nuclei 
GHSR-positive neurons have been identified in hindbrain nuclei including the DMV, 
NTS, and area postrema [120], and 4th ventricular ghrelin injection induces food intake and cFos 
expression in these areas [67, 68, 150].  Converging evidence suggest these hindbrain GHSR-
positive nuclei can function independently of the forebrain.  3rd ventricular ghrelin infusion is 
sufficient to drive food intake and induce hindbrain cFos, yet 4th ventricular ghrelin injections 
increase food intake but not forebrain cFos [67, 68, 150].  In addition, glutamatergic neuronal 
stimulation in the lateral hypothalamus activates NTS GHSR-positive neurons and promotes 
gastric motility [151].  Hence, current evidence suggests the presence of discrete forebrain and 
hindbrain ghrelin signaling pathways such that hypothalamic GHSR activation can elicit effects 
locally and in downstream hindbrain nuclei, but hindbrain GHSR activation may only act locally.  
To this end, GHSR restoration in hindbrain Phox2b expressing neurons is sufficient to restore 
ghrelin’s glucoregulatory, but not food intake, effects [70], but GHSR restoration in AgRP 
neurons is sufficient to partially restore both ghrelin-induced food intake and glycemic regulation 
[110].  A notable limitation of these studies is 1) Phox2b is expressed in both hindbrain and 
vagal sensory neurons which precludes specificity [111, 112], and 2) hypothalamic GHSR-
positive neurons project to hindbrain nuclei and it is therefore unclear where these effects are 
being mediated [95]. 
NTS and DMV neurons act as a critical relay between visceral stimuli and central 
integration, and crosstalk between these nuclei is sufficient to regulate neuronal efferent activity 
[152, 153].  Gastric afferents synapse in both the DMV and NTS, and GABAergic NTS neurons 
tonically inhibit DMV efferents [154-156].  Because GHSRs are distributed on multiple NTS 
neuron types including GABAergic and noradrenergic neurons [157, 158], it is likely ghrelin’s 
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discrete hindbrain effects (i.e. gastric motility or food intake) are mediated through spatially 
unique neurons and downstream targets.  Indeed, NTS GHSR-positive neurons are segregated 
and would provide a neuroanatomical basis for this functional distribution.  Caudal GHSRNTS 
neurons respond to gastric mechanostimuli whereas rostral GHSRNTS neurons respond to 
energetic challenges including fasting or HFD feeding [157].  However, the mechanism through 
which peripheral ghrelin activates or inhibits hindbrain nuclei and which hindbrain GHSR 
signaling pathways regulate specific metabolic effects remains unclear and requires additional 
studies. 
 
1.4.2 Peripheral ghrelin signaling 
The peripheral mechanisms regulating ghrelin’s effects have received considerably less 
attention compared with the central mechanisms.  Peripheral sensory neurons that innervate the 
gastrointestinal system provide a rapid signaling pathway through which viscerosensory 
information and gut endocrine signals can be relayed to the brain.  The gut is highly innervated 
by vagal and non-vagal sensory neurons emanating from DRGs, yet few studies have 
interrogated the role of ghrelin signaling in these neurons [59].  Activation of vagal sensory 
neurons that detect gastric nutrients or stretching decreases food intake [60, 61] and increases 
energy expenditure and brown adipose tissue (BAT) thermogenesis [62].  Ghrelin directly 
inhibits these vagal neurons indicating an important link between the gastrointestinal system, 
ghrelin signaling, and energy homeostasis control [57].  Enteroendocrine sensory integration can 
occur in hindbrain nuclei, such as the NTS and DMV, that regulate metabolic processing of food, 
nutrient partitioning, and behavioral outputs [159-163].  Moreover, these hindbrain nuclei project 
to, and receive projections from, numerous hypothalamic nuclei critical for ingestive behaviors 
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including the Arc and PVH [63-66].  In addition to the vagus, sensory neurons that detect gastric 
stimuli and endocrine signals also emanate from DRGs [59], and total sensory neuron ablation 
following capsaicin treatment, but not vagotomy alone, impairs cold-induced thermogenic 
responses, adipose tissue metabolism, and, at the very least, ghrelin-induced gut motility 
indicating sensory nerves are mandatory for metabolic control [119, 164, 165].  Indeed, previous 
work has suggested non-vagal sensory neurons regulate exogenous ghrelin-induced gut motility 
and decreased energy expenditure [117, 166], yet the mechanism through which these non-vagal 
sensory neurons regulate ghrelin-induced ingestive behaviors and/or metabolic homeostasis 
remains unclear.   
Previous work on peripheral ghrelin signaling has predominantly focused on gut motility 
as the peptide was initially characterized by its effects on gastric acid secretion and motility in 
humans and rodents [116, 167-169].  Fujino and colleagues demonstrated peripheral ghrelin-
induced gut motility is not affected by vagotomy alone, but this motility is blocked when ghrelin 
is co-injected with a GHSR antagonist in vagotomized animals [170, 171].  In addition, the same 
study found central GHSR antagonism had no effect on peripheral ghrelin-induced gut motility 
in either normal or vagotomized animals suggesting redundant peripheral mechanisms mediate 
ghrelin-induced gut motility independent of the brain [170].  Although peripheral ghrelin has 
clear effects on gut motility, few studies have investigated its role in regulating energy 
expenditure.  In lean humans and rodents, activation of gastric stretch or nutrient receptors 
promotes satiety [60, 172, 173], and their activity is directly enhanced by anorectic gut hormones 
including CCK and GLP-1and inhibited by ghrelin [61, 174].  in vivo auricular vagus nerve 
stimulation or intra-duodenal vagal lipid receptor activation increases sympathetic outflow and 
brown adipose tissue (BAT) thermogenesis [62, 175], a key mediator of whole-body energy 
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expenditure and adiposity [43, 176].  Currently, no studies have interrogated ghrelin’s role in 
activating or inhibiting these neurons, but the presence of GHSRs on these sensory neurons and 
the sufficiency of ghrelin to mediate their activity would suggest a role in regulating energy 
expenditure.  Discrete peripheral ghrelin signaling mechanisms that regulate metabolism 
independent of food intake is further evidenced by in vitro studies demonstrating that 1) 
exogenous ghrelin markedly increases electrically evoked cholinergic neural responses in rat 
stomach strips [117, 177], 2) GHSRs are present in a subset of guinea pig myenteric neurons 
[178], and 3) ghrelin evokes calcium efflux through GHSR activation in a subset of myenteric 
neurons [179].  These studies collectively suggest peripheral ghrelin signaling on gastrointestinal 
vagal and non-vagal sensory neurons is an important mediator of energy homeostasis. 
1.5 Dissertation Goals 
The goals of this dissertation are to target the separate and shared mechanisms through 
which ghrelin regulates metabolic homeostasis.  Our overarching question for this dissertation is: 
are there discrete mechanisms through which ghrelin regulates acute and chronic appetitive and 
consummatory ingestive behaviors, and through what mechanism does ghrelin regulate 
metabolic homeostasis independent of food intake.  We hypothesize that central ghrelin signaling 
primarily through Arc AgRP neurons is the major regulator of ingestive behaviors whereas 
peripheral ghrelin signaling regulates energy expenditure and adiposity independent of food 
intake.   
These dissertation goals were tested across three major experiments.  We first examined 
whether central or peripheral ghrelin is necessary and sufficient to regulate food foraging, food 
hoarding, and food intake using Siberian hamsters in our foraging and hoarding apparatus.  
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Hamsters were given either central or peripheral ghrelin in conjunction with a novel ghrelin 
receptor antagonist (JMV2915) and food foraging, hoarding, and intake measurements taken 
daily.  In addition, we characterized the central neuronal activity following an exogenous ghrelin 
challenge and JMV2959 administration to uncover the central nuclei involved in the behavioral 
phenotype.  We next examined the mechanisms through which central ghrelin regulates ingestive 
behavior by focusing on Arc AgRP neurons as they are necessary and sufficient for ghrelin-
induced food intake.  We tested whether Arc AgRP, but not NPY, knockdown was sufficient to 
block ghrelin- or food deprivation-induced increases in appetitive and/or consummatory 
ingestive behaviors using Siberian hamsters in our foraging and hoarding apparatus.  Finally, we 
examined the role of peripheral ghrelin signaling in regulating metabolic homeostasis using a 
GHSR-GFP transgenic mouse and by generating a novel, sensory neuron specific GHSR 
knockout mouse.  We identified the inherent function of these neurons using energetic challenges 
that increase circulating ghrelin (e.g. food deprivation) and characterized the necessity of ghrelin 
signaling on these neurons for the development of diet-induced obesity. 
Collectively, this dissertation serves as a critical step in our understanding of ghrelin and 
the mechanisms through which it regulates metabolic homeostasis.  In conjunction with previous 
research, this work provides complementary evidence to ghrelin’s role in driving food intake 
while simultaneously uncovering the mechanisms through which ghrelin regulates food foraging 
and food hoarding independent of food intake.  Moreover, this work identifies a novel 
mechanism through which peripheral ghrelin signaling regulates metabolic homeostasis through 
peripheral sensory neuron signaling.   
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2 CENTRAL GHRELIN INCREASES FOOD FORAGING/HOARDING THAT IS 
BLOCKED BY GHSR ANTAGONISM AND ATTENUATES HYPOTHALAMIC 
PARAVENTRICULAR NUCLEUS NEURONAL ACTIVATION 
2.1 Abstract 
The stomach-derived “hunger hormone” ghrelin increases in circulation in direct 
response to time since the last meal, increasing preprandially and falling immediately following 
food consumption.  We found previously that peripheral injection of ghrelin potently stimulates 
food foraging (FF), food hoarding (FH) and food intake (FI) in Siberian hamsters.  It remains, 
however, largely unknown if central ghrelin stimulation is necessary/sufficient to increase these 
behaviors regardless of peripheral stimulation of the ghrelin receptor [growth hormone 
secretagogue receptor (GHSR)].  We injected three doses (0.01 µg, 0.1 µg, and 1.0 µg) of ghrelin 
into the third ventricle (3V) of Siberian hamsters and measured changes in FF, FH, and FI.  To 
test the effects of 3V ghrelin receptor blockade, we used the potent GHSR antagonist JMV2959 
to block these behaviors in response to food deprivation or a peripheral ghrelin challenge.  
Finally, we examined neuronal activation in the arcuate nucleus (Arc) and paraventricular 
hypothalamic nucleus (PVH) in response to peripheral ghrelin administration and 3V GHSR 
antagonism.  Third ventricular ghrelin injection significantly increased FI through 24 h and FH 
through Day 4.  Pretreatment with 3V JMV2959 successfully blocked peripheral ghrelin-induced 
increases in FF, FH and FI at all time points and food deprivation-induced increases in FF, FH 
and FI up to 4h.  c-Fos-immunoreactivity was significantly reduced in the PVH, but not the Arc 
following pretreatment with i.p. JMV2959 and ghrelin.  Collectively, these data suggest central 
GHSR activation is both necessary and sufficient to increase appetitive and consummatory 
behaviors in Siberian hamsters.   
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2.2 Introduction 
Obesity is a primary health concern affecting both developed and developing countries 
worldwide with an incidence rate of 34.9% in the United States as of 2008 [1].  Comorbidities 
associated with obesity include type 2 diabetes, stroke, heart disease, and some cancers [2-7].  As 
a result of the increasing rate of obesity and its comorbidities, the health costs associated with 
treatment has reached $147 billion [8], making obesity a major health and economic burden.  
Many factors, including genetics, contribute to excess weight gain but the primary cause is a 
surplus of energy intake compared with energy expenditure.  This is compounded by the problem 
of easy access to calorically dense, cheap food as well as the ability to store more of these items 
for longer periods of time.  Thus, understanding the underlying behaviors and neuroanatomical 
pathways involved in weight gain is critical to find novel treatments. 
Appetitive behaviors include driving to/ shopping for food (foraging) and the storing 
(hoarding) of food in cupboards, refrigerators, freezers, and pantries, whereas consummatory 
behavior involves the consumption of food [9].  The research to date in the field has largely 
focused on consummatory behavior (food intake) in mice and rats, and in the process uncovered 
detailed central and peripheral pathways controlling this behavior .  Although considerable 
attention has been paid to consummatory appetitive behavior, little attention has been paid to 
appetitive behaviors such as the hoarding of food and foraging [for review see Ref. 10].  Food 
restriction and deprivation in laboratory rats and mice trigger subsequent increases in FI upon re-
exposure to food [for review see Rev.11]; by contrast, humans and hamsters, contrary to popular 
belief and personal anecdotes, instead ‘overhoard,’ storing considerably more food than normal, 
but do not overeat [12-15].  Furthermore, when faced with extended food deprivation (~24-48 h) 
humans and Siberian hamsters do not exhibit prolonged overeating.  Rather than increasing FI 
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for extended periods, humans and Siberian hamsters increase FH [12, 14, 16-21].  In both 
humans and rodents, periods of negative energy balance directly correlate with increases in 
circulating concentration of the endocrine hormone ghrelin [22-24].  Furthermore, peripheral 
administration of ghrelin mimics the substantial increases in FF, FH and FI after a 56 h food 
deprivation in Siberian hamsters [25, 26] indicating its importance in driving both appetitive and 
consummatory behaviors.   
Ghrelin acts on its receptor (GHSR) in diverse central and peripheral areas including the 
arcuate nucleus (Arc) [for review see Ref. 27], ventral tegmental area [for review see Ref. 28], 
suprachiasmatic nucleus [29, 30], paraventricular hypothalamic nucleus (PVH) [31], and vagus 
nerve [32].  Within the Arc, ghrelin activates agouti related protein (AgRP) / neuropeptide Y 
neurons to increase food intake [27, 33], and the co-administration of these peptides into the 3V 
increases FF, FH and FI in Siberian hamsters [34].  Ghrelin-sensitive neurons in the Arc project 
to diverse brain areas including the PVH [35, 36] and parabrachial nucleus [37, 38] to stimulate 
FI, and peripheral administration of ghrelin triggers c-Fos expression (a marker of neuronal 
activation [39, 40]) in these areas [30, 31].  Together these data demonstrate a varied and 
multifaceted role of ghrelin in driving appetitive and consummatory behaviors. 
The development of direct and indirect ghrelin antagonists have shed light on the 
physiological role of ghrelin in rodents.  Peripheral administration of an anti-ghrelin Spieglemer 
compound [41], as well as inhibition of ghrelin octanoylation, and thus its conversion into its 
active form [42], blocks exogenous ghrelin-induced neural activation both peripherally and 
centrally (given its route of administration peripherally) and short-term (<48 h) increases in FF, 
FI, and FH; however; long term (>48 h) appetitive and consummatory behaviors remain 
unchanged.  In addition to ghrelin-peptide antagonists, the development of the specific GHSR 
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antagonist JMV2959 [43, 44] allows for site-specific studies of ghrelin activity throughout the 
brain [45-47].  These studies have partially elucidated the role of ghrelin in Siberian hamsters 
and other rodent models, but it remains unclear if central GHSR activation is necessary and 
sufficient to drive appetitive ingestive behaviors independent of peripheral GHSR blockade.    
Here, we tested the sufficiency of 3V central ghrelin to increase FF, FI, and FH in 
Siberian hamsters.  After confirming the sufficiency of 3V ghrelin to drive these behaviors, we 
then tested the effects of 3V GHSR blockade by administering the GHSR antagonist JMV2959 
followed by: 1) a 48 h food deprivation challenge and 2) a peripheral ghrelin challenge.  Finally, 
we examined neuronal activation as seen by c-Fos immunoreactivity (-ir; [40]) in the Arc and 
PVH following peripheral ghrelin administration and 3V GHSR antagonism to further clarify 
neuronal activity from two structures implicated in driving appetitive behaviors in Siberian 
hamsters.   
2.3 Materials and Methods 
2.3.1 Animals 
Adult male Siberian hamsters (Phodopus sungorus; n = 39) were obtained from our 
breeding colony.  Hamsters were housed in same same-sex groups in polypropylene cages (48 X 
27 X 15cm), given ad libitum access to food (5001, Purina, St. Louis, MO) and water, and raised 
in a long-day photoperiod (16:8-h light-dark cycle; light offset 1800) from birth until used in the 
following experiment.  Room temperature was maintained at 21.0 ± 2.0˚C.  At ~2.5-3.0 mo, 
animals were transferred and singly housed in polypropylene cages (27.8 X 17.5 X 13.0 cm) with 
Alpha-Dri (Specialty Papers, Kalamazoo, MI) bedding and one cotton Nestlet (Ancare, Belmore, 
NY).  Animals were given ad libitum access to the experimental, pelleted test diet (DPPs, 
Purified 75 mg pellets; Bio-Serve, Frenchtown, NJ) and water and housed at 21.0 ± 2.0 ˚C with 
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50% humidity  ± 10 in 16L:8D (light offset 1300) for two weeks to acclimate to the new light 
offset.  All procedures were approved by the Georgia State University Institutional Animal Care 
and Use Committee and were in accordance with Public Health Service and United States 
Department of Agriculture guidelines.  
2.3.2 Foraging and hoarding apparatus 
Hamsters were acclimated for 1 wk before and after cannula implantation in specially 
designed foraging/hoarding set up as previously described [48].  In brief, two cages were 
connected using convoluted polyvinylchloride tubing (38.1 mm inner diameter and ~1.5 m long) 
with 3 bends containing wire mesh to allow for vertical and horizontal climbing between each 
cage.  The top, foraging cage was 456 X 234 X 200 mm (length X width X height) and equipped 
with a pellet dispenser, running wheel (524 mm circumference), and water bottle.  The bottom, 
hoarding cage was 290 X 180 X 130 mm (length X width X height) and contained Alpha-Dri 
bedding and 1 cotton Nestlet.  In order to mimic the darkness of a burrow, the hoarding cage was 
opaque and covered with an aluminum pan throughout the duration of the experiment.  Wheel 
revolutions were measured using a magnetic detection system connected to a computer with 
monitoring software (Med Associates, Georgia,VT).  Food was available ad libitum for 2 d 
following introduction to the foraging and hoarding apparatus.  Subsequent to this initial training 
period, access to food was removed and all food had to be earned (1 pellet/10 wheel revolutions) 
for 5 d, during which time wheel revolutions, FI, pellets earned (FF), food hoarding (FH), and 
body mass were measured daily.  Following 1 wk acclimation period, animals were placed back 
into cages with ad libitum access to food and further used for cannulation surgery. 
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2.3.3 Measurement of FF, FH, and FI 
 FF was defined as the number of pellets earned following completion of the 
required 10 wheel revolutions.  FH was defined as the number of pellets collected in the bottom, 
burrowing cage as well as pellets removed from cheek pouches.  FI was defined as the total 
number of pellets earned, minus the number of pellets left in the top cage and pellets hoarded.  
An electronic balance set to parts measurement was used to count pellets (75 mg = 1 pellet). All 
whole and fractions of food pellets were recovered from each cage and hamster food pouches 
daily (0900) then quantified as whole pellets using a precision balance set to ‘parts’ whereby one 
75 mg food pellet = 1 and fractions of pellets computed by the balance. FF, FH, and FI was 
measured daily at 0900 for the duration of the experiment. 
2.3.4 Cannula implantation, injections, and verification 
Cannulas were stereotaxically implanted into 3V under isoflurane (Aerrane; Baxter 
Healthcare, Deerfield, IL) with anesthesia as previously described [49].  In brief, each animal 
was anesthetized and head shaved to expose the skull.  A guide cannula (26-gauge stainless steel; 
Plastics One, Roanoke, VA) was lowered stereotaxically (coordinates: anterior-posterior from 
bregma 0 mm, medial-lateral from midsaggital sinus 0 mm, and dorsal-ventral from the top of 
the skull -5.5 mm) targeted for the 3V.  Cannula were secured to the skull using cyanoacrylate 
ester gel, 3/16 mm jeweler’s screws, and dental acrylic.  A removable dummy cannula was used 
to seal the opening of the guide cannula throughout the experiment.  Animals received ketofen (5 
mg/kg; s.c; Fort Dodge Animal Health, Fort Dodge, IA) to minimize postoperative discomfort 
and an apple slice to facilitate food and water intake for the first 2-3 days postsurgery.  Animals 
were kept in shoebox-type caging for 2 wk post-surgery for recovery. 
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One wk before each test d, each animal was lightly handled for 1 min and the dummy 
cannula removed and replaced to acclimate the animal to the injection protocol.  On test days, an 
injection cannulae (33-gauge stainless steel; Plastics One) extending 0.5 mm beyond the guide 
cannula was connected to a microsyringe via PE-20 tubing and inserted into the guide cannula.  
All hamsters were injected with 400 nl of ghrelin, JMV2959 or saline vehicle over the course of 
30 s and the injector was left in place for 30 s to minimize reflux up the sides of the cannula 
before removal as previously described [49].   
Following the last behavioral test in Experiment 3, an injection of 400 nl of bromophenol 
blue dye was given to each animal to confirm placement of the cannula in the 3V.  Animals were 
then given an overdose of pentobarbital sodium (100 mg/kg), transcardially perfused with 100 ml 
heparinized saline followed by 125 ml of 4% paraformaldehyde in phosphate buffered saline 
(PBS; pH = 7.4).  Brains were then removed and post fixed in 4% paraformaldehyde for 2 d 
followed by a 30% sucrose solution until sectioning.  Brains were sectioned on a freezing 
microtome at 80 µm and cannulae placement was verified using light microscopy.  Cannulae 
were considered a hit if blue dye was visible in any part of the ventricle and only these animals 
were included in the analysis.   
2.3.5 Experiment 1: Does 3V injection of ghrelin increase FF, FI, and FH in Siberian 
hamsters? 
Following the initial acclimation period, all hamsters were assigned to 4 groups 
counterbalanced for body mass, FI, FF, and FH levels.  On test days, animals were provided with 
a clean burrowing cage and blocked from accessing the top cage to prevent feeding 2 h before 
injections.  Animals were injected at light-offset with one of four 3V injections: 1) 0.01 µg 
ghrelin, 2) 0.1 µg ghrelin, 3) 1.0 µg ghrelin, or 4) vehicle and access to food was returned.  
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Following these injections, FI, FF (wheel revolutions), and FH was recorded at 2 h, 4 h, 24 h 
post injection and then daily for 8 d.  After a 1 wk washout period, a length of time previously 
determined to yield a return to baseline, the same protocol was repeated until each animal had 
received all 4 treatments (n = 30).   
2.3.5.1 Measurement of circulating plasma ghrelin concentrations 
To ensure 3V administered ghrelin does not cross the blood brain barrier, a separate 
cohort of 36 adult male hamsters were obtained from our breeding colony and singly housed in 
polypropylene cages with Alpha-Dri bedding and one cotton Nestlet.  Cannula were implanted as 
described above and animals were allowed to recover for two weeks with ad libitum food.  Daily 
food intake and body mass were recorded.  Following recovery, animals were counterbalanced 
for daily food intake and body mass and, finally, assigned into four groups: 1) 0.01 µg ghrelin, 2) 
0.1 µg ghrelin, 3) 1.0 µg ghrelin, or 4) vehicle.  Third ventricular injections were given at light-
offset and retro-orbital blood was taken from anesthetized animals according to our previously 
published method [42] at 2 h, 4 h, and 24 h post-injection.  Circulating acylated ghrelin 
concentrations were measured using ELISA (Mouse/Rat Acylated Ghrelin ELISA; Caymen 
Chemical) according to manufacturer’s instructions and previously published methods [50].  In 
brief, 500 µl of blood was collected using heparinized Natelson tubes, transferred to pre-chilled 
BD microtainers containing EDTA (Franklin Lakes, NJ), and inverted ten times.  Subsequently, 
300 µl of blood was immediately transferred from EDTA tubes to pre-chilled microcentrifuge 
tubes containing 300 µl of the transfer buffer (1.2 % 10 N NaOH, 2 mM p-
hydroxymercuribenzoic acid, 500 mM NaCl, and 25 mM EDTA in deionized water), mixed 
thoroughly by gentle inversion, and spun at 5,000 rpm at 4˚C for 10 min.  Next, 300 µl of plasma 
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was transferred to prechilled microcentrifuge tubes, acidified with 1 N HCl (1 µl HCl/10 µl 
plasma), spun at 5,000 rpm at 4˚C for 5 min andstored at -20˚C until assayed. 
2.3.6 Experiment 2: Does 3V injections of a GHSR antagonist JMV2959 prevent ghrelin-
induced increases in FF, FI, and FH in Siberian hamsters 
Following a 10 d washout period after the final test day of Experiment 1, animals were 
assigned to 4 new treatment groups counterbalanced for body mass, FI, FF, and FH levels.  In 
our pilot studies and based on Jerlhag et al. [51] and Skibicka et al. [51, 52], we determined that 
10 µg of the GHSR antagonist JMV2959 was effective in blocking the effects of exogenous 
ghrelin while not adversely affecting locomotor activity (M. A. Thomas and T. J. Bartness, 
unpublished observations); we thus chose this dose to use throughout the experiment.  Treatment 
groups consisted of: 1) intraperitoneal (i.p.) Saline + 3V saline, 2) i.p. saline + 3V JMV2959 (10 
µg) 3) i.p. ghrelin (30 µg/kg body mass) + 3V JMV2959 (10 µg), and 4) i.p. ghrelin (30 µg/kg 
body weight) + 3V saline.  On test days, animals were provided with a clean burrowing cage and 
prevented from accessing the top cage in the same manner as Experiment 1.  All injections were 
given concurrently at light-offset and access to food returned.  Following these injections, FI, FF, 
and FH was recorded at 2 h, 4 h, 24 h, and then daily for 8 d.  Following a 1 wk washout period, 
the same injection protocol was repeated until each animal had received all treatments (n=20). 
2.3.7 Experiment 3: Does 3V injections of a GHSR antagonist block food deprivation-
induced increases in FF, FI, and FH? 
Following a 10 d washout period after the final test day of Experiment 2, animals were 
divided into 2 groups counterbalanced for body mass, FI, FF, and FH levels.  Treatment groups 
consisted of 1) 3V saline and 2) 3V JMV3959 (10 µg).  Animals received injections of either 
saline or JMV2959 at the onset of food deprivation (time (T) = 0), T + 24 h, and T + 48 h.  
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Following the final injection, access to food was returned and FF, FI, and FH were recorded at 2 
h, 4 h, 24 h, and then daily until animals returned to behavioral baseline.  After returning to 
baseline, animals were transferred to shoebox cages and brain tissue was processed as above to 
verify cannulae location (n=20).   
2.3.8 Experiment 4: Does 3V injection of a GHSR antagonist prevent ghrelin-induced 
increases in c-Fos expression? 
Twenty Siberian hamsters were selected from the breeding colony and housed 
individually in shoebox cages before and after 3V cannula implantation.  A separate, age-
matched cohort of animals was used for Experiment 4 due to the within-subject design of 
Experiments 1, 2, and 3 not allowing for unconfounded test of neural activation.  Animals were 
divided into 4 treatment groups: 1) i.p. saline + 3V saline, 2) i.p. saline + 3V JMV2959 (10 µg), 
3) i.p. ghrelin (30 µg/ kg body mass) + 3V saline, and 4) i.p. ghrelin (30 µg/ kg body mass) + 3V 
JMV2959 (10 µg).  Animals were injected at light offset and perfused 2 h later.  This time point 
was chosen because preliminary data showed the largest increases in FF, FI and FH occurring 
between 2-4 h [25, 41].  Brains were sectioned at 40 µm on a freezing microtome.  For 
immunohistochemistry, free-floating brain sections were rinsed in 0.1 M PBS (2 x 15 min) 
followed by 30 min incubation in a blocking and permiablization solution consisting of 10.0 % 
normal goat serum (NGS) and 0.3 % Triton X-100 in 0.1 M PBS.  Sections were incubated 
overnight with rabbit anti-c-Fos antiserum (1:800; sc-52, Santa Cruz Biotechnology, Santa Cruz, 
CA) in 0.1 M PBS with 0.5 % NGS.  For immunohistological controls, the primary antibody was 
either omitted or preadsorbed with the immunizing peptide overnight at 4 °C resulting in 
abolished immunostaining.  Subsequently, sections were washed in 0.1 M PBS (2 x 15 min) and 
incubated with biotinylated goat anti-rabbit antibody (1:200; Vector Laboratories, Burlingame, 
32 
CA, USA) for 2 h.  Bound secondary antibody was then amplified with the Vector Elite ABC kit 
(1:800; Vector Laboratories, Burlingame, CA, USA) and antibody complexes were visualized by 
0.05 % diaminobenzidine reaction.  After mounting, sections were dehydrated and cleared 
through a series of ethanol, isopropanol and xylene solutions. Cleared slides were immediately 
mounted with Permount (Thermo Fisher Scientific, Waltham, MA, USA) and cover slipped.     
2.3.9 Quantitative and statistical analysis 
Images were viewed and captured using 100x and 200x magnification with an Olympus 
DP73 imaging photomicroscope (Olympus, Tokyo, Japan).  The PVH- and Arc-c-Fos-ir images 
were evaluated with the aid of CellSens (Olympus) and the Adobe Photoshop CS5 (Adobe 
Systems, San Jose, CA) software.  The Arc and PVH were chosen for quantification because 
previous studies showed increased neuronal activity in these areas in response to ghrelin [41, 53]. 
The c-Fos-ir neurons were considered positively labeled based on the nuclei size and shape.  
Exhaustive counts of c-Fos positive neurons at the same anatomical level in all animals were 
then averaged across all animals within each experimental group.  A mouse brain atlas [Paxinos 
and Franklin, 2007] was used to identify brain areas because no Siberian hamster brain atlas is 
available and because of the similarity in size and shape of most of the brain structures between 
Siberian hamsters and mice that are much more similar than the commercially available Syrian 
hamster stereotaxic atlas.  For the preparation of the photomicrographs, we used Adobe 
Photoshop CS5 (Adobe Systems) only to adjust the brightness and contrast, and to remove 
artifactual obstacles (i.e., obscuring bubbles) to make the composite plates. 
In Experiment 1 and 2, raw behavioral data for each individual animal were transformed 
into percent change from saline control before statistical analysis according to the formula: [((X-
vehicle)/vehicle) x 100], where X is equal to the measured value in response to experimental 
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treatment and vehicle is equal to the value measured for the individual following control 
injection (Experiment 1 = 3V saline; Experiment 2 = IP saline + 3V saline).  Thus, each animal 
serves as its own control and data are reported as a percent change from baseline measurements.  
No statistical comparisons were made across the time intervals due to the unequal duration of the 
intervals.  Behavioral data were analyzed using one-way repeated measures ANOVA across all 
treatments within each time point followed by the post-hoc Bonferroni’s test using NCSS 
(version 2009, Kaysville, UT).  For all measures of foraging, intake, and hoarding in Experiment 
1 and Experiment 2, data were reported as the mean percent difference from vehicle control 
(100%) ± SEM.  Circulating acyl-ghrelin concentrations in experiment 1 were analyzed using 
one-way ANOVA at each time point.  For Experiment 3, data were not transformed into percent 
change because animals were only food deprived once and, therefore, cannot serve as their own 
control because Siberian hamsters do not overeat after food deprivation and therefore take weeks 
to return to their initial body mass readily.  Raw data for FF, FI, and FH were analyzed using 
Mann-Whitney U test.  For Experiment 4, c-Fos-ir for all groups was analyzed using one-way 
ANOVA.  Exact probabilities and test values were omitted for simplicity and clarity of 
presentation.  Differences were considered statistically significant if P < 0.05.     
2.4 Results 
2.4.1 Experiment 1: Does 3V injection of ghrelin increase FF, FI, and FH? 
2.4.1.1 FF 
No significant increase in FF was seen across all three doses of 3V ghrelin at all time 
points examined compared with saline controls (Fig. 2.1A).  A trend of increased FF was 
observed at the 2-4 h post injection for both 0.1 µg and 1.0 µg ghrelin doses, but only reached a 
maximum increase of ~160 % compared with saline (P = 0.10; Fig. 2.1A). 
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2.4.1.2 FI 
FI was significantly increased by ~200% of control at 2-4 h post injection for the 1.0 µg 
ghrelin dose (P < 0.05 vs. 3V Saline; Fig. 2.1B).  No significant increase was seen for 3V 
injection of either the 0.01 µg or 0.1 µg ghrelin doses at any time point examined (Fig. 2.1B).   
2.4.1.3 FH 
3V ghrelin significantly increased FH at 0-2 h through Day 4 for the 1.0 µg dose (P < 
0.05 vs. 3V Saline; Fig. 2.1C).  FH reached a maximum of ~600% following 1 µg ghrelin 
compared with control values at 48 h post injection and gradually declined to baseline at Day 5.  
0.1 µg ghrelin significantly increased FH at 2-4 h and Day 3, reaching a maximum increase of 
~400% (P < 0.05 vs. 3V Saline; Fig. 2.1C).  No increase was observed at any time point for the 
0.01 µg ghrelin dose (Fig. 2.1C) compared with the saline control.   
2.4.1.4 Circulating acyl-ghrelin concentrations 
To ensure 3V administered ghrelin was not crossing the blood brain barrier, we repeated 
experiment 1 and measured peripheral circulating acyl-ghrelin concentrations at 2 h, 4 h, and 24 
h post-injection.  No dose of 3V administered ghrelin significantly affected peripheral circulating 
acyl-ghrelin concentrations at any time point examined (Fig. 2.2). 
2.4.2 Experiment 2: Does 3V injection of a GHSR antagonist JMV2959 prevent peripheral 
ghrelin-induced increases in FF, FI, and FH in Siberian hamsters? 
2.4.2.1 FF 
FF was significantly increased at the 4-24 h time point for the IP ghrelin + 3V saline 
group (P < 0.05 vs. IP Saline + 3V Saline; Fig. 2.3A) by ~350% compared with the control 
group.  Foraging was attenuated at the 4-24 h time point in animals receiving IP ghrelin + 3V 
JMV2959 treatment, reaching a maximum of ~200% compared with saline (P = 0.28; Fig. 2.3A).  
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No change from the control treatment was seen across all time points in animals receiving IP 
saline + 3V JMV2959 (Fig. 2.3A).  Foraging returned to baseline at 48 h for all groups (Fig. 
2.3A). 
2.4.2.2 FI 
FI was significantly increased by ~200% of control at the 0-2 h time point for animals 
receiving IP ghrelin + 3V saline (P < 0.05 vs. IP Saline + 3V Saline; Fig. 2.3B).  FI was 
attenuated at 0-2 h and 2-4 h following IP ghrelin + 3V JMV2959 treatment and reached a 
maximum of ~160% at 4-24 h (P < 0.05 vs. IP Saline + 3V Saline). No change in pellets eaten 
was observed following IP saline + 3V JMV2959 treatment (Fig. 2.3B).   
2.4.2.3 FH 
Pellets hoarded were significantly increased at all time points, except for 48 hs, examined 
through Day 5 in animals receiving IP ghrelin + 3V saline (P < 0.05 vs. IP Saline + 3V Saline; 
Fig. 2.3C), and reaching a maximum of ~400% at Day 5.  FH was attenuated in animals 
receiving IP ghrelin + 3V JMV2959 treatment at all time points and reaching a maximum of 
~200% at Day 5; however, without statistical significance (P = 0.16; Fig. 2.3C).  No change in 
pellets hoarded was observed for the IP saline + 3V JMV2959 treatment group at all time points.   
2.4.3 Experiment 3: Does 3V injection of a GHSR antagonist block food deprivation-induced 
increases in FF, FI, and FH in Siberian hamsters? 
2.4.3.1 FF 
FF was significantly decreased in animals receiving 3V JMV2959 0-2 h and 2-4 h time 
points post injection compared with 3V saline control (P < 0.05; Fig. 2.4A).  No difference was 
observed between the two groups 4-24 h or 48 h post injection (Fig. 2.4A).   
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2.4.3.2 FI 
Pellets eaten was significantly decreased in animals receiving 3V JMV2959 at 0-2 h post 
injection compared with 3V saline control (P < 0.05; Fig. 2.4B).  No difference in pellets eaten 
was observed 2-4 h, 4-24 h, and 48 h post injection (Fig. 2.4B).   
2.4.3.3 FH 
FH was significantly decreased in animals receiving 3V JMV2959 0-2 h and 2-4 h post 
injection compared with 3V saline control (P < 0.05; Fig. 2.4C).  No difference in pellets 
hoarded was observed at the 4-24 h through Day 7 for both groups (Fig. 2.4C).  Animals 
receiving 3V JMV2959 displayed a trend of increased food hoarding following the 48 h time 
point, although never reaching statistical significance (Fig. 2.4C).  
2.4.4 Experiment 4: Does 3V injection of a GHSR antagonist prevent ghrelin-induced 
increases in c-Fos expression? 
IP ghrelin significantly increased c-Fos-ir in the Arc compared with IP saline controls (P 
< 0.05; Fig. 2.5A, c); however, 3V JMV2959 failed to block ghrelin-induced Arc neuronal 
activation (Fig. 2.5A, d).  IP ghrelin (30 µg/kg body weight) + 3V saline significantly increased 
c-Fos-ir in the PVH (P < 0.05; Fig. 2.5B, g) 2 h postinjection compared with IP saline and 
JMV2959 blocked this effect (P < 0.05; Fig. 2.5B, h).   
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Fig. 2.1 3V ghrelin drives FF, FI, and FH. 
Mean ± SE % difference in FF (A), FI (B), and FH (C) in response to 3V injection of 
0.01 µg ghrelin (white bars), 0.1 µg ghrelin (grey bars), or 1.0 µg ghrelin (black bars).  
*p<0.05 compared with saline controls; n = 30 for each group. 
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Fig. 2.2 3V ghrelin has no effect on plasma ghrelin concentrations. 
Mean ± SE of plasma acyl-ghrelin concentrations in animals receiving 3V injection of 
saline (white bars), 0.01 µg ghrelin (white, crossed bars), 0.1 µg ghrelin (grey bars), or 
1.0 µg ghrelin (black bars).  n= 9 for each group. 
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Fig. 2.3 Central GHSR antagonism blocks peripheral ghrelin-induced FF, FI, and FH. 
Mean ± SE % difference in FF (A), FI (B), and FH (C) in response to i.p. saline + 10 µg 
3V JMV2959 (white bars), 30 µg/kg i.p. ghrelin + 10 µg 3V JMV2959 (grey bars), or 30 
µg/kg i.p. ghrelin + 3V saline (black bars).  *p<0.05 compared with i.p. saline + 3V 
saline controls; n = 21 for each group. 
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Fig. 2.4 Central GHSR antagonism blocks food deprivation-induced FF, FI, and FH. 
Mean ± SE number of wheel revolutions (A), pellets eaten (B), and pellets hoarded (C) 
following 48 h food deprivation and 3V injection of saline (white bars) or JMV2959 
(black bars). *p<0.05 compared with saline control; n = 10 for each group. 
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Fig. 2.5 Central GHSR antagonism blocks peripheral ghrelin-induced c-Fos in the PVH. 
Mean ± SE number of c-Fos-ir cells and representative photographs in the Arc (A, a-d) 
and the PVH (B, e-h) in response to i.p. saline + 3V saline (a, e), i.p. saline + 10 µg 3V 
JMV2959 (b, f), 30 µg/kg i.p. ghrelin + 3V saline (c,g), or 30 µg/kg i.p. ghrelin + 10 µg 
3V JMV2959 (d,h).  *p<0.05 compared with i.p. saline + 3V saline controls; Scale bar= 
100 µm.  n = 5 for each group. 
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2.5 Discussion 
The current study was designed to test the sufficiency and necessity of central and 
peripheral GHSR activation to increase appetitive and consummatory behaviors in Siberian 
hamsters.  Similar to previous reports in laboratory mice and rats [26, 54-56], 3V administration 
of ghrelin was sufficient to increase FI in ad libitum fed Siberian hamsters.  We showed here for 
the first time however that 3V ghrelin is sufficient to increase appetitive and consummatory 
behaviors independent of peripheral GSHR stimulation/blockade.  We next tested the hypothesis 
that central GHSR activation mediates the appetitive and consummatory response to peripheral 
ghrelin.  The GHSR antagonist JMV2959 successfully blocked exogenous ghrelin-induced 
increases in FF, FI and attenuated FH from the first time point measured post injection (2 h) 
through the end of the study (8 d).  To further elucidate the neuronal mechanism underlying this 
effect, we measured c-Fos-ir in the Arc and PVH following administration of 3V JMV2959 and 
i.p. ghrelin.  Pretreatment with JMV2959 significantly decreased c-Fos positive cells in the PVH 
but not in the Arc following a peripheral ghrelin challenge, suggesting peripheral ghrelin-
induced increases in FF, FI and FH are mediated by neuronal activity in the PVH rather than the 
Arc.   
In line with previous experiments testing the effects of peripheral ghrelin, 3V ghrelin 
potently stimulated both appetitive and consummatory behaviors in Siberian hamsters.  By 
contrast to i.p. injections [25, 41], 3V administration circumvents possible peripherally mediated 
mechanisms driving appetitive and consummatory behavior.  For instance, activation of the 
stomach-vagal-hindbrain-midbrain axis [32, 57, 58] increases FI whereas 3V administration 
prevents peripheral GHSR involvement.  3V ghrelin potently stimulated FF, FI, and FH for both 
0.1 µg and 1.0 µg (Fig. 2.1A-C).  Furthermore, 3V ghrelin administration closely mimicked the 
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drastic increases in FH observed following i.p. injection reaching an apex of ~600% (Fig. 2.1C).  
We thus hypothesize that centrally mediated ghrelin activity is sufficient to induce appetitive and 
consummatory behaviors independent of peripheral GHSR stimulation/blockade.  This is further 
supported by our finding that 3V ghrelin does not significantly affect peripheral circulating 
ghrelin concentrations and indicates 3V ghrelin does not cross the blood brain barrier.  The 
marked increase in ghrelin plasma concentration following an exogenous ghrelin challenge or 
prolonged food deprivation activates peripheral and central GHSRs and markedly increases FF, 
FI, and FH [25]; however, by circumventing peripheral GHSR involvement we have for the first 
time directly examined the discrete role of central GHSR activation in driving appetitive and 
consummatory behaviors in Siberian hamsters.  The central and peripheral distribution of 
GHSRs suggests the effects of ghrelin are mediated by a number of distinct areas [59].  
Furthermore, our findings here that 3V ghrelin markedly increases FF, FI, and FH independent 
of peripheral GHSR activation further supports the presence of multiple, redundant systems 
mediating appetitive and consummatory behaviors [60].  Overall, we demonstrated that 3V 
ghrelin is sufficient to increase both appetitive and consummatory behaviors independent of 
peripheral GHSR1a activation. 
Our previous tests on the necessity of ghrelin focused on peripheral mechanisms to block 
ghrelin directly [41] or prevent its conversion into its physiological active form [42] without 
directly blocking its receptor.  We therefore tested the necessity of central GHSR activation to 
increase FF, FI, and FH in response to a peripheral ghrelin challenge using the potent GHSR 
antagonist JMV2959.  JMV2959 administration attenuates FI [61] and ghrelin-induced operant 
responding for food reward in rodents [45].  Here, 3V injection of JMV2959 abolished the 
ghrelin-induced increases in both appetitive and consummatory behavior at all time points 
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examined (Fig. 2.3A-C).  Furthermore, 3V JMV2959 + IP saline did not affect FF compared 
with 3V saline + IP saline indicating the blockade of FF, FI and FH is not due to non-specific 
effects on locomotor activity.  The inhibition observed following central GHSR antagonism is in 
contrast to previous work with Siberian hamsters attempting to block the appetitive and 
consummatory effects of exogenous ghrelin, both directly and indirectly [41, 42, 62, 63], in that 
there was a complete blockade of both appetitive and consummatory behaviors throughout the 
duration of the experiment.  Furthermore, direct 3V administration of JMV2959 circumvents 
peripheral GHSR manipulation and therefore directly tests the discrete role of central GHSR 
activation.  The blockade of appetitive behaviors in response to a peripheral ghrelin challenge 
suggests central GHSR activation is integral for these effects and could in turn be a more useful 
clinical treatment option if the mechanism for this complete blockade could be discerned.  It 
remains unclear however the exact ghrelin-dependent pathway being inhibited as 3V 
administration of JMV2959 blocks GHSR activation throughout the brain and future studies are 
needed to delineate the precise pathways driving appetitive and consummatory behaviors.  We 
have collectively demonstrated for the first time that central GHSR activation is integral in 
driving appetitive and consummatory behaviors in Siberian hamsters.   
To further examine the ability of JMV2959 to block ghrelin-induced increases in 
appetitive and consummatory behaviors, we chronically injected JMV2959 throughout a 48 h 
food deprivation, which has previously been shown to potently increase FF, FI and FH and 
circulating ghrelin levels in Siberian hamsters [18, 19, 64-66].  We chose to repeatedly inject 
JMV2959 in 12 h increments to block GHSR activation throughout food deprivation in line with 
previous experiments [41] because ghrelin is continuously released in response to the negative 
energy balance that would occur during the 48 h food deprivation.  3V treatment with JMV2959 
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blocked FF and FI through 2 h and FH through 4 h post refeeding (Fig. 2.4A-C).  By contrast to 
a single peripheral ghrelin challenge, food deprivation chronically increases circulating ghrelin 
concentrations.  In turn, acute GHSR antagonism is able to block exogenous ghrelin, but not food 
deprivation-induced increases in both long-term appetitive and consummatory behaviors.  These 
data suggest that JMV2959 blocks the effects of ghrelin throughout food deprivation, but once its 
effectiveness is diminished the food deprivation-induced circulating ghrelin begins to drive the 
appetitive ingestive behaviors.  Taken together, Experiment 2 and Experiment 3 demonstrate that 
central activation of GHSR is necessary for exogenous ghrelin-induced increases in FF, FI, and 
FH, but not for long-term food deprivation-induced increases.  This result supports previous 
reports suggesting ghrelin is integral in food deprivation increases in appetitive behavior, but not 
necessary due to the abundance of other physiological mechanisms compensating in its absence , 
that is the multiple redundant systems driving ingestive behaviors [60, 67].   
In order to determine brain areas involved in ghrelin-induced changes in appetitive and 
consummatory behaviors in a preliminary examination, c-Fos-ir in the Arc and PVH was 
quantified following exogenous ghrelin treatment and 3V administration of JMV2959.  We 
chose these areas due to previous work indicating significantly increased neuronal activity 
following peripheral ghrelin injection [41, 53].  Here, and in previous reports, exogenous ghrelin 
potently increased FI and FH 0-4 h post injection [25, 41, 62].  We therefore examined c-Fos-ir 
in the Arc and PVH at 2 h following identical treatments as in Experiment 2.  Increased c-Fos-ir 
in response to exogenous ghrelin was observed in the Arc and PVH 2 h postinjection in line with 
previous reports [31, 41, 68].  Pretreatment with JMV2959 blocked neuronal activation in the 
PVH following exogenous ghrelin, but, interestingly, the Arc was unaffected (Fig. 2.5A-B).  
Approximately 94% of AgRP neurons express GHSRs [69] and exogenous ghrelin markedly 
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increases AgRP/NPY expression [70].  Moreover, subthreshold injection of AgRP and NPY 
increases FF, FI, and FH in Siberian hamsters [34].  AgRP neurons project to a number of 
downstream nuclei including the PVH [35, 71], where it antagonizes melanocortin receptors 3 
and 4 (MC3R and MC4R) to promote food intake.  In addition, AgRP neurons directly inhibit 
neighboring POMC neurons [72, 73].  As GHSR antagonism predominantly affects AgRP 
neurons, one potential explanation for our finding is GHSR blockade disinhibits POMC neurons 
and in turn, ghrelin-induced c-Fos-ir is comparable in the Arc regardless of GHSR antagonism.    
GHSR antagonism may therefore attenuate ghrelin-induced FF, FI, and FH through blockade of 
AgRP  PVH neuron signaling, and thereby inhibit PVH c-Fos-ir, while other Arc neurons 
remain active.  However, as the identity of these c-Fos-positive neurons remains a mystery, we 
can only speculate as to the reasoning for this finding.  
Ghrelin acts primarily in the Arc to promote food intake [56, 59]; however, GHSRs are 
expressed in a number of brain nuclei including the PVH [59].  We hypothesize however that 
GHSR blockade attenuates FF, FI, and FH in an Arc-dependent manner based on the following 
data: 1) peripheral ghrelin administration markedly increases Arc AgRP expression and these 
neurons project to the PVH [53, 72, 74], 2) Complete Arc or NPY neuron ablation markedly 
decreases both central and peripheral ghrelin-induced food intake [75, 76] indicating Arc 
activation mediates ghrelin-induced food intake, and 3) photostimulation of AgRP neurons 
markedly increases food intake [37, 77] whereas concurrent AgRP photostimulation and AgRP 
 PVH chemoinhibition attenuates this increase [37] indicating AgRP  PVH activation 
primarily drives food intake. Collectively, these data indicate the inhibition of PVH neuronal 
activity here is due to downstream effects of Arc GHSR blockade.  Based on behavioral results 
in Experiment 2, we hypothesize that peripheral ghrelin may increase appetitive behaviors in the 
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very least in a PVH-involved mechanism and GHSR blockade attenuates ghrelin-induced 
neuronal activity of PVH inputs.  It remains unclear, however, if PVH activity is in response to 
hindbrain activity (or vice versa), other brain areas, or both and future experiments will expand 
on this question.  We are aware of the circumstantial evidence provided by c-Fos-ir in that the 
absence of neuronal activity in the PVH does not necessarily indicate the absence of activity as 
some neurons use other immediate-early genes [40].  We therefore interpret these findings as 
being suggestive of a possible PVH involved mechanism driving appetitive behaviors in Siberian 
hamsters.   
 These data collectively indicate central activation of GHSR by exogenous ghrelin 
is integral in driving appetitive and consummatory behaviors in Siberian hamsters.  In addition, 
central GHSR antagonism is able to block food deprivation-induced short term increases in 
appetitive behaviors, but not long term due to the continued release of ghrelin (e.g., food 
deprivation).  The blockade of appetitive behaviors in response to GHSR antagonism and a 
peripheral ghrelin challenge appear to involve the PVH which receives projections from a 
number of discrete brain areas including the Arc.  Although GHSR antagonism successfully 
blocked ghrelin-induced increases in appetitive and consummatory behaviors, future studies are 
needed to delineate the precise pathways involved. 
2.6 Perspective and Significance  
 Understanding the complex relationship of central integration of peripheral satiety 
signals is an important step in the development of clinically useful obesity treatment options.  
We have developed a novel model to study human food foraging and food hoarding, a relatively 
unstudied facet of obesity, in Siberian hamsters.  Here, we show for the first time central 
blockade of GHSRs prevents the marked increase in both short-term and long-term food 
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foraging, food hoarding, and food intake following a peripheral ghrelin challenge.  In addition, 
we show for the first time this blockade prevents neuronal activation of the PVH, but not the 
Arc, suggesting PVH activity is integral in driving both appetitive and consummatory behaviors.   
2.7 Acknowledgements 
This work is dedicated to the memory of our friend and mentor, Dr. Timothy J. Bartness.  
The authors would like to thank Babette Aicher (AeternaZentaris, Inc) for the GHSR antagonist 
JMV2959, and Johnny Garretson and Fardowsa Robow for their continued help in data 
collection. 
2.8 Disclosures 
The authors have nothing to disclose. 
2.9 References 
[1] Ogden, C. L., Carroll, M. D. Prevalence of Overweight, Obesity, and Extreme Obesity 
Among Adults: United States, Trends 1960-1962 Through 2007-2008. 2010. 
[2] Calle, E. E., Rodriguez, C., Walker-Thurmond, K., Thun, M. J. Overweight, obesity, and 
mortality from cancer in a prospectively studied cohort of U.S. adults. N.Engl.J Med. 
2003,348:1625-38. 
[3] Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., et 
al. Guidelines for the primary prevention of stroke: a guideline for healthcare 
professionals from the American Heart Association/American Stroke Association. Stroke. 
2011,42:517-84. 
[4] Harvey, A. E., Lashinger, L. M., Hursting, S. D. The growing challenge of obesity and 
cancer: an inflammatory issue. Ann.N.Y.Acad.Sci. 2011,1229:45-52. 
[5] Rao, G. H., Thethi, I., Fareed, J. Vascular disease: obesity and excess weight as modulators 
of risk. Expert.Rev.Cardiovasc.Ther. 2011,9:525-34. 
[6] Vague, J., Vague, P., Tramoni, M., Vialettes, B., Mercier, P. Obesity and diabetes. Acta 
Diabetol.Lat. 1980,17:87-99. 
[7] Zalesin, K. C., Franklin, B. A., Miller, W. M., Peterson, E. D., McCullough, P. A. Impact of 
obesity on cardiovascular disease. Med.Clin.North Am. 2011,95:919-37. 
49 
[8] Finkelstein, E. A., Trogdon, J. G., Cohen, J. W., Dietz, W. Annual medical spending 
attributable to obesity: payer-and service-specific estimates. Health Aff.(Millwood.). 
2009,28:822-31. 
[9] Craig, W. Appetites and aversions as constituents of instincts. Biol.Bull. 1918,34:91-107. 
[10] Bartness, T. J., Demas, G. E. Comparative studies of food intake: Lessons from non-
traditionally studied species. In: Stricker EM, Woods SC, eds. Food and Fluid Intake. 
New York: Plenum; 2004. p. 423-67. 
[11] Bartness, T. J., Day, D. E. Food hoarding: a quintessential anticipatory appetitive behavior. 
Progress in Psychobiology and Physiological Psychology. 2003,18:69-100. 
[12] Dodd, D. K., Stalling, R. B., Bedell, J. Grocery purchases as a function of obesity and 
assumed food deprivation. Int.J Obes. 1977,1:43-7. 
[13] Hetherington, M. M., Stoner, S. A., Andersen, A. E., Rolls, B. J. Effects of acute food 
deprivation on eating behavior in eating disorders. Int.J Eat.Disord. 2000,28:272-83. 
[14] Mela, D. J., Aaron, J. I., Gatenby, S. J. Relationships of consumer characteristics and food 
deprivation to food purchasing behavior. Physiol Behav. 1996,60:1331-5. 
[15] Levitsky, D. A., DeRosimo, L. One day of food restriction does not result in an increase in 
subsequent daily food intake in humans. Physiol Behav. 2010,99:495-9. 
[16] Bartness, T. J., Keen-Rhinehart, E., Dailey, M. J., Teubner, B. J. Neural and hormonal 
control of food hoarding. Am.J Physiol. 2011,301:R641-R55. 
[17] Beneke, W. M., Davis, C. H. Relationship of hunger, use of a shopping list and obesity to 
food purchases. Int.J.Obes. 1985,9:391-9. 
[18] Wood, A. D., Bartness, T. J. Food deprivation-induced increases in hoarding by Siberian 
hamsters are not photoperiod-dependent. Physiol Behav. 1996,60:1137-45. 
[19] Bartness, T. J., Clein, M. R. Effects of food deprivation and restriction, and metabolic 
blockers on food hoarding in Siberian hamsters. Am.J.Physiol. 1994,266:R1111-R7. 
[20] Day, D. E., Bartness, T. J. Fasting-induced increases in hoarding are dependent on the 
foraging effort level. Physiology and Behavior. 2003,78:655-68. 
[21] Garretson, J. T., Bartness, T. J. Dynamic modification of hoarding in response to hoard size 
manipulation. Physiol Behav. 2014,127:8-12. 
[22] Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K. Ghrelin is a 
growth-hormone-releasing acylated peptide from stomach. Nature. 1999,402:656-60. 
50 
[23] Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., et al. 
Ghrelin enhances appetite and increases food intake in humans. J.Clin.Endocrinol.Metab. 
2001,86:5992. 
[24] Toshinai, K., Mondal, M. S., Nakazato, M., Date, Y., Murakami, N., Kojima, M., et al. 
Upregulation of ghrelin expression in the stomach upon fasting, insulin- induced 
hypoglycemia, and leptin administration. Biochemical and Biophysical Research 
Communications. 2001,281:1220-5. 
[25] Keen-Rhinehart, E., Bartness, T. J. Peripheral ghrelin injections stimulate food intake, 
foraging and food hoarding in Siberian hamsters. Am.J.Physiol. 2005,288:R716-R22. 
[26] Tschop, M., Smiley, D. L., Heiman, M. L. Ghrelin induces adiposity in rodents. Nature. 
2000,407:908-13. 
[27] Andrews, Z. B. Central mechanisms involved in the orexigenic actions of ghrelin. Peptides. 
2011,32:2248-55. 
[28] Dickson, S. L., Egecioglu, E., Landgren, S., Skibicka, K. P., Engel, J. A., Jerlhag, E. The 
role of the central ghrelin system in reward from food and chemical drugs. Mol.Cell 
Endocrinol. 2011,340:80-7. 
[29] Yannielli, P. C., Molyneux, P. C., Harrington, M. E., Golombek, D. A. Ghrelin effects on 
the circadian system of mice. J Neurosci. 2007,27:2890-5. 
[30] Bradley, S. P., Pattullo, L. M., Patel, P. N., Prendergast, B. J. Photoperiodic regulation of 
the orexigenic effects of ghrelin in Siberian hamsters. Hormones and Behavior. 
2010,58:647-52. 
[31] Kobelt, P., Wisser, A. S., Stengel, A., Goebel, M., Inhoff, T., Noetzel, S., et al. Peripheral 
injection of ghrelin induces Fos expression in the dorsomedial hypothalamic nucleus in 
rats. Brain Res. 2008,1204:77-86. 
[32] Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Matsuo, H., et al. The 
role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone 
secretion in rats. Gastroenterology. 2002,123:1120-8. 
[33] Bradley, S. P., Pattullo, L. M., Patel, P. N., Prendergast, B. J. Photoperiodic regulation of 
the orexigenic effects of ghrelin in Siberian hamsters. Horm.Behav. 2010. 
[34] Teubner, B. J., Keen-Rhinehart, E., Bartness, T. J. Third ventricular coinjection of 
subthreshold doses of NPY and AgRP stimulate food hoarding and intake and neural 
activation. Am.J.Physiol Regul.Integr.Comp Physiol. 2012,302:R37-R48. 
[35] Cowley, M. A., Pronchuk, N., Fan, W., Dinulescu, D. M., Colmers, W. F., Cone, R. D. 
Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular 
nucleus: evidence of a cellular basis for the adipostat. Neuron. 1999,24:155-63. 
51 
[36] Krashes, M. J., Shah, B. P., Madara, J. C., Olson, D. P., Strochlic, D. E., Garfield, A. S., et 
al. An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. 
Nature. 2014,507:238-42. 
[37] Wu, Q., Boyle, M. P., Palmiter, R. D. Loss of GABAergic signaling by AgRP neurons to 
the parabrachial nucleus leads to starvation. Cell. 2009,137:1225-34. 
[38] Wu, Q., Palmiter, R. D. GABAergic signaling by AgRP neurons prevents anorexia via a 
melanocortin-independent mechanism. Eur.J Pharmacol. 2011,660:21-7. 
[39] Verbalis, J. G., Stricker, E. M., Robinson, A. G., Hoffman, G. E. Cholecystokinin activates 
cFos expression in hypothalamic oxytocin and corticotropin releasing hormone neurons. 
Journal of Neuroendocrinology. 1991,3:205-13. 
[40] Hoffman, G. E., Smith, M. S., Verbalis, J. G. c-Fos and related immediate early gene 
products as markers of activity in neuroendocrine systems. Frontiers in 
Neuroendocrinology. 1993,14:173-213. 
[41] Teubner, B. J., Bartness, T. J. Anti-ghrelin Spiegelmer inhibits exogenous ghrelin-induced 
increases in food intake, hoarding, and neural activation, but not food deprivation-
induced increases. Am.J.Physiol Regul.Integr.Comp Physiol. 2013,305:R323-R33. 
[42] Teubner, B. J., Garretson, J. T., Hwang, Y., Cole, P. A., Bartness, T. J. Inhibition of ghrelin 
O-acyltransferase attenuates food deprivation-induced increases in ingestive behavior. 
Horm.Behav. 2013,63:667-73. 
[43] Moulin, A., Demange, L., Berge, G., Gagne, D., Ryan, J., Mousseaux, D., et al. Toward 
potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. 
Synthesis and pharmacological in vitro and in vivo evaluations. Journal of medicinal 
chemistry. 2007,50:5790-806. 
[44] Moulin, A., Brunel, L., Boeglin, D., Demange, L., Ryan, J., M'Kadmi, C., et al. The 1,2,4-
triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 
2959, a potent antagonist. Amino acids. 2013,44:301-14. 
[45] Skibicka, K. P., Hansson, C., Egecioglu, E., Dickson, S. L. Role of ghrelin in food reward: 
impact of ghrelin on sucrose self-administration and mesolimbic dopamine and 
acetylcholine receptor gene expression. Addict.Biol. 2011. 
[46] Salome, N., Hansson, C., Taube, M., Gustafsson-Ericson, L., Egecioglu, E., Karlsson-
Lindahl, L., et al. On the central mechanism underlying ghrelin's chronic pro-obesity 
effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist. J 
Neuroendocrinol. 2009,21:777-85. 
[47] Sarvari, M., Kocsis, P., Deli, L., Gajari, D., David, S., Pozsgay, Z., et al. Ghrelin modulates 
the fMRI BOLD response of homeostatic and hedonic brain centers regulating energy 
balance in the rat. PloS one. 2014,9:e97651. 
52 
[48] Day, D. E., Bartness, T. J. Effects of foraging effort on body fat and food hoarding by 
Siberian hamsters. J.Exp.Zool. 2001,289:162-71. 
[49] Dailey, M. J., Bartness, T. J. Appetitive and consummatory ingestive behaviors stimulated 
by PVH and perifornical area NPY injections. Am.J.Physiol Regul.Integr.Comp Physiol. 
2009,296:R877-R92. 
[50] Barnett, B. P., Hwang, Y., Taylor, M. S., Kirchner, H., Pfluger, P. T., Bernard, V., et al. 
Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. 
Science. 2010,330:1689-92. 
[51] Jerlhag, E., Egecioglu, E., Landgren, S., Salome, N., Heilig, M., Moechars, D., et al. 
Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A. 
2009,106:11318-23. 
[52] Skibicka, K. P., Hansson, C., Egecioglu, E., Dickson, S. L. Role of ghrelin in food reward: 
impact of ghrelin on sucrose self-administration and mesolimbic dopamine and 
acetylcholine receptor gene expression. Addiction biology. 2012,17:95-107. 
[53] Cowley, M. A., Smith, R. G., Diano, S., Tschop, M., Pronchuk, N., Grove, K. L., et al. The 
distribution and mechanism of action of ghrelin in the CNS demonstrates a novel 
hypothalamic circuit regulating energy homeostasis. Neuron. 2003,37:649-61. 
[54] Wren, A. M., Small, C. J., Ward, H. L., Murphy, K. G., Dakin, C. L., Taheri, S., et al. The 
novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. 
Endocrinology. 2000,141:4325-8. 
[55] Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H., Wakabayashi, I. Central effect 
of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene 
expression. Endocrinology. 2000,141:4797-800. 
[56] Wren, A. M., Small, C. J., Abbott, C. R., Dhillo, W. S., Seal, L. J., Cohen, M. A., et al. 
Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001,50:2540-7. 
[57] Date, Y. Ghrelin and the vagus nerve. Methods in enzymology. 2012,514:261-9. 
[58] Date, Y., Shimbara, T., Koda, S., Toshinai, K., Ida, T., Murakami, N., et al. Peripheral 
ghrelin transmits orexigenic signals through the noradrenergic pathway from the 
hindbrain to the hypothalamus. Cell Metab. 2006,4:323-31. 
[59] Zigman, J. M., Jones, J. E., Lee, C. E., Saper, C. B., Elmquist, J. K. Expression of ghrelin 
receptor mRNA in the rat and the mouse brain. J.Comp Neurol. 2006,494:528-48. 
[60] Grill, H. J. Distributed neural control of energy balance: contributions from hindbrain and 
hypothalamus. Obesity (Silver.Spring). 2006,14 Suppl 5:216S-21S. 
53 
[61] Gomez, J. L., Ryabinin, A. E. The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or 
JMV2959 on ethanol, water, and food intake in C57BL/6J mice. Alcoholism, clinical and 
experimental research. 2014,38:2436-44. 
[62] Keen-Rhinehart, E., Bartness, T. J. MTII attenuates ghrelin- and food deprivation-induced 
increases in food hoarding and food intake. Hormones and Behavior. 2007,52:612-20. 
[63] Keen-Rhinehart, E., Bartness, T. J. NPY Y1 receptor is involved in ghrelin- and fasting-
induced increases in foraging, food hoarding, and food intake. Am.J Physiol 
Regul.Integr.Comp Physiol. 2007,292:R1728-R37. 
[64] Bartness, T. J., Morley, J. E., Levine, A. S. Effects of food deprivation and metabolic fuel 
utilization on the photoperiodic control of food intake in Siberian hamsters. Physiology 
and Behavior. 1995,57:61-8. 
[65] Day, D. E., Mintz, E. M., Bartness, T. J. Diet self-selection and food hoarding after food 
deprivation by Siberian hamsters. Physiology and Behavior. 1999,68:187-94. 
[66] Tups, A., Helwig, M., Khorooshi, R. M., Archer, Z. A., Klingenspor, M., Mercer, J. G. 
Circulating ghrelin levels and central ghrelin receptor expression are elevated in response 
to food deprivation in a seasonal mammal (Phodopus sungorus). J.Neuroendocrinol. 
2004,16:922-8. 
[67] Billington, C. J., Levine, A. S. Appetite regulation: Shedding new light on obesity. Current 
Biology. 1996,6:920-3. 
[68] Ruter, J., Kobelt, P., Tebbe, J. J., Avsar, Y. Y., Veh, R., Wang, L., et al. Intraperitoneal 
injection of ghrelin induces Fos expression in the paraventricular nucleus of the 
hypothalamus in rats. Brain Res. 2003,991:26-33. 
[69] Willesen, M. G., Kristensen, P., Romer, J. Co-localization of growth hormone secretagogue 
receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology. 
1999,70:306-16. 
[70] Dickson, S. L., Luckman, S. M. Induction of c-fos messenger ribonucleic acid in 
neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate 
nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. 
Endocrinology. 1997,138:771-7. 
[71] Bagnol, D., Lu, X. Y., Kaelin, C. B., Day, H. E., Ollmann, M., Gantz, I., et al. Anatomy of 
an endogenous antagonist: relationship between Agouti- related protein and 
proopiomelanocortin in brain. Journal of Neuroscience. 1999,19:RC26. 
[72] Atasoy, D., Betley, J. N., Su, H. H., Sternson, S. M. Deconstruction of a neural circuit for 
hunger. Nature. 2012,488:172-7. 
54 
[73] Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., et al. 
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate 
nucleus. Nature. 2001,411:480-4. 
[74] Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., et al. A role 
for ghrelin in the central regulation of feeding. Nature. 2001,409:194-8. 
[75] Tamura, H., Kamegai, J., Shimizu, T., Ishii, S., Sugihara, H., Oikawa, S. Ghrelin Stimulates 
GH But Not Food Intake in Arcuate Nucleus Ablated Rats. Endocrinology. 
2002,143:3268-75. 
[76] Bugarith, K., Dinh, T. T., Li, A. J., Speth, R. C., Ritter, S. Basomedial hypothalamic 
injections of neuropeptide Y conjugated to saporin selectively disrupt hypothalamic 
controls of food intake. Endocrinology. 2005,146:1179-91. 
[77] Aponte, Y., Atasoy, D., Sternson, S. M. AGRP neurons are sufficient to orchestrate feeding 
behavior rapidly and without training. Nat Neurosci. 2011,14:351-5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Physiology and Behavior 
M. Alex Thomas, Vy Tran, Vitaly Ryu, Bingzhong Xue, Timothy J. Bartness 
2017 
56 
3 AGRP KNOCKDOWN BLOCKS LONG-TERM APPETITIVE, BUT NOT 
CONSUMMATORY, FEEDING BEHAVIORS IN SIBERIAN HAMSTERS 
3.1 Abstract 
Arcuate hypothalamus-derived agouti-related protein (AgRP) and neuropeptide Y (NPY) 
are critical for maintaining energy homeostasis.  Fasting markedly upregulates AgRP/NPY 
expression and circulating ghrelin, and exogenous ghrelin treatment robustly increases acute 
food foraging and food intake, and chronic food hoarding behaviors in Siberian hamsters.  We 
previously demonstrated that 3rd ventricular AgRP injection robustly stimulates acute and 
chronic food hoarding, largely independent of food foraging and intake.  By contrast, 3rd 
ventricular NPY injection increases food foraging, food intake, and food hoarding, but this effect 
is transient and gone by 24 h post-injection.  Because of this discrepancy in AgRP/NPY-induced 
ingestive behaviors, we tested whether selective knockdown of AgRP blocks fasting and ghrelin-
induced increases in food hoarding.  AgRP gene knockdown by a novel DICER small interfering 
RNA (AgRP-DsiRNA) blocked food-deprivation induced increases in AgRP expression, but had 
no effect on NPY expression.  AgRP-DsiRNA attenuated acute (1 day), and significantly 
decreased chronic (4-6 days), food deprivation-induced increases in food hoarding.  In addition, 
AgRP-DsiRNA treatment blocked exogenous ghrelin-induced increases in food hoarding 
through day 3, but had no effect on basal food foraging, food intake, or food hoarding prior to 
ghrelin treatment.  Lastly, chronic AgRP knockdown had no effect on body mass, fat mass, or 
lean mass in either food deprived or ad libitum fed hamsters.  These data collectively suggest 
that the prolonged increase in food hoarding behavior following energetic challenges, and food 
deprivation especially, is primarily regulated by downstream AgRP signaling. 
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3.2 Introduction  
Obesity is a critical health concern facing both developed and developing countries 
worldwide due to its many secondary comorbidities including stroke, type 2 diabetes, 
cardiovascular disease, and cancer [1-5].  Energy intake that exceeds energy expenditure is the 
primary cause of obesity, and the prevalence of readily accessible, calorically dense foods 
contributes to a state of chronic energy surplus in obese persons [6].  Previous research on 
ingestive behaviors has largely focused on uncovering the neuroendocrine mechanisms 
governing food intake using laboratory mice and rats, yet in humans the search for food (i.e. food 
shopping/foraging) invariably precedes the immediate consumption or long-term storage (i.e. in 
refrigerators, freezers, and pantries) or hoarding of food.  Hence, ingestive behaviors are more 
accurately dichotomized as appetitive behaviors that bring animals into contact with food (i.e. 
food foraging and food hoarding) and consummatory behaviors in which animals consume food 
[7].  Previous studies have suggested obese or food deprived persons purchase more calorically 
dense, high-fat foods and hoard these items for longer periods of time relative to lean or satiated 
persons [8-11].  In turn, elucidating the mechanisms mediating ingestive behaviors as a whole 
represents a novel approach for the development of obesity reversal or prevention options.  
To investigate the central nuclei regulating appetitive (i.e. food foraging and hoarding) 
and consummatory (i.e. food intake) ingestive behaviors necessitates an animal model that 
naturally hoards food.  Siberian hamsters (Phodopus sungorus), like humans, are natural and 
prodigious food hoarders [12], and we have previously shown that energetic challenges (e.g. 
food deprivation and ghrelin) robustly increase this behavior [12-14].  We have developed a 
unique experimental approach to test the central and peripheral factors regulating ingestive 
behaviors by which animals earn food through wheel running in a top “foraging” cage, and store 
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this food for future meals in a bottom “hoarding” cage [15].  With this experimental set up, we 
have begun to elucidate the complex neuroendocrine network mediating these appetitive and 
consummatory ingestive behaviors (for review see [6]). 
The stomach-derived orexigenic hormone ghrelin is of particular interest in the context of 
ingestive behaviors due to its preprandial rise and postprandial decrease [16-18].  Exogenous 
ghrelin treatment, mimicking an energy deplete state, markedly increases ingestive behaviors in 
humans and laboratory rodents including Siberian hamsters  [19-22].  We have recently shown 
that third ventricular or intraperitoneal exogenous ghrelin treatment acutely increases food intake 
and food foraging (~2-4 h), and drives chronic (~5-7 days) food hoarding increases, both of 
which are blocked by central ghrelin receptor antagonism [23].  The ghrelin receptor (growth 
hormone secretagogue receptor 1a [GHSR]) is broadly distributed in the brain [24, 25], including 
on hypothalamic arcuate nucleus (Arc) neurons that coexpress agouti-related protein (AgRP), 
neuropeptide Y (NPY), and gamma-aminobutyric acid (GABA)- termed AgRP neurons as AgRP 
is spatially limited to the Arc [25, 26].  The Arc contains receptors for numerous circulating 
endocrine signals (e.g. ghrelin and leptin), and exogenous ghrelin treatment robustly increases 
AgRP/NPY expression [27, 28].  A critical role of these neurons in regulating energy 
homeostasis is further supported by the finding that ablation of these neurons in adult mice 
results in profound hypophagia [29].  In addition, AgRP neurons regulate ingestive behaviors 
through temporally discrete mechanisms.  Pharmacogenetic or optogenetic AgRP neuron 
activation drives rapid, NPY/GABA-dependent food intake, and delayed, but prolonged, AgRP-
dependent food intake in mice [30].  Although AgRP and NPY are sufficient to mediate food 
intake through distinct temporal mechanisms, it remains unclear if these neuropeptides regulate 
acute and chronic food foraging and food hoarding through similar mechanisms.  To this end, we 
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recently demonstrated that central NPY administration markedly increases food foraging, food 
hoarding, and food intake in Siberian hamsters, but this effect is transient and gone by 24 h post-
injection [31].  ICV blockade of the NPY Y1 receptor completely blocks fasting- and ghrelin-
induced food foraging and food intake, but has comparatively little effect on food hoarding, 
suggesting either other NPY receptors or neurochemical systems mediate this behavior [32].  In 
support of an NPY-independent mechanism regulating multi-day food hoarding following 
energetic challenges, we found that central AgRP robustly increases both acute and chronic 
(through 7 days) food hoarding to a much greater extent than food foraging or food intake in 
Siberian hamsters [33].  These findings collectively suggest the presence of separate 
neurochemical mechanisms regulating appetitive and consummatory behaviors following 
energetic challenges, and that this differential neuropeptide regulation of ingestive behaviors 
occurs through temporally discrete mechanisms such that acute changes in consummatory 
behavior are not intrinsically followed by changes in appetitive behaviors.  We therefore tested 
whether AgRP discretely regulates food deprivation- or ghrelin-induced appetitive and 
consummatory ingestive behavior, including food intake, foraging, and hoarding. 
To test the necessity of AgRP in regulating food deprivation- and ghrelin-induced 
increases in ingestive behaviors necessitates a novel approach that specifically targets AgRP.  
The development of DICER small interfering RNA (DsiRNA) duplexes and other antisense 
oligonucleotides has facilitated in vivo, targeted mRNA knockdown in non-genetically 
engineered animals including humans (for review see [34]).  AgRP-DsiRNA mediated gene 
knockdown circumvents the inherent confounds of germ-line knockout models or non-specific 
receptor antagonism, and affords the ability to directly test the endogenous function of AgRP in a 
natural animal model of food hoarding.  Here, we tested the role of AgRP in the regulation of 
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ingestive behaviors by giving chronic AgRP-DsiRNA injections throughout energetic challenges 
in Siberian hamsters housed in our foraging and hoarding system. In addition, we have used a 
protocol modified from our previous studies, which enables us to more accurately examine the 
effects of AgRP knockdown on ingestive behaviors at discrete time points. 
3.3 Materials and Methods 
3.3.1 Animals 
Adult male Siberian hamsters aged ~2 months and weighing 30-40 g were obtained from 
our breeding colony as previously described [35]. Hamsters were sexed and group housed from 
birth in a summer-like photoperiod (16:8-h light-dark cycle, light offset at 1900) with ad libitum 
access to food (formula 5001, Purina, St. Louis, MO) and water.  Room temperature was 
maintained at 21.0 ± 2ᵒC.  All procedures were approved by the Georgia State University 
Institutional Animal Care and Use Committee and were in compliance with the Public Health 
Service and United States Department of Agriculture guidelines 
3.3.2 RNAi-mediated gene knockdown 
To specifically knockdown Arc AgRP, we chose a DICER small interfering RNA 
(DsiRNA) directed against AgRP (MMC.RNAI.N007427.12.1; Integrated DNA Technologies 
[AgRP-DsiRNA]) and a control scrambled RNA (DsiRNA; NC1; Integrated DNA Technologies 
[scRNA]) directed against no known mRNA sequence.  scRNA and AgRP-DsiRNA were 
initially reconstituted in sterile dH2O, aliquoted, and frozen at -80°C to prevent RNA 
degradation.  For hydrodynamic injections, scRNA (0.4µg/g body mass [BM]) and AgRP-
DsiRNA (0.4µg/g BM) were diluted in sterile saline and rapidly injected intraperitoneally (i.p.) 
as previously described [36-38].    
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3.3.3 Blood brain barrier permeability and central effects of DsiRNA-mediated AgRP 
knockdown 
Blood brain barrier permeability was tested using peripheral sodium fluorescein 
injections (10%, 5ml/kg, i.p.; Sigma-Aldrich).  Following a single i.p. injection, animals were 
returned to their home cage for 30 min and then killed by an overdose of Fatal Plus (300 mg/kg, 
i.p.; Vortech Pharmaceuticals).  Animals were transcardially perfused with 10 ml ice cold 0.1 M 
PBS followed by 30 ml ice cold 4.0% paraformaldehyde in 0.1 M PBS.  Brains were then 
extracted and transferred to 4.0% paraformaldehyde in 0.1 M PBS overnight and then 18.0% 
sucrose at 4°C.  Brains were subsequently sectioned with a cryostat at 20 µm and the Arc 
immediately visualized with fluorescent microscopy. 
To test the efficacy of AgRP-DsiRNA-mediated gene knockdown, we chose a 48 h food 
deprivation challenge as this energetic challenge typically causes a marked increase of AgRP and 
NPY expression in Siberian hamsters [39, 40].  Preliminary experiments indicated daily AgRP-
DsiRNA (0.4µg/g BM i.p.) injections most effectively blocked AgRP mRNA expression (data 
not shown), so we adopted this approach for all subsequent experiments [Fig. 1A].  In one cohort 
of hamsters used for in situ hybridization, animals were food deprived for 48 h and given either 
scRNA (0.4µg/g BM i.p.) or AgRP-DsiRNA (0.4µg/g BM i.p.) daily at 0900 (two total injections 
at t=0 and t + 24 h).  Animals were killed by an overdose of Fatal Plus 48 h after food removal 
(i.e. 24 h after the last injection), and then transcardially perfused with 75 ml of heparinized 
0.9% NaCl in RNase free 0.01% diethylpyrocarbonate (DEPC)-treated dH2O followed by 150 ml 
4.0% paraformaldehyde in 0.1 M PBS in sterile filtered dH2O.  Brains were subsequently 
removed, post fixed in sterile 4.0% paraformaldehyde in 0.1 M PBS overnight, and then 
transferred to sterile 0.01% DEPC-treated 18.0% sucrose at 4°C.  Brains were sectioned with a 
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cryostat at 20 µm in series across 3 slides to cover the entirety of the Arc, and then frozen at -
80°C to reduce mRNA degradation. 
In a separate cohort of hamsters used for quantitative PCR (qPCR) analysis, animals were 
either food deprived or allowed ad libitum access to food.  Food deprived and ad libitum fed 
animals were given either scrambled RNA (scRNA) or AgRP-DsiRNA (0.4µg/g BM i.p.) 
injections daily at 0900 across 48 h (two total injections at t=0 and t + 24 h).  Animals were 
killed by rapid decapitation 24 h later (i.e. t + 48 h), the brain extracted, and 1 mm sagittal 
sections taken from both sides of the midline.  The hypothalamus was identified and cut rostrally 
at the optic chiasm, caudally at the mammillary bodies, and a ~0.5 mm dorsal cut made to isolate 
the Arc which was immediately flash frozen in liquid nitrogen.  Frozen hypothalamic tissue was 
stored at -80°C until processing to reduce mRNA degradation.  Importantly, qPCR analysis was 
repeated in three separate cohorts of animals to ensure consistent results and a robust 
physiological effect of the AgRP-DsiRNA. 
3.3.4 Fluorescent in situ hybridization for AgRP and NPY mRNA 
We used double-fluorescent in situ hybridization to analyze both AgRP and NPY 
expression following a 48 h food deprivation challenge and treatment with either scRNA or 
AgRP-DsiRNA as previously described [40, 41].  In brief, single-stranded antisense mRNA 
fragments against rat AgRP (a generous gift from Dr. Kevin Grove) and hamster NPY (provided 
by S. Chua, Columbia University, New York, NY) were reverse transcribed from plasmid DNA 
and labeled with digoxigenin (DIG RNA Labeling Mix; Roche Applied Sciences) or FITC (FITC 
RNA Labeling Mix; Roche Applied Sciences).  A rat antisense AgRP riboprobe was used as 
previously described [42] because of its consistently robust, specific staining. Frozen slides 
containing the mounted sections were removed from -80°C ~20 min before use to reach room 
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temperature.  Slides were submerged in 2x SSC, acetylated with 0.1 M triethanolamine/0.25% 
acetic anhydride solution in 0.1% DEPC-treated dH2O, and then fixed the tissues with a 1:1 
acetone/methanol mixture.  We next added 150 µl prehybridization buffer, coverslipped the 
slides, and left the sections at room temperature for 30 min.  Coverslips were then removed and 
tissues hybridized with antisense riboprobes (150 ng/slide) for AgRP and NPY in a humid 
chamber for 16-20 h at 58°C.  Slides were subsequently removed from humid chambers and 
submerged in an RNase A/ 2x SSC solution (20µg/ml) at 37°C to degrade unbound RNA.  
Sections were washed in decreasing 2x SSC concentrations to 0.5x, quenched for endogenous 
peroxidase activity with 1.0% H2O2, and permeabilized with 0.5% Tween 20 in 0.1 M Tris-HCL.  
Sections were then blocked in 10% normal sheep serum (NshS) and 5.0% casein in 0.1 M tris-
buffered saline (TBS) for 30 min.  We next incubated the sections with sheep anti-digoxigenin 
FAB fragments (1:250; Roche Applied Sciences) in 10.0% NShS and 5.0% casein in 0.1 M TBS 
for 2 h at room temperature and amplified the signal with tyramide signal amplification (TSA; 
1:200; TSA Plus Cyanine 3 Kit; PerkinElmer Lifer and Analytical Sciences).  To amplify and 
reveal the second (FITC) riboprobe, we used a second peroxidase quenching step with 3% H2O2 
in 0.1 M TBS, blocked the sections for 30 min in 10% NShS and 5.0% casein, and then 
incubated the sections for 2 h at room temperature with anti-FITC FAB fragments (1:250; Roche 
Applied Sciences) that were subsequently amplified via TSA (1:200; TSA Plus Fluorescein; 
PerkinElmer Life and Analytical Sciences).  Slides were coverslipped with Prolong antifade 
fluorescent medium (Invitrogen) and stored at room temperature, shielded from light, until image 
capture.   
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3.3.5 Fluorescent quantification 
Fluorescent labeling in the Arc was quantified with experimenters blind to treatment 
conditions.  A mouse brain atlas (Paxinos and Franklin [43]) was used as it most closely matches 
the Siberian hamster brain and no Siberian hamster brain atlas exists.  Total cells expressing 
NPY and AgRP were counted across the Arc in each animal and then averaged for each 
treatment group.    Relative fluorescent intensity (RFI) was measured for each mRNA probe for 
all animals as previously described [40, 44].  In brief, background was normalized for all 
sections and NIH ImageJ software was used to capture and measure fluorescent intensity of a 
defined Arc region.  Intensity measurements of either AgRP or NPY were then averaged across 
all animals for each treatment group.   
3.3.6 Quantitative PCR analysis 
RNA from frozen hypothalamic tissue was extracted using TRIzol Reagent (Thermo 
Fisher) and subsequently reverse transcribed into cDNA with a High-Capacity cDNA Reverse 
Transcription Kit (Thermo Fisher) according to the manufacturer’s instructions.  AgRP and NPY 
gene expression was measured using TaqMan Gene Expression Master Mix (Thermo Fisher) and 
a 7500-Fast RT-PCR machine (Applied Biosystems).  As Siberian hamster TaqMan primers and 
probes are not commercially available, custom primer/probe sets were generated (Applied 
Biosystems) based on previously described Siberian hamster AgRP and NPY sequences [45].  
AgRP primers/probe- forward primer: AGGCCCTGCTGCAGAAG, reverse primer: 
GACTCGCGATTCTGTGGATCTAG, reporter probe: ACCTCCGCCAACGCT; NPY 
primers/probe- forward primer: CTCCGCTGGTGCATCCT, reverse primer: 
GTGCTGGCTGAGGGATACC, reporter probe: AAGCCTGACAATCCTG.  Mouse 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Applied Biosystems) was used as an 
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endogenous control as its expression was consistent across all animals and treatments (A.T. and 
T.J.B. unpublished observations). 
3.3.7 Foraging and hoarding apparatus 
At the start of the experiment, animals were transferred to the foraging/hoarding room 
and singly housed in polypropylene cages (27.8 X 17.5 X 13.0 cm) with Alpha-dri bedding 
(Specialty Papers, Kalamazoo, MI) and a single cotton Nestlet (Ancare, Belmore, NY).  Animals 
were allowed ad libitum access to the experimental diet (purified 75-mg Dustless Precision 
Pellets, Bio-Serve, Frenchtown, NJ) and water, and given two weeks to acclimate to the new 
light cycle (16:8-h light-dark cycle, light offset at 1200).  Following acclimation to the new 
photoperiod, animals were transferred to our foraging and hoarding apparatus, modified from 
Perrigio and Bronson [46], as previously described [15].  In brief, animals were given 
unrestrained access to a top “foraging” cage (456 mm long × 234 mm wide × 200 mm high) 
equipped with a running wheel, pellet dispenser, and water bottle, and a bottom “hoarding” cage 
(290 mm long × 180 mm wide × 130 mm high) containing Alpha-Dri bedding and one cotton 
nestlet.  The foraging and hoarding cages were connected by convoluted polyvinylchloride 
tubing (38.1 mm inner diameter, ~1.5 m long) with bends and runs to facilitate movement 
between the two cages.  Animals were allowed a two-week training period to the foraging and 
hoarding apparatus before experimental manipulation.  During the first two days of this training 
period, animals were given free access to food pellets and were able to earn an additional pellet 
by completing 10 wheel revolutions.  Following this two-day period, free access to food was 
removed and all food had to be earned through wheel running (1 pellet/10 wheel revolutions), 
during which time wheel revolutions, pellets earned, food intake, and food hoarding were 
measured daily.   
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3.3.8 Measurement of food foraging, food hoarding, and food intake experimental protocol 
For all behavioral experiments, food foraging, food hoarding, and food intake was 
assessed daily at 0900.  Food foraging was defined as the number of wheel revolutions divided 
by 10, as 10 revolutions were required for each pellet delivery.  Food hoarding was defined as 
the number of pellets present in the bottom hoarding cage in addition to pellets removed from the 
cheek pouches of hamsters.  Food intake was defined as [the number of pellets earned – (number 
of pellets remaining in the top cage that were not hoarded + number of pellets hoarded)].  All 
food pellets were weighed on an electronic scale set to “parts” measurement with one 75 mg 
food pellet= 1, and fractions of pellets calculated as well.  
3.3.8.1 Experiment 1: Does AgRP-DsiRNA block food deprivation-induced increases in 
appetitive behaviors? 
At the end of the training period, animals were divided into two groups counterbalanced 
for BM, food foraging, food hoarding, and food intake: 1) scRNA (0.4µg/g BM i.p.); 2) AgRP-
DsiRNA (0.4µg/g BM i.p.).  At the start of the food deprivation challenge, animals were 
transferred to a new hoarding cage, provided water, and blocked in this cage to prevent access to 
the top foraging cage for 48 h. At the conclusion of the 48 h food deprivation, animals were 
unblocked from the hoarding cage at lights off (1200) and allowed access to the foraging cage.  
scRNA or AgRP-DsiRNA injections were given daily (at 0900) throughout the food deprivation, 
and then daily at the same time as data collection (0900) throughout the duration of the 
experiment for a total of 8 injections (i.e. 2 days of food deprivation and 6 total days of post-fast 
refeeding behavioral data collection) [Fig. 1B].  
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3.3.8.2 Experiment 2: Does AgRP-DsiRNA block Ghrelin-induced increases in appetitive 
behaviors?  
Following the training period in a separate cohort of hamsters, animals were divided into 
four groups counterbalanced for BM, food foraging, food hoarding, and food intake: 1) i.p. saline 
+ scRNA (0.4µg/g BM i.p.); 2) i.p. ghrelin (30 µg/kg BM i.p.) + scRNA (0.4µg/g BM i.p.); 3) 
i.p. ghrelin (30 µg/kg BM i.p.) + AgRP-DsiRNA (0.4µg/g BM i.p.); 4) i.p. saline + AgRP-
DsiRNA (0.4µg/g BM i.p.).  To ensure adequate AgRP knockdown, animals received either 
scRNA or AgRP-DsiRNA injections (at 0900) for two days prior to ghrelin injection.  On 
experimental test day, food was removed from the top foraging cage and animals were placed 
into a new, clean hoarding cage immediately following AgRP-DsiRNA injections. Animals were 
blocked in this cage at 0900 to prevent wheel running, food intake, or food hoarding prior to 
ghrelin injection at lights off at 1200 as previously described [22, 23].  Immediately after lights 
off, animals were injected with either saline or ghrelin and cages were unblocked to allow for 
access to the top cage.  On subsequent days, animals were given either scRNA or AgRP-
DsiRNA injections at the same time as data collection for the duration of the experiment (0900).  
Hence, animals received a total of 9 injections throughout the experiment (i.e. 2 days prior to 
ghrelin injection, the morning of ghrelin injection, and 6 days of post-ghrelin behavioral data 
collection) [Fig. 1C].  
3.3.9 Body composition measurements 
Body composition measurements for experiment 1 and experiment 2 hamsters were taken 
using our Minispec LF90 TD-NMR analyzer (Bruker Optics).  For all measurements, animals 
were briefly removed from their home cage, placed in the body composition analyzer, and then 
immediately returned to their home cage.  Body composition measurements were taken for all 
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animals prior to the start of experiment 1 and experiment 2, and then again at the conclusion of 
the experiments. 
3.3.10 Statistical analysis 
All data are expressed as mean ± S.E.  Relative AgRP and NPY gene expression as 
measured by quantitative PCR were normalized to GAPDH.  For behavioral experiments, data 
for each animal on experiment day(s) (i.e., number of pellets earned, consumed, or hoarded) 
were compared with the average data across the three days prior to the experiment start (i.e. 
baseline values) for the same animal.  For a subset of statistical analyses where percent baseline 
(% baseline) was used, % baseline for each animal on experimental day(s) was calculated as 
given by the formula [(animal X on experimental day(s)/animal X baseline)*100] and compared 
with that animals normalized baseline value as given by the formula [(animal X baseline/average 
for all animals in the group)*100].  Data were analyzed by a Student’s t-test, Mann-Whitney U 
test, or a one-way or two-way ANOVA followed by Duncan’s Multiple-Comparison post-hoc 
analysis where appropriate.  For all experiments, differences among groups was considered 
statistically significant at P<0.05 and trending toward significance at P<0.1.   
3.4 Results 
3.4.1 AgRP-DsiRNA blocks food deprivation-induced Arc AgRP expression 
i.p. sodium fluorescein injections revealed extensive neuronal labeling within the Arc, but 
not in nearby hypothalamic nuclei including the ventromedial hypothalamus (VMH) or 
dorsomedial hypothalamus (DMH) [Fig. 3.2A], indicating that peripherally administered drugs 
are sufficient to reach Arc neurons.  We therefore sought to test whether i.p. administered AgRP-
DsiRNA was sufficient to block AgRP, but not NPY, expression following an energetic 
challenge that typically causes marked increases in AgRP and NPY expression in Siberian 
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hamsters [40].  We initially used in situ hybridization against AgRP and NPY mRNA to 
visualize mRNA expression following a 48 h fast, and measured relative fluorescent intensity 
and neuronal number as markers for AgRP and NPY activation [Fig. 3.1A].  We observed 
extensive AgRP and NPY mRNA expression in scrambled RNA (scRNA) treated animals [Fig. 
3.2, B-D], but a marked decrease in AgRP, but not NPY, mRNA expression in AgRP-DsiRNA 
treated animals [Fig. 3.2, E-G].  Relative fluorescent intensity quantification revealed AgRP-
DsiRNA significantly decreased AgRP mRNA expression by approximately 50% [P<0.05; Fig. 
3.2H], but had no effect on NPY mRNA Expression [Fig. 3.2I].  In addition, the number of 
AgRP-positive neurons was significantly decreased in AgRP-DsiRNA treated animals compared 
with scRNA treatment [P<0.05; Fig. 3.2J], but there was no effect on NPY-positive neurons 
[Fig. 3.2J].   
To confirm our in situ data, and to further validate the efficacy of AgRP-DsiRNA, we 
repeated the 48 h food deprivation challenge in a separate cohort of animals and measured AgRP 
and NPY mRNA expression with quantitative PCR (qPCR).  AgRP-DsiRNA significantly 
decreased AgRP mRNA expression in ad libitum fed animals compared with scRNA treated 
animals [P<0.05; Fig. 3.3A].  Moreover, 48 h food deprivation significantly increased AgRP 
mRNA expression in scRNA treated animals, but this effect was abrogated by AgRP-DsiRNA 
treatment [P<0.05; Fig. 3.3A].  By contrast to AgRP mRNA expression, AgRP-DsiRNA 
treatment had no effect on NPY mRNA expression in either ad libitum fed animals or 48 h food 
deprived animals compared with control scRNA treated animals [Fig. 3.3B].   
3.4.2 AgRP-DsiRNA attenuates food deprivation-induced food hoarding 
After confirming the efficacy of AgRP-DsiRNA, we tested whether AgRP knockdown 
affects food foraging, food intake, or food hoarding following a food deprivation challenge [Fig. 
70 
3.1B].  Upon refeeding after a 48 h fast, the number of pellets earned was significantly decreased 
in both scRNA and AgRP-DsiRNA treated animals relative to baseline, and this marked decrease 
in foraging effort failed to return to baseline levels throughout the experiment [P<0.05; Fig. 
3.4A].  In addition, a trend of increased pellets earned (foraging) was observed in AgRP-
DsiRNA treated animals compared with scRNA treatment at day 1 [P<0.1; Fig. 3.4A].  
However, we observed no difference in foraging effort between treatment groups at days 2-6 
post-refeeding.  Food intake was significantly decreased at day 1 and day 2 post-refeeding for 
both scRNA and AgRP-DsiRNA treated animals relative to baseline [P<0.05; Fig. 3.4B], but 
AgRP-DsiRNA had no effect on pellets consumed compared with scRNA treatment at any time 
point examined [Fig. 3.4B].  By contrast, food hoarding was markedly increased relative to 
baseline for both AgRP-DsiRNA and scRNA treated animals on days 1 and 2 post-refeeding 
[P<0.05; Fig. 3.4C], but AgRP knockdown blocked this relative increase at day 4.  Moreover, 
AgRP-DsiRNA significantly decreased food hoarding at days 1 and 4 post-refeeding compared 
with scRNA treated animals [P<0.05; Fig. 3.4C], and a trend of decreased food hoarding was 
observed at day 5 post-refeeding [P=0.1; Fig. 3.4C].   
Because we previously found central AgRP increases food hoarding across multiple days 
[33], we combined the total number of pellets earned, consumed, or hoarded across days 2-3 and 
4-6 post-refeeding (Fig. 3.4D-F) to identify changes in behavioral trends that may not otherwise 
be apparent when discretely examining each day as previously described [40].  Of note, we 
omitted day 1 from our analysis of combined days 2-3 as the data at this time point were 
markedly different from ensuing time points and tended to skew the data on these days.  Despite 
the trend of decreased food foraging at day 1 post-refeeding [P<0.1; Fig. 3.4D], we found no 
difference in foraging effort on days 2-3 or 4-6 [Fig. 3.4D].  In addition, AgRP-DsiRNA 
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treatment had no effect on food intake on either day 1 post-refeeding, or on combined days 2-3 
or 4-6 [Fig. 3.4E].  By contrast to food foraging and food intake, AgRP-DsiRNA treatment 
significantly decreased pellets hoarded at day 1 post refeeding [P<0.05; Fig. 3.4F], and a trend 
of decreased pellets hoarded was observed on combined days 4-6 compared with scRNA treated 
animals [P=0.054; Fig. 3.4F].   
We next converted raw food foraging, food intake, and food hoarding values into 
percentage of baseline (% baseline) (Fig. 3.4G-I) to compare the effects of AgRP-DsiRNA on 
ingestive behaviors in an energy deplete state with an ad lib-fed condition.  Food deprivation 
markedly decreased food foraging in both AgRP-DsiRNA and scRNA treated animals compared 
with baseline on day 1 post-refeeding and for combined days 2-3 and 4-6, and never returned 
above ~80% baseline levels [P<0.05; Fig. 3.4G].  AgRP-DsiRNA treatment tended to increase 
pellets earned on day 1 post-refeeding compared with control animals [P<0.1; Fig. 4G], which 
reached statistical significance on combined days 2-3 [P<0.05; Fig. 3.4G].  Food deprivation 
significantly decreased food intake relative to baseline in both AgRP-DsiRNA and scRNA 
treated animals on day 1 and combined days 2-3 post-refeeding [P<0.05; Fig. 3.4H], with the 
food intake returned to baseline values on combined days 4-6 post-refeeding [Fig. 3.4H]. 
However, no difference in food intake was observed between treatments at any time point 
examined.  By contrast to the marked decrease in food foraging and food intake, food 
deprivation robustly increased food hoarding relative to baseline at day 1 post-refeeding, and 
remained increased over baseline on days 2-3 and 4-6 post-refeeding in scRNA treated hamsters 
[P<0.05; Fig. 3.4I].  AgRP-DsiRNA treatment significantly decreased food hoarding by ~50% 
on day 1 post-refeeding compared with control animals [P<0.05; Fig. 3.4I], and attenuated this 
increase on days 4-6 [P<0.05; Fig. 3.4I].  
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48 h food deprivation resulted in a profound ~20% decrease in body mass in both scRNA 
and AgRP-DsiRNA treated animals, and this change in body mass remained significantly 
decreased relative to baseline in both groups for the duration of the experiment [P<0.05; Fig. 
3.5A].  Moreover, food deprivation significantly decreased % fat mass and increased % lean 
mass relative to baseline for both AgRP-DsiRNA and scRNA treated animals [P<0.05; Fig. 3.5B 
and 3.5C], but we found no differences in % fat mass or % lean mass at any time point between 
these groups (Fig. 3.5B and 3.5C).  
3.4.3 AgRP-DsiRNA attenuates ghrelin-induced food hoarding 
Because food deprivation markedly increases circulating ghrelin, we next tested whether 
AgRP mRNA knockdown is sufficient to block ghrelin-induced ingestive behaviors [Fig. 3.1C].  
AgRP-DsiRNA treatment had no effect on pellets earned, consumed, or hoarded prior to the 
exogenous ghrelin treatment when compared with baseline values [Fig. 3.6A-C].  However, we 
found a significant decrease in foraging effort for all groups on day 1 following exogenous 
ghrelin [P <0.05; Fig. 3.6A], an effect likely stemming from the novelty of the experimental 
procedure as ghrelin injections occurred at lights off (1200) on the preceding day and pre-ghrelin 
scRNA or AgRP-DsiRNA injections (at 0900) had no effect on behavior arguing against a 
possible pain response.  Subsequent to this initial decrease in food foraging, we found no 
differences in food foraging for the remainder of the experiment nor food intake at any time 
point examined for all groups following exogenous ghrelin [Fig. 3.6A and 3.6B].  By contrast, 
systemic ghrelin significantly increased food hoarding compared with control saline + scRNA 
treated animals at day 1 post-injection [P<0.05; Fig. 3.6C], and AgRP-DsiRNA treatment 
attenuated this increase.  We found no subsequent differences in the number of pellets hoarded 
among any group on days 2-6 post-injection [Fig. 3.6C]. 
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We next combined the raw pellets foraged for, consumed, or hoarded on days 1-3 and 4-6 
(Fig. 3.6D-F) and then converted these values into a percent change from baseline (Fig. 6G-I) to 
identify any cumulative effects of exogenous ghrelin or AgRP-DsiRNA on behavior.  We found 
no difference between any group in the absolute number of pellets earned [Fig. 3.6D], consumed 
[Fig. 3.6E], or hoarded [Fig. 3.6F] on either combined days 1-3 or 4-6.  By contrast, we found a 
significant decrease in pellets earned relative to baseline for all groups on days 1-3 post injection 
[Fig. 3.6G], most likely stemming from the novelty of the procedure.  Although exogenous 
ghrelin had no effect on food foraging in combined days 1-3, we found a significant increase 
compared with scRNA treated animals on days 4-6, and this effect was attenuated with AgRP-
DsiRNA treatment [P<0.05; Fig. 3.6G].  In line with our food deprivation data, exogenous 
ghrelin significantly decreased food intake during combined days 1-3 relative to baseline in 
ghrelin + scRNA, but this effect was absent in AgRP-DsiRNA treated animals [P<0.05; Fig. 
3.6H].  Moreover, saline + AgRP-DsiRNA treatment significantly increased pellets consumed 
compared with saline + scRNA and ghrelin + scRNA treatment on combined days 1-3 and 4-6 
[P<0.05; Fig. 3.6H].  Ghrelin + AgRP-DsiRNA treatment also significantly increased pellets 
consumed compared with ghrelin + scRNA treatment on combined days 1-3 [P<0.05; Fig. 3.6H]. 
As expected, exogenous ghrelin robustly and significantly increased food hoarding relative to 
baseline on days 1-3 post-injection compared with all other groups [P<0.05; Fig. 3.6I].  Of note, 
we found no change in food hoarding in AgRP-DsiRNA treated animals compared with baseline 
or scRNA control animals, indicating AgRP knockdown specifically abrogated ghrelin-induced 
hoarding behavior.  No subsequent change in food hoarding was observed in any group on 
combined days 4-6 post-injection [Fig. 3.6I].  
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Concurrent with our behavior experiment, we measured body mass and body composition 
to uncover any effects of AgRP-DsiRNA on body mass, % fat mass, or % lean mass across time.  
We found no difference in body mass change across time, or in % fat mass or % lean mass at 
either baseline or at the conclusion of the experiment [Fig. 3.7A-C].   
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Fig. 3.1 Experimental timeline. 
Experimental timeline for AgRP-DsiRNA (0.4µg/g BM i.p.)  in situ hybridization and 
quantitative PCR efficacy tests (A).  Experimental timelines for training, AgRP-DsiRNA 
(0.4µg/g BM i.p.) or scRNA (0.4µg/g BM i.p.) treatment, and data collection for 
behavioral Experiment 1 (B) or behavioral Experiment 2 (C). 
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Fig. 3.2 AgRP-DsiRNA selectively blocks AgRP expression. 
Representative image of arcuate nucleus neuronal labeling following sodium fluorescein 
injections (10%, 5ml/kg, i.p) (A).  Representative double-fluorescent in situ hybridization 
images for AgRP (green), NPY (red), and merged sections in scRNA (0.4µg/g BM i.p.) 
(B-D) and AgRP-DsiRNA (0.4µg/g BM i.p.) treated (E-G) animals.  Relative fluorescent 
intensity (RFI) measurements for AgRP (H) and NPY (I) (n=4-5 per group).  Average 
number of arcuate nucleus AgRP-positive and NPY-positive neurons in AgRP-DsiRNA 
and scRNA treated animals (J) (n=4-5 per group).  Scale bar in A-G= 100 µm.  Data 
reported as mean ± S.E.M.  *P<0.05 vs. scRNA treatment. 
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Fig. 3.3 AgRP-DsiRNA blocks food deprivation-induced AgRP increases. 
Relative arcuate nucleus AgRP (A) and NPY (B) mRNA expression as measured by qPCR 
in ad libitum fed and food deprived animals receiving either scRNA (0.4µg/g BM i.p.) or 
AgRP-DsiRNA (0.4µg/g BM i.p.) (n=8-15 per group).  Data are averages across three 
experimental cohorts.  Data reported as mean ± S.E.M.  Values that do not share a 
common superscript are significantly different at P<0.05. 
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Fig. 3.4 AgRP knockdown attenuates food deprivation-induced food hoarding. 
Average number of pellets earned (A), consumed (B), and hoarded (C) prior to food 
removal (baseline) and upon refeeding after a 48 h food deprivation challenge in scRNA 
(0.4µg/g BM i.p.) and AgRP-DsiRNA (0.4µg/g BM i.p.) treated animals.  Day 1 and 
combined days 2-3 and 4-6 number of pellets earned (D), consumed (E), and hoarded (F) 
following refeeding.  Percent baseline converted pellets earned (G), pellets consumed 
(H), and pellets hoarded (I) for day 1 and combined days 2-3 and 4-6.  n= 19-20 per 
group.  (A-C), baseline values were calculated as the 3 day pellet average prior to 
experimental start time.  (G-I), baseline (i.e. 100%) was calculated for each animal using 
the formula [(3 day animal baseline average/ average of all animals in the group)*100] 
when comparing day 1, [((3 day animal baseline average*2)/ average of all animals in the 
group)*100] when comparing days 2-3, or [((3 day animal baseline average*3)/ average 
of all animals in the group)*100] when comparing days 4-6.  Data reported as mean ± 
S.E.M.  aP<0.05 vs. AgRP-DsiRNA treated animals; *P<0.05 vs. baseline. 
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Fig. 3.5 AgRP knockdown has no effect on body mass, fat mass, or lean mass following 
food deprivation. 
Baseline, food returned (Day 0), and daily body mass change measurements in food-
deprived scRNA (0.4µg/g BM i.p.) and AgRP-DsiRNA (0.4µg/g BM i.p.) treated animals 
(A).  Baseline, food returned (Day 0), and final fat mass (Day 6) (B) and percent lean 
mass (C) body composition measurements for scRNA and AgRP-DsiRNA treated 
animals. n= 19-20 per group for all measurements.  Data reported as mean ± S.E.M.  
*P<0.05 vs. baseline. 
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Fig. 3.6 AgRP knockdown blocks ghrelin-induced food hoarding. 
Number of pellets earned (A), consumed (B), and hoarded (C) prior to injections 
(baseline) and in response to saline + scRNA (0.4µg/g BM i.p.), ghrelin (30µg/kg i.p.) + 
scRNA (0.4µg/g BM i.p.), ghrelin (30µg/kg i.p.) + AgRP-DsiRNA (0.4µg/g BM i.p.), or 
saline + AgRP-DsiRNA (0.4µg/g BM i.p.).  Combined number of pellets earned (D), 
consumed (E), and hoarded (F) on days 1-3 and 4-6.  Percent baseline converted pellets 
earned (G), consumed (H), and hoarded (I) on combined days 1-3 and 4-6. n=15 per 
group.  (A-C), baseline values were calculated as the 3 day pellet average prior to 
experimental start time.  (G-I), baseline (i.e. 100%) was calculated for each animal using 
the formula [((3 day animal baseline average*3)/ average of all animals in the 
group)*100].  Data reported as mean ± S.E.M.  aP<0.05 vs. saline + scRNA treatment; 
bP<0.05 vs. ghrelin + AgRP-DsiRNA treatment; cP<0.05 vs. saline + AgRP-DsiRNA 
treatment; *P<0.05 vs. baseline. 
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Fig. 3.7 AgRP knockdown has no effect on ghrelin-induced changes in body mass, fat 
mass, or lean mass. 
Body mass change measurements in scRNA (0.4µg/g BM i.p.) or AgRP-DsiRNA 
(0.4µg/g BM i.p.) treated animals at baseline and following exogenous ghrelin (30µg/kg 
i.p.) or saline treatment (at Day 0) (A).  Baseline and final percent fat mass (B) and 
percent lean mass (C) body composition measurements for all animals and groups. n= 15 
per group for all measurements.  Data reported as mean ± S.E.M. 
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3.5 Discussion 
Given the multitude of pharmacological studies by us and others implicating discrete 
functional and temporal roles of AgRP and NPY in regulating ingestive behaviors [30, 31, 33], 
we tested here for the first time if AgRP knockdown affects food hoarding following energetic 
challenges.  We initially confirmed that peripherally administered substances, and thus antisense 
oligos, are sufficient to reach the Arc and, in turn, circumvents the need for central cannulations 
and drug delivery.  By employing a novel AgRP-DsiRNA, we were able to attenuate food 
deprivation-induced increases in AgRP mRNA expression and decrease basal AgRP expression 
in ad libitum fed hamsters without affecting NPY mRNA expression.  We chose to test the 
efficacy of AgRP-DsiRNA using a 48 h food deprivation challenge as this represents a natural 
energetic challenge that markedly upregulates AgRP and NPY expression [40, 47, 48].  
Importantly, we confirmed the efficacy of AgRP-DsiRNA-mediated gene knockdown with two 
complementary techniques (in situ hybridization and qPCR), repeated across multiple 
experimental cohorts, and found a comparable ~40-50% knockdown with both approaches.  
Although antisense oligo stability in vivo may be increased with the use of transfection agents 
[49], the sufficiency of saline diluted oligos demonstrated here and by others [38] circumvents 
possible toxicity affecting behavior (for review see [34]).  In addition, modified oligo duplexes 
(i.e. DsiRNAs) have an elimination half-life of approximately ~0.8 h compared with ~1.5 h for 
conjugated duplexes [50]; however, we overcame this temporal limitation by giving a relatively 
high dose of AgRP-DsiRNA (0.4µg/g BM) daily to efficiently block AgRP expression.  Our 
experimental approach employed here has several advantages and broad implications for future 
work.  Of note, DsiRNA facilitates targeted gene knockdown without surgery, virally mediated 
gene delivery, or genome modification, and is in turn clinically relevant for humans.  Indeed, 
83 
there are currently at least 20 antisense drugs in development and one currently approved 
(Vitravene) for humans [34, 51].  Moreover, this approach can be rapidly adapted to any animal 
species and mRNA sequence with minimal side effects, and therefore avoids the inherent 
limitations of generating knockout or knockin animal models.   
Our findings here that AgRP knockdown attenuates food deprivation- and ghrelin-
induced increases in food hoarding is complementary to our recent pharmacological data 
demonstrating central AgRP drives food hoarding largely independent of food foraging or food 
intake [33].  AgRP-DsiRNA attenuated short-term (days 1-3) food hoarding following food 
deprivation and exogenous ghrelin, and prolonged (combined days 4-6) food deprivation-
induced hoarding.  This is of particular importance and clinical relevance as studies suggest food 
deprivation increases food hoarding but not food intake in humans [8-11].  Although AgRP 
knockdown attenuated food deprivation-induced increases in food hoarding on days 4-6 relative 
to baseline, we found no difference between AgRP-DsiRNA and scRNA treatment on days 2-3 
post-refeeding.  To this end, the profound energy deficit following a food deprivation challenge 
markedly upregulates AgRP and NPY expression, and although AgRP-DsiRNA significantly 
decreases AgRP mRNA, we speculate that remaining AgRP mRNA due to an incomplete 
knockdown is sufficient to drive the acute increase in food hoarding relative to baseline.  Our 
findings that AgRP-DsiRNA treatment had no effect on basal hoarding levels compared with 
controls (i.e. saline + scRNA) prior to exogenous ghrelin or on any subsequent day for the 
duration of the experiment would support this and suggests food hoarding increases are 
dependent on AgRP upregulation.  We cannot, however, rule out the possibility that NPY 
signaling is sufficient to regulate food hoarding on days 2-3 post-refeeding or basal food 
hoarding in the absence of AgRP.  In addition, we did not examine other Arc neuron populations 
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that AgRP antagonizes, including neurons expressing the anorectic peptide pro-opiomelanocortin 
(POMC) [27, 52].  It is therefore possible an increase in POMC due to inhibition release, or 
compensatory decrease due to an absence of AgRP antagonism, is involved in our observed 
phenotype.  However, as POMC neurons are also inhibited by NPY [53], which was left 
unchanged during AgRP knockdown, we speculate that POMC neurons are not involved in 
AgRP-DsiRNA-mediated hoarding blockade.   
Under the baseline condition where food was abundantly available, we observed the 
significantly large “surplus” pellets left on top of the foraging apparatus. This was possibly due 
to their constant effort to forage enough pellets in order to prevent any possible food deficiency; 
whereas under energetic challenges (eg, food deprivation), they forage less, hoard more, and 
waste less to conserve energy, and to achieve the same purpose, to avoid future food deficiency. 
Under the latter condition, the marked food deprivation-induced increase in food hoarding was 
coupled with significantly decreased food intake and food foraging compared with baseline in 
both scRNA and AgRP-DsiRNA treated animals.  Although food intake returned to baseline by 
day 3 or combined days 4-6 post-refeeding, food foraging remained depressed for the duration of 
the experiment in both groups.  Of note, this decrease in food foraging and food intake was 
coupled with a marked decrease in body mass and % fat mass, and would lend support to our 
previous findings that lipectomized hamsters markedly increase food hoarding and decrease 
foraging across 12 weeks [54].  We speculate this decrease in food foraging is an evolutionary 
adaption to conserve energy in response to the profound energetic challenge of food deprivation 
and resulting depletion of energy stores.  Food deprivation markedly increases AgRP expression, 
which conveys a negative valence signal [55], causing the avoidance of situations associated 
with painful experiences (hunger).  Animals compensate for decreased energy supply, in part, by 
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decreasing energy expenditure (i.e. wheel running) [56], and once food becomes available, food 
hoarding is markedly increased as a mechanism to avoid future energetic challenges and negative 
valence signals.  As the number of pellets earned is decreased, and pellets hoarded increased, 
there is a resulting decrease in pellets consumed and surplus pellets.  Hence, animals decrease 
wheel running/foraging effort (thereby conserving energy), hoard more, and waste less in an 
effort to regain body mass and avoid future energetic challenges.  Our data would support this 
idea as there is a marked decrease in surplus pellets following refeeding (~50 pellets) compared 
with baseline (~320 pellets).  Moreover, the number of pellets hoarded is several orders of 
magnitude greater than baseline at day 1, and this corresponds with the greatest decrease in food 
intake and pellet surplus.  On days 2-3 and 4-6, food intake begins to return to baseline and there 
is a concurrent decrease in food hoarding.  As we found a significant difference in foraging effort 
between AgRP-DsiRNA and scRNA treated animals, we speculate that AgRP knockdown 
attenuates the negative valence signals conveyed by AgRP neurons and this translates, at least 
initially, to a relative increase in food foraging and decrease in food hoarding.  The marked 
decrease in body mass and food foraging through day 6 post-refeeding strongly suggests the 
profound energy deficit following fasting is compensated for through increased food hoarding 
and decreased food foraging. 
Although we found here a marked increase in food hoarding following exogenous ghrelin 
at combined days 1-3, this was coupled with a notable absence, and in fact significant decrease, 
in food foraging and food intake in contrast to our previous findings [22, 23].  We posit that 
these seemingly contrasting results are primarily due to differences in experimental design.  We 
have previously used a within subject design when measuring the effects of ghrelin on ingestive 
behaviors at hourly time points, and converted data to % control (i.e. relative to vehicle) rather 
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than a between subject design in this study in which data are expressed as raw values or % 
baseline.  In turn, stress associated with the novelty of the injection procedure is abrogated with a 
within subject, but readily apparent in a between subject design or when compared with % 
baseline (in which animals are not manipulated).  Moreover, and perhaps most significantly, 
ghrelin-induced increases in food foraging and food intake are comparatively small relative to 
hoarding and are gone by ~4 h post- injection [22, 23].  In turn, the experimental design here in 
which we examine daily changes in ingestive behaviors following energetic challenges does not 
allow for the temporal resolution necessary to identify changes in food foraging or food intake 
following exogenous ghrelin treatment.  We therefore speculate significant increases in hoarding 
are apparent with daily measurements, but increases in food foraging and food intake necessitate 
greater temporal resolution (e.g. hourly measurements).  As such, we are as of now unable to 
definitely state that AgRP knockdown has no effect on acute food foraging or food intake 
following energetic challenges. 
3.6 Conclusions 
In summary, our results collectively indicate a critical role of AgRP signaling in 
regulating food hoarding following energetic challenges.  To this end, AgRP neurons project, in 
discrete populations, to a distributed network of forebrain and hindbrain nuclei [57]; however, 
future work investigating AgRP efferent nuclei is necessary to fully elucidate the exact 
mechanism of AgRP-mediated food hoarding.  Coupled with our previous findings that central 
AgRP selectively drives food hoarding, our finding here showing that AgRP knockdown 
attenuates ghrelin- and food deprivation-induced increases in food hoarding strongly suggests 
downstream AgRP signaling underlies this important behavior.  Moreover, as NPY drives acute 
increases in ingestive behaviors [31], we hypothesize that energetic challenges increase 
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appetitive and consummatory feeding behaviors through temporally distinct mechanisms.  AgRP 
neurons function, at least in part, to negate energy deficits (i.e. following food deprivation) 
through short-term, NPY-mediated food intake and prevent future challenges through AgRP-
mediated food hoarding.   
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4 GHRELIN ACTIVATES PERIPHERAL SENSORY NEURONS TO REGULATE 
METABOLIC HOMEOSTASIS INDEPENDENT OF FOOD INTAKE 
4.1 Abstract 
Obesity is a major health and economic burden with approximately 35% of United States 
citizens classified as either overweight or obese, and medical spending for treating obesity and 
its comorbidities exceeds $200 billion annually. The stomach-derived orexigenic hormone 
ghrelin is a key mediator of energy homeostasis and adiposity in humans due to its regulation of 
food intake, gut motility, energy expenditure, nutrient partitioning, glycemia, and body 
temperature. The ghrelin receptor, growth hormone secretagogue receptor 1a (GHSR), is widely 
expressed in the brain and on gastrointestinal vagal sensory neurons, and neuronal GHSR 
knockout results in a profoundly beneficial metabolic profile and diet-induced obesity (DIO) 
resistance. Moreover, ghsr knockout mice have impaired metabolic regulation during energetic 
challenges, and ghsr restoration in the brain does not fully restore ghrelin’s effects suggesting 
peripheral ghrelin signaling is critical for metabolic control. In the current study, we demonstrate 
that in addition to the well characterized vagal GHSRs, gastrointestinal sensory neurons 
emanating from spinal dorsal root ganglia (DRG) robustly express GHSRs that are activated by 
energetic challenges indicating a novel mechanism mediating ghrelin’s effects on energy 
homeostasis.  Sensory neuron GHSR deletion attenuates DIO through increased energy 
expenditure and sympathetic outflow to BAT and WAT, and this upregulated sympathetic 
outflow results in a marked increase in cold tolerance and adipose tissue browning capacity.  
Hence, these findings demonstrate a novel ghrelin signaling pathway critical for maintaining 
energy homeostasis and provides another point of attack for behavioral and/or pharmacological 
interventions to combat obesity. 
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4.2 Introduction 
The number of overweight and obese persons worldwide has continually risen across the 
last four decades with the current number of affected persons estimated 1.9 billion [1].  
Prolonged energy intake that exceeds energy expenditure can result in obesity and markedly 
increase the risk for secondary health consequences including type 2 diabetes, cardiovascular 
disease, and cancer [2-4].  As such, there has been considerable effort placed on uncovering the 
mechanisms regulating energy homeostasis.  Neuroendocrine systems that mediate this 
homeostasis are broadly distributed in the brain and periphery and form a complex, 
interconnected framework governing energy intake and expenditure, adipose tissue metabolism, 
and ingestive behaviors [5-7].  Both central and peripheral endocrine signaling is sufficient to 
regulate metabolism (for review see [5]), yet the mechanisms through which these pathways 
function independently or in parallel is largely unstudied.  To this end, gastric sensory neurons 
that detect nutrients or distension express endocrine receptors [8], and these afferents are 
sufficient to regulate adipose tissue metabolism [9].  Moreover, these sensory neurons can form 
short or long feedback loops within the spinal cord and hindbrain respectively [9-11], and this 
central-peripheral crosstalk is critical for maintaining metabolic homeostasis.  As the number of 
obese persons worldwide continues to increase, a comprehensive study investigating the 
peripheral mechanisms controlling ingestive behaviors and energy homeostasis may provide 
more accessible pharmacological interventions as these receptors are independent of the brain 
and blood brain barrier. 
Ghrelin is a 28-amino acid peptide hormone secreted from the stomach [12]. Circulating 
ghrelin levels rise pre-prandially (i.e. during fasting) and decrease post-prandially, and the rise 
and fall of ghrelin concentrations is suggested as contributor to normal energy homeostasis and 
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overall metabolic health [13, 14]. In both humans and rodents, activation of the ghrelin receptor, 
growth hormone secretagogue receptor 1a (GHSR) [15], markedly increases adiposity through 
increased food intake [16, 17], decreased energy expenditure, and reduced fatty acid utilization 
[18, 19]. Moreover, exogenous ghrelin decreases core body temperature [20], attenuates brown 
adipose tissue (BAT) thermogenesis [20], and reduces insulin secretion resulting in 
hyperglycemia [21, 22]. GHSRs are widely expressed in the brain and on peripheral neurons 
including gastric vagal afferents [23, 24], and GHSR deletion or blockade prevents diet-induced 
obesity (DIO), ghrelin-induced ingestive behaviors [17, 25, 26], and significantly increases 
energy expenditure [27], thermogenic capacity [27], and insulin sensitivity [28]. However, ghsr 
restoration in the brain does not fully restore ghrelin’s effects suggesting peripheral ghrelin 
signaling is critical for metabolic control [29]. Integration of peripheral sensory information in 
the brain is mandatory for maintaining energy homeostasis [30-32], and dysregulated sensory 
neuron function and ghrelin signaling is well documented in the obese [33-35]. In lean humans 
and rodents, activation of gastric stretch or nutrient receptors promotes satiety [36-38], and their 
activity is directly enhanced by anorectic gut hormones and inhibited by ghrelin [5, 39]. In 
addition, activation of intestinal nutrient receptors increases BAT thermogenesis [9], a key 
mediator of whole body energy expenditure and adiposity [40], indicating an important link 
between gastrointestinal stimuli, sensory neuron activation, ghrelin signaling, and metabolic 
control. Initial studies suggested ghrelin-mediated energy expenditure regulation, thermogenesis, 
gut motility, and glycemic control is dependent on intact gastric vagal afferents [41-43]. 
However, non-vagal sensory neurons innervate the gut at all levels [44], and vagotomized 
animals have normal adaptation to cold challenges and gastric responses to an exogenous ghrelin 
challenge suggesting non-vagal GHSR-containing sensory neurons are sufficient to mediate 
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these responses [45-48]. Total sensory neuron ablation following capsaicin treatment impairs 
adipose tissue metabolism, cold-induced thermogenic responses, and, at the very least, ghrelin’s 
gastric effects indicating DRG sensory neurons are mandatory for metabolic control [49-51].  
To interrogate the role of peripheral ghrelin signaling in regulating metabolic 
homeostasis, we used a GHSR-IRES-tauGFP mouse [52] and found robust GHSR expression on 
DRG sensory neurons that are activated by energetic challenges including food deprivation and 
cold exposure. We next characterized the necessity of this peripheral ghrelin signaling pathway 
in regulating metabolic homeostasis by generating a novel, sensory neuron specific GHSR 
knockout mouse, and found these mice had a marked increase in energy expenditure and adipose 
thermogenic gene expression that resulted in diet-induced obesity resistance and improved cold 
tolerance despite no changes in food intake. This peripheral ghrelin signaling pathway functions 
in parallel to previously defined central feeding circuits and indicates a novel mechanism 
through which sensory neuron ghrelin signaling regulates adipose tissue metabolism and whole-
body energy homeostasis. Hence, this discrete sensory neuron pathway may provide a novel 
therapeutic avenue to prevent or reverse obesity. 
4.3 Materials and Methods 
4.3.1 Animals 
Adult Ghsr-IRES-tauGFP mice were obtained from the Jackson Laboratory (Stock No: 
019908).  To generate a sensory neuron specific Ghsr knockout model, we crossed our existing 
Advillin-Cre mouse line [53, 54] with Ghsrf/f mice [27] (mouse lines were kindly provided by 
Drs. Fan Wang from Duke University and Yuxiang Sun at Texas A&M University respectively) 
to generate Advillin-Cre+/-;Ghsrf/f mice (henceforth referred to as AGKO).  Male AGKO or f/f 
littermate mice were fed either a standard chow diet (catalog no.: 5001; LabDiet; Purina, St. 
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Louis, MO) or high fat diet (HFD) consisting of 60% calories from fat (catalog no. 12492; 
Research Diets, New Brunswick, NJ).  Body mass measurements were taken weekly for the 
duration of the experiment.  Animals were maintained at ~23°C with 12-hour light/dark cycles 
(0700-1900 light).  All procedures were approved by the Georgia State University Institutional 
Animal Care and Use Committee and were in compliance with the Public Health Service and 
United States Department of Agriculture guidelines. 
4.3.2 Physiology Measurements 
Glucose and insulin tolerance tests were performed on male AGKO or f/f littermate mice 
after 12 weeks on either Chow or high-fat diet (HFD) as we observed the greatest difference in 
body mass during this time.  For glucose tolerance tests, animals were fasted for 16 hours 
overnight.  Baseline glucose measurements were obtained from a tail nick using a OneTouch 
Ultra Blood Glucose Meter and glucose test strips (LifeScan, Inc., Milpitas, CA).  Following the 
initial measurement, mice were intraperitoneally injected with a 20% dextrose solution (1g/kg 
body mass), and subsequent blood glucose measurements were performed at 15, 30, 60, 90, and 
120 minutes after the glucose injection.  For the insulin tolerance test (ITT), mice were fasted for 
4 hours prior to the start of the procedure, and baseline blood glucose was measured from a small 
tail nick.  Mice were then intraperitoneally injected with 1.0 U/kg insulin (Humulin R; Eli Lilly, 
Indianapolis, IN), and blood glucose was measured at the same time points used for the GTT.  
Energy expenditure, oxygen consumption, carbon dioxide production, respiratory exchange ratio, 
and physical activity data were collected for male AGKO or f/f littermate mice using a TSE 
PhenoMaster metabolic chamber system (TSE Systems, Chesterfield, MO) after 12 weeks on 
Chow or HFD.  Animals were allowed a 48-hour acclimation period prior to the start of data 
collection and then returned to their home cage at the end of the experiment. 
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4.3.3 Body Composition Measurements 
Body composition measurements were taken for HFD-fed male AGKO or f/f littermate 
mice using our Minispec LF90 TD-NMR analyzer (Bruker Optics).  For all measurements, 
animals were briefly removed from their home cage, placed in the body composition analyzer, 
and then immediately returned to their home cage.  Body composition measurements were taken 
for all animals prior to the start of HFD feeding, after 8 weeks of HFD feeding, and then again at 
the conclusion of the experiment. 
4.3.4 Tissue Collection 
At the end of each experiment, mice were euthanized using carbon dioxide inhalation.  
Blood serum was collected and stored at −80°C until analysis.  Animals were then perfused with 
ice cold 0.1M PBS and fat pads (brown (iBAT), epididymal (eWAT), and inguinal (iWAT)), 
liver, brain, and DRGs (L5-T5 levels) dissected and flash frozen in liquid nitrogen.  For brain 
microdissection, the brain was placed on an ice cold cutting block and 1 mm sagittal sections 
taken from both sides of the midline.  The arcuate hypothalamus, paraventricular hypothalamus, 
ventromedial hypothalamus, and ventral tegmental area were then microdissected according to a 
mouse brain atlas (Paxinos and Franklin [55]) and flash frozen in liquid nitrogen.  A sample of 
each fat pad and liver was taken prior to freezing and placed in formalin for later histological 
analysis.  In a separate set of Ghsr-GFP mice used for immunohistochemical analysis, animals 
were euthanized by carbon dioxide inhalation and then transcardially perfused with 75 ml 0.9% 
heparinized saline followed by 150 ml 4.0% paraformaldehyde in 0.1 M PBS in sterile filtered 
dH2O.  DRGs (L5-T5 levels) were subsequently removed and dehydrated in an 18% sucrose 
solution until immunohistochemical analysis.   
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4.3.5 Fast Blue Injections 
1% Fast Blue in sterile dH2O (17740-1, Polysciences, Warrington, PA) was used as a 
fluorescent retrograde neuronal tracer to identify gastrointestinal-projecting sensory neurons.  In 
brief, animals were deeply anesthetized with 1-2% isoflurane, and a small incision was made on 
the ventral midline to expose the peritoneal cavity and discrete gut regions (i.e. stomach and 
small and large intestine).  A series of 0.5-1 µl injections were given across 4 loci along greater 
curvature of the stomach or across 8 evenly spaced loci along the small or large intestine through 
a 26-gauge needle and syringe.  The peritoneal cavity was then closed with sterile dissolvable 
sutures and the skin incision closed with sterile wound clips.  Animals were given 7 days to 
recover and allow for retrograde Fast Blue transport before euthanization and tissue extraction as 
described above. 
4.3.6 Histological Analysis 
For DRG GFP immunohistochemical quantification in our Ghsr-GFP mice injected with 
Fast Blue (see above), DRGs (L5-T5 levels) were removed from the sucrose solution and sliced 
in a cryostat at 25 µm.  DRG sections were taken in series across three slides (SuperFrost Plus 
slides (Thermo Fisher Scientific); 8 sections/slide total) to prevent a single neuron being present 
multiple times on the same slide as previously described [30, 53].  For immunohistochemical 
staining, in brief, slides were washed 3X15 min in sterile 0.1M PBS on a rotator.  DRG sections 
were blocked with 5% normal horse serum containing 0.3% Triton X-100 in 0.1M PBS for 1 h.  
Slides were then incubated overnight at room temperature with rabbit anti-cFOS (1:500; sc-52, 
Santa Cruz Biotechnology, Santa Cruz, CA) and chicken anti-GFP (1:400; GFP2020, AvesLabs, 
Tigard, OR) antibodies in 0.1M PBS with 0.3% Triton X-100 and 10% normal horse serum.  
Next, slides were washed 3X 15 min in 0.1M PBS and then incubated at 4°C for 24 h with 
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donkey anti-chicken-488 (1:1000; 703-545-155, Jackson Immunoresearch, West Grove, PA) and 
donkey anti-rabbit-CY3 (1:400; 711-165-152, Jackson Immunoresearch, West Grove, PA) in 
0.1M PBS.  Slides were then washed 3 X 15 min with 0.1M PBS and coverslipped with Prolong 
antifade fluorescent medium (Invitrogen).  Images were captured using an Olympus DP73 
photomicroscope and CellSens software (Olympus, Waltham, MA).  For GFP, cFOS, and Fast 
Blue quantification, total cell numbers were estimated by counting the number of fluorescently 
positive neurons on a single section and then multiplying this number by 8 as each slide contains 
8 sections as previously described [32].   
For adipose tissue immunohistochemical analysis, samples were removed from formalin, 
dehydrated through a series of increasing isopropanol washes, and embedded in paraffin blocks. 
iBAT, iWAT, and eWAT were sliced at 5 µm on a rotating microtome and mounted on 
SuperFrost Plus slides (Thermo Fisher Scientific).  Slides were deparaffinized and hydrated by 
washing in p-xylenes followed by a series of decreasing ethanol washes.  Sections were next 
incubated in DAKO antigen retrieval solution (DAKO, S1699) and heated in a microwave for 14 
minutes total.  Rabbit anti-UCP1 antibody (ab10983, Abcam) 1:150 was applied to all sections 
and then incubated overnight at 4°C.  Slides were then washed 4 X 30s in a tris buffer solution 
and the secondary biotinylated mouse adsorbed donkey anti-rabbit antibody (Jackson 
ImmunoResearch, 711-065-152) applied to all sections and incubated for 30 min. at room 
temperature.  Slides were washed 4 X 30s in tris buffer and then incubated in an ABC solution 
(Vector Labs, PK-6100) for 30 min. at room temperature.  Sections were then washed 2 X 30s in 
1M tris-HCl solution and then incubated in a DAB reaction solution (Vector Labs, SK-4100) for 
5-15 min.  Slides were washed in dH2O for 5 min. and then dehydrated through graded alcohol 
washes followed by a final p-xylene wash.  Slides were then coverslipped with permount (Fisher, 
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SP15-100), allowed to dry, and imaged with an Olympus DP73 photomicroscope and CellSens 
software (Olympus, Waltham, MA). 
For hematoxylin and eosin adipose tissue histology, samples were removed from 
formalin, dehydrated through a series of increasing isopropanol washes, and embedded in 
paraffin blocks. iBAT, iWAT, and eWAT were sliced at 5 µm on a rotating microtome and 
mounted on SuperFrost Plus slides (Thermo Fisher Scientific). Tissue morphology was visually 
analyzed using hematoxylin and eosin staining (Sigma-Aldrich). Adipose histology images were 
captured using an Olympus DP73 photomicroscope and CellSens software (Olympus, Waltham, 
MA). 
4.3.7 In Vitro DRG Culture 
Adult Ghsr-GFP mice were euthanized by carbon dioxide inhalation, and DRGs (L5-T5 
levels) immediately removed and placed in ice cold 0.1M PBS with 20mM HEPES.  This 
solution was then replaced with 1mg/ml collagenase 1 (Worthington Biochemical Corporation 
CLS-1) in 0.1M PBS and 20mM HEPES for 60-90 min at 37°C followed by 0.05% Trypsin-
EDTA (Sigma T9201) solution in 0.1M PBS and 20mM HEPES for 7 min at 37°C.  DRGs were 
then washed 2X with 1ml complete neurobasal media (Fisher 10888022) with 1X B-27 (Fisher 
17504044) and 200µM L-glutamine (Fisher 25030149).  Next, 600µl complete neurobasal media 
was added and the DRGs triturated 30X.  Dissociated neurons were filtered through a 100µm 
cell strainer into a new microcentrifuge tube and then washed 2X with 500µl complete 
neurobasal media.  Neurons were then centrifuged for 5 min at 200g, the supernatant removed 
and replaced with 1ml complete neurobasal media, triturated 3X, and then seeded onto Poly-D-
Lysine and Laminin coated coverslips.  Cultured neurons were transferred to a 37°C + 0.5% CO2 
incubator until use. 
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4.3.8 Calcium Imaging and Electrophysiology 
For calcium imaging, coverslips containing cultured DRG neurons were transferred to a 
new 3.5mm dish containing 5µM Fura-2 AM (MilliporeSigma 344905) in complete neurobasal 
media and placed in a 37°C + 0.5% CO2 incubator for 30 min.  Neurons were then washed 3X 
with an extracellular recording solution composed of 152mM NaCl, 2.8mM KCl, 10mM HEPES, 
2mM CaCl2, and 10mM glucose and placed in a 37°C for 20-30 min to allow for intracellular 
deesterification.  Neuronal recording was performed using a Polychrome V monochromator 
(TILL Photonics).  In brief, GFP-positive neurons were identified under a microscope and 
baseline calcium currents were measured for 5-10 min.  Next, either 100nM ghrelin (Bachem 
4033076) or vehicle (extracellular recording solution) was administered and changes in calcium 
currents measured for 30-60 min.  At the end of each recording, 60mM KCL was given as a 
positive control for neuronal viability, and only neurons that were depolarized by KCl were used 
for analysis. 
For electrophysiological recordings, DRG neurons were extracted from Ghsr-GFP mice 
and dissociated as described above.  Dissociated neurons were plated into 35 mm plastic dishes 
coated with poly-D-lysine and used for recording 3-5 days after plating.  GFP-labeled DRG 
neurons were visualized using a GFP-filtered excitation and emission fluorescent light under an 
inverted microscope.  Patch-clamp recordings were performed using a Multiclamp 700B 
amplifier, Digidata 1440A interphase, and pClamp 10 software (Molecular Devices, Union City, 
CA) under voltage-clamp and current clamp modes.  The external solution (pH 7.3) consisted of 
152 mM NaCl, 2.8 mM KCL, 10 mM HEPES, 2 mM CaCl2, and 10 mM glucose.  The 
intracellular solution (pH 7.3) consisted of 130 mM K-gluconate, 10 mM HELES, 0.6 mM 
EGTA, 0.3 mM K-ATP, 0.3 mM Na-GTP, and 10 mM phosphocreatine. 
102 
4.3.9 Quantitative Gene and Protein Analysis 
RNA from frozen tissues was extracted using TRIzol Reagent (Thermo Fisher) according 
to the manufacturer’s instructions.  Gene expression was measured using a 7500-Fast RT-PCR 
machine (Applied Biosystems), ABI Universal PCR Master Mix (Applied Biosystems, Foster 
City, CA), and primer and probe sets purchased from Applied BioSystems.  Relative gene 
expression was determined using the ΔΔCt method with cyclophilin as an internal control [56].  
The following genes were assayed: 
Acyl-CoA Oxidase 1 (Acox1); β3 Adrenergic Receptor (β3AR); Carnitine 
Palmitoyltransferase 1B (Cpt1b); Cell Death-Inducing DFFA-Like Effector A (Cidea); 
Cyclooxygenase 1 (Cox1); ELOVL Fatty Acid Elongase 3 (Elovl3); Growth Hormone 
Secretagogue Receptor 1a (Ghsr);  Iodothyronine Deiodinase 2 (Dio2); Peroxisome Proliferator 
Activated Receptor Alpha (Ppar-α); Peroxisome Proliferator Activated Receptor Gamma (Ppar-
γ); PPARG Coactivator 1 Beta (Pgc-1β); PR domain containing 16 (Prdm16); Uncoupling 
Protein 1 (Ucp-1); Uncoupling Protein 3 (Ucp-3). 
For Western blot analysis, proteins were extracted using a radioimmunoprecipitation 
assay buffer with protease inhibitor cocktails (Sigma-Aldrich, St. Louis, MO) and a handheld 
homogenizer.  Protein concentration was quantified with a DC Protein Assay (BioRad, Hercules, 
CA), and protein samples were denatured at 37°C for 30 minutes.  20 to 30 µg protein was 
loaded onto a 4% to 15% gradient polyacrylamide gel (Criterion TGX; BioRad, Hercules, CA) 
and then transferred to a polyvinylidene difluoride membrane. We immunoblotted the 
membranes by blocking with 5% nonfat milk and followed by antibodies against uncoupling 
protein 1 (1:500) (catalog no. 23841; Abcam, Cambridge, MA), tyrosine hydroxylase (1:1000) 
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(catalog no. AB152; Millipore Sigma, Burlington, MA), pHSL (1:1000) (catalog no. 4126; Cell 
Signaling, Danvers, MA), or α-tubulin (1:500) (catalog no. ABCENT4777; Advanced 
Biochemicals, Lawrenceville, GA) overnight at 4°C.  Next, samples were incubated in an Alexa 
Fluor goat anti-rabbit 680 secondary antibody (catalog no. A21109; Thermo Fisher Scientific, 
Waltham, MA) at 1:5000 concentration for 3 hours. Bands were visualized and quantified using 
an Odyssey Fc Imaging System (Li-Cor, Lincoln, NE) with background subtracted. All 
membranes were immunoblotted with and normalized to α-tubulin antibody at 1:500 dilution 
(catalog no. 2144S; Cell Signaling). 
4.3.10 Cold Exposure 
2 weeks prior to the start of cold exposure, 10-week-old AGKO and f/f littermate mice 
were implanted with temperature transponders (IPTT-300, BMDS, Seaford, DE).  In brief, 
animals were deeply anesthetized with 1-2% isoflurane and a small incision made along the 
ventral midline to expose the peritoneal cavity.  Sterile temperature transponders were inserted 
into the peritoneal cavity, the incision closed with sterile dissolvable sutures, and the skin 
incision closed with sterile wound clips.  Following transponder implantation, animals were 
singly housed in shoebox cages with only corn cob bedding for recovery.  At the start of the 
experiment, baseline body temperature measurements were taken for all animals before being 
placed in a 10°C cooler for 7 days.  Core body temperature measurements were taken for all 
mice every hour for the first 8 hours of the study, and then every 2 hours through 24 h.  
Measurements were taken every 2 hours from 0700 to 1900 for the remaining 6 days.  At the end 
of the experiment, animals were removed from the cooler, immediately euthanized, and tissues 
extracted as described above.  In a separate set of Ghsr-GFP mice used for 
immunohistochemical analysis, mice were placed in the 10°C cooler for 7 days exactly as 
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described above, but without implantation of temperature transponders or core body temperature 
measurements taken. 
4.3.11 Food Intake Studies 
For ghrelin-induced food intake measurements, single housed ad libitum Chow-fed or 
HFD-fed AGKO and f/f littermate mice were given a 0.5 mg/kg subcutaneous ghrelin challenge 
(4033076, Bachem, Torrance, CA) at 0800.  Food intake was measured at 30, 60, 90, and 120 
min post-injection.  For food deprivation-induced food intake, single housed Chow-fed or HFD-
fed AGKO and f/f littermate mice were food deprived for 16 hours.  At 0800, food was returned, 
and food intake measured at 30, 60, 90, and 120 min post-refeeding. 
4.3.12 Statistical Analysis 
All data were expressed as mean ± S.E.  Relative expression for all genes measured by 
quantitative PCR were normalized to cyclophilin.  For calcium imaging experiments, ΔF/F% was 
calculated by first taking the average baseline fluorescence across the initial 5-10 min. of the 
study.  Next, % change in fluorescence was calculated at each timepoint using the formula 
[[(TimepointX-baseline)/baseline] * 100].  Experimental data were analyzed by a Student’s t-
test, paired t-test, or a two-way or three-way Repeated Measures ANOVA followed by Duncan’s 
Multiple-Comparison post-hoc analysis where appropriate.  For all experiments, differences 
among groups was considered statistically significant at P<0.05 and trending toward significance 
at P≤0.1.   
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4.4 Results 
4.4.1 GHSRs are expressed in vagal and DRG neurons that project to the gastrointestinal 
system 
We first sought to identify organs innervated by GHSR-containing sensory neurons using 
the neuronal tracer Fast Blue.  Because ghrelin is predominantly produced in the stomach, we 
hypothesized that gastrointestinal sensory neurons would express GHSRs.  Indeed, we found that 
stomach, small intestine, and large intestine sensory neurons largely originate in the vagus nerve, 
but significant DRG innervation exists between T12 and T5 ganglia for all areas [Fig. 4.1 A].  
GFP immunohistochemistry revealed strong, consistent labeling in the nodose ganglia and across 
all DRG levels in our Ghsr-IRES-tauGFP mice (data not shown), but because Fast Blue most 
strongly labeled T12-T5 ganglia we chose to focus our efforts on these levels [Fig. 4.1 B].  
Extensive GFP and Fast Blue double labeled neurons were present in these ganglia [Fig. 4.1 C-
E].  We found significant GFP and Fast Blue colocalization in vagal and DRG neurons that 
project to the stomach [Fig. 4.1 F] or small intestine [Fig. 4.1 G] with between 10%-40% GFP 
neurons co-labeled with Fast Blue and between 20%-60% Fast Blue neurons co-labeled with 
GFP.  By contrast, we found significantly less Fast Blue and GFP colocalization in large 
intestine projecting sensory neurons and therefore focused our efforts on the stomach and small 
intestine (data not shown).  Although the presence of GFP indicates GHSR expression in DRGs 
and the nodose ganglia, we confirmed these GHSRs were responsive to ghrelin using in vitro 
DRG cultures and a combination of electrophysiology and calcium imaging.  Using dissociated 
DRG neurons from Ghsr-IRES-tauGFP mice, we found that 100 nmol ghrelin increased the 
neurons membrane potential and resulted in spontaneous action potentials [Fig. 4.1 H].  
Moreover, patch clamp studies found that 100 nmol ghrelin, but not vehicle, significantly 
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decreased neuron hyperpolarization [Fig. 4.1 I-J].  We next used in vitro calcium imaging to 
confirm our electrophysiology results on Ghsr-IRES-tauGFP mouse DRG neurons.  100 nmol 
ghrelin markedly increased calcium efflux from GFP-positive DRG neurons, but this effect was 
absent in GFP-negative neurons given 100 nmol ghrelin and in GFP-positive and GFP-negative 
neurons receiving vehicle [Fig. 4.1 K-L]. 
4.4.2 Sensory neuron GHSRs are activated by energetic challenges 
After we identified the anatomical distribution of sensory neuron-containing GHSRs and 
their response to ghrelin in vitro, we next tested whether these neurons are activated by energetic 
challenges.  We chose overnight food deprivation and acute (24 h) cold exposure challenges as 
these elicit a robust increase in circulating ghrelin [13, 57].  We found that both fasting and cold 
exposure significantly increased Arc GHSR expression, but only cold exposure significantly 
increased DRG GHSR expression [Fig. 4.2 A, E].  By contrast, neither fasting nor cold exposure 
significantly affected the total number of GFP-positive DRG or vagal sensory neurons [Fig. 4.2 
B, F].  We next examined whether food deprivation or cold exposure activated DRG and vagal 
GHSR-positive neurons in vivo using triple labeling for GFP, Fast Blue, and the neuronal 
activity marker cFos [58].  We found that both food deprivation and cold exposure significantly 
increased stomach [Fig. 4.2 C, G] and small intestine [Fig. 4.2 D, H] projecting GHSR sensory 
neuron activity, and that these energetic challenges robustly induced cFos immunoreactivity 
allowing for triple immunofluorescence labeling [Fig. 4.2 I-L]. 
4.4.3 Sensory neuron GHSR knockout does not affect chow-fed mice 
We next examined the endogenous role of sensory neuron GHSR signaling in regulating 
energy homeostasis by generating a novel, sensory neuron GHSR knockout mouse model.  To 
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accomplish this, we crossed our sensory neuron-specific advillin-cre driver mouse line with the 
recently generated ghsrf/f mouse [27, 53].  The resultant offspring (henceforth referred to as 
AGKO) had normal hypothalamic GHSR expression, but an approximately 90% decrease in 
DRG GHSR expression indicating GHSR deletion is specific to peripheral sensory neurons [Fig. 
4.3 A].  Chow-fed AGKO mice had no difference in body mass [Fig. 4.3 B, D] nor in 
interscapular brown adipose tissue (iBAT), epididymal adipose tissue (eWAT), inguinal adipose 
tissue (iWAT), or liver mass compared with f/f littermates [Fig. 4.3 C, E-G].  As GHSRs are 
necessary for exogenous ghrelin-induced food intake, we next tested whether AGKO mice 
respond to a peripheral ghrelin challenge (0.5 mg/kg body mass) and whether these mice have a 
normal feeding response following an overnight fast.  In line with previous work indicating 
central GHSRs are sufficient to regulate food intake [16, 29], we found that both an exogenous 
ghrelin challenge and an overnight fast comparably increased food intake in AGKO and f/f 
control mice [Fig. 4.3 H-I].  Moreover, we found no difference in 24 h food intake between 
AGKO and f/f littermates [Fig. 4.3 G].   Because ghrelin and ghsr knockout mice have improved 
glucose disposal and insulin sensitivity, we next tested glucose and insulin tolerance in our 
AGKO mice.  We found that chow-fed AGKO and f/f littermate mice had no difference in 
glucoregulation following a glucose tolerance test [Fig. 4.3 K], overnight fasting [Fig. 4.3 L], 
insulin tolerance test [Fig. 4.3 M], or in ad lib fed plasma insulin concentrations [Fig. 4.3 N].   
4.4.4 Chow-fed AGKO mice have increased energy expenditure and adipose thermogenic 
gene expression 
To characterize the metabolic phenotype of our AGKO mice, we used indirect 
calorimetry measurements in our metabolic cage system.  We found that AGKO and f/f control 
mice had slightly elevated energy expenditure at several time points throughout the experiment 
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[Fig. 4.4 A], although we found no significant difference in area under the curve [Fig. 4.4 B].  
We found several instances of AGKO mice having higher respiratory quotient measurements 
indicating a preferential use of carbohydrates [Fig. 4.4 C], but no difference between AGKO and 
f/f mice during either daytime or nighttime as measured by area under the curve [Fig. 4.4 D].  To 
identify the mechanism driving this increased energy expenditure, we examined thermogenic 
gene expression in adipose tissue as previous studies demonstrated ghsr knockout mice have 
significantly increased thermogenic capacity [27].  We found that AGKO mice had markedly 
increased thermogenic and β3-adrenergic receptor gene expression in iBAT, eWAT, and iWAT 
compared with f/f controls suggesting increased adipose tissue thermogenesis underlies the 
elevated energy expenditure in AGKO mice [Fig. 4.4 E-G].  Moreover, AGKO mice had 
significantly increased UCP-1 protein content in iBAT, a trend of increased UCP1 in eWAT, and 
significantly increased TH proteins in eWAT and iWAT compared with f/f control mice 
compared with [Fig. 4.4 H-J]. 
To confirm our gene and protein expression results, we analyzed AGKO and f/f adipose 
tissues using hematoxylin and eosin (H&E) staining and UCP-1 immunohistochemistry (IHC).  
Compared with f/f H&E and UCP-1IHC stained iBAT [Fig. 4.5 A, C], AGKO iBAT was 
notably darker and had a greater density of UCP-1 staining [Fig. 4.5 B, D].  H&E stained eWAT 
was comparable in f/f [Fig. 4.5 E] and AGKO [Fig. 4.5 F], yet AGKO mice had significantly 
more UCP-1 staining compared with f/f mice [Fig. 4.5 G, H].  iWAT histological analysis 
revealed a marked difference between H&E stained f/f [Fig. 4.5 I] and AGKO [Fig. 4.5 J] mice 
such that AGKO iWAT was significantly more BAT-like.  Indeed, UCP-1 IHC revealed 
markedly more staining in AGKO iWAT compared with f/f iWAT [Fig. 4.5 K, L]. 
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4.4.5 Diet-induced obesity is attenuated in AGKO mice 
The significant increase in energy expenditure and thermogenic capacity led us to 
hypothesize that AGKO mice would resist the development of diet induced obesity.  We found 
that a HFD consisting of 60% calories from fat markedly increased body mass and overall fat 
mass in f/f control mice, but this effect was attenuated in AGKO mice [Fig. 4.6 A-B, D].  Tissue 
analysis revealed a significant decrease in liver and iWAT mass and a trend for decreased iBAT 
mass [Fig. 4.6 C, E-H].  We next tested the food intake response to an exogenous ghrelin 
(0.5mg/kg body mass) or overnight fasting challenge, and found that, like chow-fed mice, HFD-
fed AGKO and f/f control mice had comparable food intake following both ghrelin and fasting 
[Fig. 4.6 I-J].  In addition, AGKO and f/f mice have comparable 24 h food intake suggesting 
sensory neuron GHSR knockout does not affect food intake on HFD [Fig. 4.6 K].  As obese can 
lead to Type 2 Diabetes development in humans and mice, we tested the glucoregulatory ability 
in HFD-fed AGKO and f/f mice.  We found that sensory neuron GHSR deletion significantly 
improved glucose disposal during a glucose tolerance test and decreased fasting glucose [Fig. 4.6 
L-M].  In addition, AGKO mice had a trend of decreased circulating glucose 15 min. after an 
insulin challenge [Fig. 4.6 N] and decreased ad lib fed plasma insulin concentrations [Fig. 4.6 
O] suggesting these mice are more insulin sensitive compared with f/f controls. 
4.4.6 HFD-fed AGKO mice have increased energy expenditure and thermogenic gene 
expression 
We hypothesized that the DIO resistance in AGKO mice was due to increased energy 
expenditure as we found chow-fed mice had increased energy expenditure and thermogenic 
capacity [Fig. 4.4 and Fig. 4.5].  Indeed, HFD-fed AKO mice had significantly increased energy 
expenditure during both daytime and nighttime compared with f/f control mice [Fig. 4.7 A-B].  
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In addition, AGKO mice had significantly decreased respiratory quotient during nighttime hours 
indicating a preferential utilization of fatty acids as fuel [Fig. 4.7 C-D].  In contrast, there was no 
difference in the activity levels between fl/fl and AGKO mice (data not shown). We next 
examined adipose tissue gene expression with a focus on thermogenic genes as these were 
upregulated in chow-fed animals.  We found a significant increase in numerous thermogenic and 
browning genes in iBAT [Fig. 4.7 E], eWAT [Fig. 4.7 F], and iWAT [Fig. 4.7 G] when 
compared with f/f control mice suggesting the increased energy expenditure is due to 
upregulated thermogenic pathways in adipose tissue.  Moreover, we found significantly higher 
UCP1, TH, and a trend of increased pHSL protein content in AGKO iBAT compared with f/f 
animals [Fig. 4.7 H].  We observed a trend of increased TH protein in AGKO eWAT and 
significantly higher pHSL protein in AGKO iWAT compared with f/f control mice [Fig. 4.7 I-J]. 
We next performed H&E staining and UCP-1 IHC in fat tissues to confirm our gene and 
protein expression data.    We found that f/f mice had significantly larger adipocyte cell size in 
iBAT compared with AGKO mice [Fig. 4.8 A, B], and significantly less iBAT UCP-1 staining 
when compared with AGKO mice [Fig. 4.8 C, D].  Moreover, compared with f/f mice, we found 
a marked reduction in adipocyte size in AGKO eWAT [Fig. 4.8 E, F], iWAT [Fig. 4.8 I, J], and 
significantly decreased liver lipid deposits [Fig. 4.8 G, H]. 
4.4.7 AGKO mice are markedly more cold tolerant 
The marked increase in adipose tissue thermogenic genes would suggest AGKO mice 
have a greater capacity to maintain body temperature during a cold challenge.  Hence, we next 
tested the thermoregulatory ability in AGKO and f/f mice during an acute (1 day) 4°C or chronic 
(10 day) 10°C cold challenge.  We found that AGKO mice had significantly increased baseline 
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body temperature and were able to more rapidly normalize their temperature compared with f/f 
control mice in response to an acute 4°C cold challenge [Fig. 4.9 A].  In addition, AGKO mice 
had significantly increased core body temperature at several time points during a 7 day 10°C 
challenge and as measured by area under the curve [Fig. 4.9 B-C].  We next examined adipose 
thermogenic gene expression in these mice and found that a 1 day 4°C cold challenged AGKO 
mice had significantly increased thermogenesis and browning genes in iBAT, eWAT, and iWAT 
[Fig. 4.9 D-F].  Similarly, we found a 7 day 10°C challenged AGKO mice had significantly 
upregulated thermogenic genes in iBAT, eWAT, and iWAT [Fig. 4.9 G-I].   
We further examined adipose depots from 1 day and 7 day cold exposed animals using 
H&E and UCP-1 IHC analysis.  H&E staining was comparable for 1 day cold exposed f/f and 
AGKO iBAT and eWAT [Fig. 4.10 A, B and E, F], although AGKO mice had significantly 
increased UCP-1 IHC staining  in iBAT [Fig. 4.10 C, D] and eWAT [Fig. 4.10 G, H].  H&E 
stained iWAT in AGKO mice had a more BAT-like morphology compared with f/f mice [Fig. 
4.10 I, J], and iWAT UCP-1 IHC revealed markedly more staining for AGKO mice compared 
with f/f mice [Fig. 4.10 K, L].  Our analysis of adipose tissues from 7 day cold exposed animals 
complemented 1 day tissue analysis.  Compared with f/f mice, 7 day cold exposed AGKO mice 
had significantly darker H&E stained iBAT [Fig. 4.10 M, N], eWAT [Fig. 4.10 Q, R], and 
iWAT [Fig. 4.10 U, V].  Moreover, we found a marked increase in UCP-1 IHC staining in 
AGKO iBAT [Fig. 4.10 O, P], eWAT [Fig. 4.10 S, T], and iWAT [Fig. 4.10 W, X] as compared 
with f/f mice.  
We next sought to further study whether increased BAT thermogenesis and WAT beiging 
in AGKO mice during cold exposure was due to increased sympathetic activity by measuring TH 
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protein levels using Western Blot analysis.  We found 1 day cold exposure significantly 
increased AGKO TH protein in iBAT [Fig. 4.11 A] and iWAT [Fig. 4.11 C], but not in eWAT 
[Fig. 4.11 B].  In addition, 7 day cold exposed AGKO mice also had a trend of increased TH 
protein in iBAT [Fig. 4.11 D], eWAT [Fig. 4.11 E], and iWAT [Fig. 4.11 F].  Interestingly, we 
also found a significant increase in iWAT pHSL in 7 day cold exposed AGKO mice [Fig. 4.11 
F]. 
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Fig. 4.1 GHSR-positive neurons emanate from DRGs. 
Average number of stomach, small intestine, or large intestine injected Fast Blue positive 
neurons in the vagus and L5/6-C1 DRG levels (A) (n=8).  Average number of GFP-positive 
neurons in the vagus and T12-T5 DRG levels (B) (n=8).  Representative fluorescent image of 
T10 level DRG stained for GFP (C) and Fast Blue (D), and superimposed images showing 
colocalization of staining (E).  Average number of GFP-positive neurons labeled with Fast Blue 
and number of Fast Blue-positive neurons expressing GFP that project to the stomach (F) or 
small intestine (G) (n=4-6 per group).  Representative electrophysiology recording from GFP-
positive DRG neurons given 100 nmol ghrelin (H).  Representative patch clamp recording from 
GFP-positive DRG neuron given either vehicle (green trace) or 100 nmol ghrelin (blue trace) (I).  
Quantification from all GFP-positive DRG patch clamp experiments (J) (n=6 neurons).  Average 
intracellular calcium change for GFP-positive and GFP-negative DRG neurons given either 100 
nmol ghrelin (Ghrl.) or vehicle (Veh.) (K), and the maximum change in fluorescence (L) (n=5-12 
neurons per group).  White arrows in C-E denote GFP and Fast Blue double labeled neurons.  
Data reported as mean ± S.E.M. *P<0.5 vs. baseline. 
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Fig. 4.2 GHSR-positive sensory neurons are activated by energetic challenges. 
Relative GHSR expression in the arcuate nucleus, lumbar DRGs, Thoracic DRGs, or Cervical 
DRGs following 12h food deprivation (A) or 24h cold exposure challenge (E) (n=4 per group).  
Average number of GHSR-positive neurons in the vagus and T12-T5 DRG levels following 12h 
food deprivation (B) or 24h cold exposure challenge (F) (n=4-6 per group).  Number of triple 
labeled (GFP, cFos, and Fast Blue) neurons projecting to the stomach (C) or small intestine (D) 
following a 12h food deprivation challenge (n=4-5 per group).  Number of triple labeled (GFP, 
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cFos, and Fast Blue) neurons projecting to the stomach (G) or small intestine (H) following a 
24h cold exposure challenge (n=4-5 per group).  Representative T7 DRG level fluorescent 
immunostaining for GFP (I), cFOS (J), Fast Blue (K), and superimposed labeling showing 
colocalization (L). White arrows in I-L denote GFP, cFos, and Fast Blue triple labeled neurons.  
Data reported as mean ± S.E.M. *P<0.5 vs. ad libitum fed or room temperature control animals. 
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Fig. 4.3 Sensory neuron specific GHSR knockout has no effect on chow-fed mice. 
Relative GHSR expression in DRGs, arcuate nucleus (ARC), paraventricular hypothalamus 
(PVH), ventromedial hypothalamus (VMH), and ventral tegmental area (VTA) in AGKO and 
WT mice (A) (n=4-6 per group).  Body mass (B) and tissue mass (C) for AGKO and WT mice 
chow-fed for 12 weeks (n=7-8 per group). Food intake measurements for AGKO and WT mice 
following a saline or ghrelin challenge (0.5mg/kg body mass S.C.) (D), or an overnight fast (E) 
(n=8-9 per group).  24-hour food intake measurements for AGKO and WT mice (F) (n=8-9 per 
group).  Glucose tolerance test (1.5mg/kg body mass) (G), fasting blood glucose (H), insulin 
tolerance test (1U/kg body mass) (I), and ad lib fed plasma insulin concentrations (N) for AGKO 
and WT mice (n=8 per group).  Data reported as mean ± S.E.M. *P<0.5 vs. WT control animals. 
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Fig. 4.4 Chow-fed AGKO mice have upregulated thermogenic genes and proteins. 
Average daily energy expenditure for AGKO and WT mice (A) and day/night area under the 
curve values (B) (n=7 per group).  Average daily respiratory quotient for AGKO and WT mice 
(C) and day/night area under the curve values (D) (n=7 per group).  Relative expression of 
thermogenic genes in iBAT (E), eWAT (F), and iWAT (G) for AGKO and WT mice (n=8 per 
group). Relative thermogenic protein content in iBAT (H), eWAT (I), and iWAT (J) for AGKO 
and WT mice (n=4 per group).  Data reported as mean ± S.E.M. *P<0.5 vs. WT control animals. 
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Fig. 4.5.  12 wk. chow-fed H&E and UCP-1 IHC adipose tissue histology. 
Representative images of H&E stained iBAT from f/f (A) and AGKO mice (B), and 
representative UCP-1 IHC iBAT images from f/f (C) and AGKO mice (D).  Representative 
images of H&E stained eWAT from f/f (E) and AGKO mice (F), and representative UCP-1 IHC 
eWAT images from f/f (G) and AGKO mice (H).  Representative images of H&E stained iWAT 
from f/f (I) and AGKO mice (J), and representative UCP-1 IHC iWAT images from f/f (K) and 
AGKO mice (L). 
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Fig. 4.6 Sensory neuron GHSR knockout attenuates diet induced obesity. 
Weekly body mass measurements for AGKO and WT mice (A) (n=15-17 per group).  Baseline, 
8 week, and 16 week fat mass for AGKO and WT mice (B) (n=15-17 per group).  Tissue weights 
following 12 week high-fat-diet feeding for AGKO and WT mice (C) (n=8 per group). 
Representative images of AGKO and WT mice (D), iBAT (E), eWAT (F), iWAT (G), and the 
liver (H). Food intake measurements for high-fat-diet fed AGKO and WT mice following a 
saline or ghrelin challenge (0.5mg/kg body mass) (I), or an overnight fast (J) (n=8 per group).  
24-hour food intake measurements for high-fat-diet fed AGKO and WT mice (K) (n=9 per 
group).  Glucose tolerance test (1.5mg/kg body mass) (L), fasting blood glucose (M), insulin 
tolerance test (1U/kg body mass) (N), and ad lib fed plasma insulin concentrations (O) for high-
fat-diet fed AGKO and WT mice (n=8 per group). Data reported as mean ± S.E.M. *P<0.5 vs. 
WT control animals. 
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Fig. 4.7 Sensory neuron GHSR knockout mice have increased energy expenditure and 
thermogenic capacity on high-fat-diet. 
Average daily energy expenditure for high-fat-diet fed AGKO and WT mice (A) and day/night 
area under the curve values (B) (n=7 per group).  Average daily respiratory quotient for high-fat-
diet fed AGKO and WT mice (C) and day/night area under the curve values (D) (n=7 per group).  
Relative expression of thermogenic genes in iBAT (E), eWAT (F), and iWAT (G) for high-fat-
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diet fed AGKO and WT mice (n=8 per group).  Relative thermogenic protein content in iBAT 
(H), eWAT (I), and iWAT (J) for AGKO and WT mice (n=4 per group).  Data reported as mean 
± S.E.M. *P<0.5 vs. WT control animals. 
 
 
Fig. 4.8.  12 wk. HFD-fed H&E and UCP-1 IHC histological analysis. 
Representative images of H&E stained iBAT from f/f (A) and AGKO mice (B), and 
representative UCP-1 IHC iBAT images from f/f (C) and AGKO mice (D).  Representative 
images of H&E stained eWAT from f/f (E) and AGKO mice (F), and H&E stained liver from f/f 
(G) and AGKO mice (H).  H&E stained iWAT from f/f (I) and AGKO mice (J). 
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Fig. 4.9 Sensory neuron GHSR knockout mice have increased cold tolerance. 
Body temperature measurements in AGKO and WT mice following an acute 4°C cold challenge 
(A) (n=5-7 per group). Body temperature measurements in AGKO and WT mice following a 7 
day 10°C cold challenge (B) and area under the curve values (C) (n=10 per group). Relative 
expression of thermogenic genes in iBAT (D), eWAT (E), and iWAT (F) for acute 4°C cold 
challenged AGKO and WT mice (n=5-7 per group). Relative expression of thermogenic genes in 
iBAT (G), eWAT (H), and iWAT (I) for 7 day 10°C cold challenged AGKO and WT mice (n=10 
per group).  Data reported as mean ± S.E.M. *P<0.5 vs. WT littermate control animals. 
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Fig. 4.10. 1 day and 7 day cold exposure H&E and UCP-1 IHC adipose tissue histology. 
Representative images of 1 day cold exposed H&E stained iBAT from f/f (A) and AGKO mice 
(B), and representative UCP-1 IHC iBAT images from 1 day cold exposed f/f (C) and AGKO 
mice (D).  Representative images of H&E stained eWAT from 1 day cold exposed f/f (E) and 
AGKO mice (F), and representative UCP-1 IHC eWAT images from 1 day cold exposed f/f (G) 
and AGKO mice (H).  Representative images of H&E stained iWAT from 1 day cold exposed  
f/f (I) and AGKO mice (J), and representative UCP-1 IHC iWAT images from 1 day cold 
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exposed f/f (K) and AGKO mice (L).  Representative images of 7 day cold exposed H&E stained 
iBAT from f/f (A) and AGKO mice (B), and representative UCP-1 IHC iBAT images from 7 day 
cold exposed f/f (C) and AGKO mice (D).  Representative images of H&E stained eWAT from 7 
day cold exposed f/f (E) and AGKO mice (F), and representative UCP-1 IHC eWAT images 
from 7 day cold exposed f/f (G) and AGKO mice (H).  Representative images of H&E stained 
iWAT from 7 day cold exposed  f/f (I) and AGKO mice (J), and representative UCP-1 IHC 
iWAT images from 7 day cold exposed f/f (K) and AGKO mice (L). 
 
 
 
Fig. 4.11 1 day and 7 day adipose tissue western blot analysis. 
Relative thermogenic protein content in iBAT (A), eWAT (B), and iWAT (C) for acute 4°C cold 
challenged AGKO and WT mice (n=5-7 per group). Relative thermogenic protein content in 
iBAT (D), eWAT (E), and iWAT (F) for 7 day 10°C cold challenged AGKO and WT mice (n=4 
per group). 
 
4.5 Discussion 
In the current study, we have identified a novel ghrelin signaling mechanism through 
which peripheral sensory neurons mediate energy expenditure and adipose tissue metabolism 
independent of central GHSRs.  While central GHSR signaling has been extensively studied, the 
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mechanisms through which ghrelin activates peripheral sensory neurons has received 
considerably less attention.  We have identified here broad GHSR expression on DRGs that 
respond to ghrelin both in vitro and in vivo, and confirm previous reports demonstrating the 
presence of ghrelin responsive sensory neurons in the nodose ganglia.  Many of these GHSR 
expressing DRG neurons project to the stomach and are activated by both food deprivation and 
cold exposure.  Interrogating the physiological role of these neurons in the context of metabolic 
homeostasis necessitated the generation of a novel, sensory neuron specific GHSR knockout 
mouse.  We crossed our sensory neuron specific advillin-cre mouse driver line with the newly 
developed ghsrf/f mouse to generate AGKO mice.  These mice have increased energy 
expenditure, thermogenic capacity, and attenuated HFD-induced obesity.  Collectively, our 
results demonstrate a novel mechanism through which ghrelin regulates whole body energy 
homeostasis. 
Given the multitude of studies demonstrating ghrelin’s role in obesity development and 
pathological conditions such as Prader-Willi Syndrome [25, 59-61], it is unsurprising ghrelin has 
emerged as an important regulator of metabolic homeostasis.  Within the brain, GHSRs are 
expressed across the neuroaxis including on agouti-related protein/neuropeptide Y expressing 
neurons (AgRP neurons) in the hypothalamic arcuate nucleus (Arc) [16, 23].  Discrete AgRP 
neuron activation is sufficient to rapidly drive food intake [62], and ablation of these neurons in 
adults results in profound hypophagia [63, 64].  AgRP neurons can mediate ghrelin’s orexigenic 
effects independent of other central nuclei or peripheral GHSR activation [65], and these neurons 
have been extensively studied in the context of ghrelin signaling and obesity development.  
However, GHSRs are also expressed on the vagus nerve and in numerous hindbrain nuclei 
involved in metabolic control including the dorsal motor vagus (DMV) and nucleus tractus 
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solitarius (NTS), and fourth ventricular ghrelin infusion is sufficient to drive food intake 
independent of forebrain nuclei [66-68].  The DMV and NTS receive significant peripheral 
sensory information from the vagus nerve and DRGs, and these nuclei are critical for modulating 
sympathetic outflow [69-72].  Vagal GHSRs were initially hypothesized to be necessary and 
sufficient to ghrelin signaling [41], yet subsequent studies in vagotomized animals found no 
change in, at the very least, ghrelin-induced food intake [73].  Our finding here that GHSRs are 
also expressed in DRGs, and that total sensory neuron GHSR deletion (i.e. on both vagal and 
DRGs) imparts a beneficial metabolic phenotype, suggests a possible DRG-involved 
compensatory mechanism that is sufficient to mediate ghrelin’s peripheral effects independent of 
the vagus.  Indeed, Dass et al. found that exogenous ghrelin elicits prokinetic activity in rat and 
human gastric preparations and hypothesized these effects are mediated by both vagal and 
enteric innervation [46].   
The broad GHSR distribution on both vagal and DRG neurons strongly suggests the 
presence of parallel central and peripheral mechanisms regulating ghrelin’s downstream effects 
on energy expenditure.  Our finding that sensory neuron specific GHSR knockout attenuates DIO 
development furthers our understanding of ghrelin’s role in obesity development, and 
complements previous studies showing global GHSR ablation affords similar obesity resistance 
and improved glycemic regulation.  This improved insulin sensitivity and glucose disposal 
manifests as diabetes resistance in HFD-fed animals, yet the absence of ghrelin signaling in 
whole body GHSR knockout mice results in hypoglycemia during fasting [25, 74].  Selective 
GHSR restoration in AgRP neurons or hindbrain Phox2b expressing neurons restores fasting 
glucose levels suggesting these neurons are sufficient to mediate ghrelin’s glucoregulatory 
effects [29, 75].  However, Phox2b is expressed in both hindbrain and peripheral sensory 
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neurons [76, 77], and it is therefore impossible to delineate the central or peripheral mechanism 
mediating this effect.  Our results demonstrating that peripheral, sensory neuron specific GHSR 
knockout has no effect on fasting glucose levels in chow-fed animals would suggest the 
improved glucoregulation in Phox2b GHSR-restored mice involves a central mechanism.  
Because GHSRs are ablated in both DRG and vagal neurons, we hypothesize that neurons 
downstream of the DMV and NTS, including Arc AgRP neurons [10, 11, 78], regulate glucose 
metabolism.  On the other hand, the mild improvement of insulin sensitivity in HFD-fed AGKO 
mice may be secondary to their protection from diet-induced obesity. 
Previous GHSR knockout studies have shown that, despite comparable food intake to 
WT mice, obesity resistance is due to a marked upregulation in energy expenditure mediated by 
increased sympathetic outflow to adipose tissue [25, 27, 61].  The dissociation between ghrelin-
induced food intake and augmented energy expenditure suggests discrete nuclei regulate these 
effects.  To this end, adipose tissue sympathetic outflow neurons are found in numerous 
hindbrain and forebrain nuclei [11, 79], and many of these nuclei concurrently integrate 
peripheral sensory neuron information to regulate energy expenditure [10, 80].  We have 
identified here a novel peripheral GHSR signaling mechanism that functions to decrease energy 
expenditure, and we hypothesize this circuit elicits its effects through two possible mechanisms.  
First, ghrelin signaling on sensory neurons may decrease energy expenditure through short 
feedback loops at the level of the spinal column.  In support of this, sensory-sympathetic cross 
talk at the level of the spinal cord exists in gastrointestinal system [81], and spinal column 
damage impairs normal gastric function despite intact vagal signaling [82].  Second, and more 
plausibly, ghrelin-mediated energy expenditure may be mediated through sensory integration in 
hindbrain nuclei.  Previous work has demonstrated fourth ventricular ghrelin injections is 
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sufficient to decrease energy expenditure and elicit neuronal activity in several hindbrain nuclei 
that receive sensory neuron input including the DMV and NTS [66, 67].  As these neurons also 
send sympathetic projections to adipose tissue, it is likely that peripheral ghrelin signaling 
inhibits these neurons in WT animals.  Hence, we find increased thermogenic gene expression in 
iBAT, eWAT, and iWAT pads in our AGKO knockout mice, possibly due to an upregulated 
sympathetic response, as shown by increased β3AR mRNA and TH protein levels.  This 
upregulated energy expenditure paradigm following peripheral GHSR ablation is an important 
finding in the context of clinical approaches to combat obesity.  Because our animals have 
normal glucose regulation and food intake while simultaneously resisting obesity, a treatment 
regimen targeting peripheral ghrelin signaling would prove beneficial as it has fewer side effects 
compared with non-specific GHSR antagonism and would circumvent the need to bypass the 
blood brain barrier.  In turn, our results may provide a novel approach for obesity treatment.   
The marked upregulation of thermogenic genes across iBAT, eWAT, and iWAT 
engender improved thermoregulation during an acute or chronic cold challenge and provides a 
mechanism for the elevated energy expenditure that attenuates obesity development.  Although 
global and neuronal GHSR knockout mice have upregulated thermogenic genes in adipose 
tissues [25, 27, 74], to our knowledge this is the first demonstration that sensory neuron GHSR 
signaling functions to decrease expression of these genes.  While the exact mechanism through 
which the absence of GHSR signaling increases adipose thermogenic gene expression 
necessitates further study, we propose a mechanism involving gut-brain crosstalk.  We have 
shown here both vagal and DRG GHSR-positive neurons innervate the stomach and small 
intestine [Fig. 1], and nutrient activation of gut afferents is sufficient to increase iBAT 
temperature [9].  Because endogenous ghrelin signaling inhibits these enteric sensory neurons 
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[41, 83], it is likely that the absence of GHSRs results in a chronic, uninhibited afferent activity 
that drives adipose thermogenic gene expression.  In addition, the same study found that NTS 
NMDA blockade inhibited this nutrient-induced increase in iBAT activity [9], and, given the 
colocalization of gastric afferents in the NTS, it is likely that GHSR activation of these neurons 
would similarly decrease glutamatergic NTS neuron activity.   
In sum, our results demonstrate a novel peripheral ghrelin signaling pathway that 
responds to energetic challenges and regulates metabolic homeostasis.  As this pathway is 
independent of central ghrelin signaling, it strongly suggests the presence of multiple ghrelin-
involved mechanisms that regulate whole body energy homeostasis.  Hence, peripheral ghrelin 
signal intervention may provide novel therapeutic approaches that increase basal energy 
expenditure and prevent or reverse obesity. 
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5 CONCLUDING REMARKS 
This dissertation serves as an important step forward in our understanding of how the 
orexigenic hormone ghrelin regulates whole body energy homeostasis.  We approached these 
studies with a complementary focus on interrogating the behavioral and physiological 
mechanisms through which ghrelin mediates metabolism.  We have expanded the known role of 
ghrelin in driving ingestive behaviors by demonstrating 1) central ghrelin signaling is necessary 
and sufficient to drive appetitive and consummatory behaviors, 2) central ghrelin acts through 
AgRP neurons to drive these behaviors, and 3) AgRP signaling is necessary for the long-term 
increases in food hoarding following an exogenous ghrelin challenge or fasting.  Moreover, we 
have identified a novel peripheral sensory neuron ghrelin signaling pathway that is critical for 
metabolic regulation.  The novelty of this work lies in the multifaceted behavior and physiology 
experimental paradigms that contrast with approaches aimed at a single outcome (e.g. food 
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intake).  Hence, we have elucidated ghrelin’s role in two discrete mechanisms that drive 
excessive weight gain. 
Our finding that central GHSR activation is necessary and sufficient to drive ingestive 
behaviors and the chronic increases in food hoarding is regulated by AgRP peptide signaling 
complements previous studies in other laboratory rodent species [134, 180, 181].  The long-term 
behavioral adaptation in which animals, including humans, hoard food to prevent future caloric 
deficiencies is a major contributor to weight regain following dieting.  Our results here serve as a 
critical step toward understanding the mechanism through which this is mediated.  However, the 
downstream nuclei that regulate long-term food hoarding remain to be identified.  AgRP neurons 
project to numerous nuclei involved in food intake and/or energy expenditure control [95], and 
advances in neuron specific circuit mapping is an attractive approach to interrogate the role of 
these projections in the context of appetitive behaviors.  Discrete Arc→PVH projections are 
likely critical for driving food intake, and several studies have demonstrated selective activation 
of these projections drives food intake comparable to total AgRP neuronal activation [95].  We 
show here that central GHSR antagonism blocks appetitive and consummatory ingestive 
behaviors and PVH neuronal activity while leaving the Arc relatively unaffected [28].  Because 
redundant AgRP projections to downstream nuclei sufficient to drive food intake exist, it may be 
possible that non-PVH nuclei receiving AgRP neuron input are also sufficient to mediate other 
ingestive behaviors. Unfortunately, the genetic models required for neuron-specific mapping are 
available only in mice and, to a lesser extent, rats.  It is therefore impossible to employ the 
spatial and temporal experimental resolution necessary to directly test this in Siberian hamsters.   
In an evolutionary context, a dual physiological approach that simultaneously drives 
energy consumption and energy conservation would markedly increase an animal’s survival 
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probability.  However, these adaptive responses must be balanced as food foraging inherently 
requires energy expenditure.  The mechanisms through which this balance is maintained and at 
what point animals stop appetitive behaviors in favor of conserving energy remains unclear, yet 
converging experimental and anecdotal evidence suggests unconstrained, elevated circulating 
ghrelin concentrations causes this switch.  Central GHSR responsive neurons (i.e. within the 
Arc) may be more sensitive to circulating ghrelin or require significantly fewer neurons to be 
activated to elicit ingestive behaviors compared with peripheral GHSR neurons.  Prolonged 
caloric restriction results in unimpeded stomach ghrelin production and AgRP neuron 
upregulation and may in turn reach a plateau at which point higher circulating ghrelin cannot 
further drive ingestive behaviors.  Because GI-derived anorectic hormones that oppose ghrelin’s 
peripheral sensory neuron effects would concurrently reach nadir, elevated ghrelin 
concentrations would maximally activate vagal and DRG sensory neurons causing a switch to 
energy conservation rather than ingestive behaviors.  In support of this hypothesis, activation of 
as few as 400 AgRP neurons is sufficient to drive maximum food intake in mice [95], and we 
have observed very large ghrelin doses (~1mg/kg i.p.) cause Siberian hamsters to remain in their 
bottom hoarding cage rather than foraging for and gathering food for hoarding (Thomas and 
Bartness unpublished observations).  By contrast, physiological ghrelin doses (~30 µg/kg i.p.) 
cause a robust increase in appetitive behaviors and drive long term behavioral adaptations [22, 
28, 182].  Although the experimental and anecdotal evidence presented here would support this 
hypothesis, future work is clearly needed to fully elucidate this mechanism.   
The presence of GHSRs on DRG and vagal neurons raises several important, unanswered 
questions.  First, although DRG and vagal ghrelin signaling is necessary to mediate metabolic 
homeostasis, it is unclear how this information is integrated centrally and where any 
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hindbrain/forebrain crosstalk may or may not occur.  Hindbrain nuclei including the NTS and 
DMV receive broad peripheral sensory neuron information from DRG and vagal sensory 
neurons, and these nuclei can elicit a metabolic response directly or relay this information to 
hypothalamic and forebrain nuclei for further processing [37, 39, 183-185].  In addition, these 
nuclei are integral in regulating sympathetic outflow to adipose tissues suggesting a possible 
mechanism through which sensory neuron ghrelin signaling can regulate adipose metabolism 
[38, 186-188].  These hindbrain nuclei may therefore serve to integrate peripheral GHSR 
signaling and then relay this information to other central nuclei or mount a metabolic response 
directly, and future work is needed to examine this hypothesis.  Second, it is unclear if DRG and 
vagal sensory neurons act as redundant peripheral ghrelin signaling pathways or if they drive 
discrete metabolic effects.  Previous work has demonstrated sensory neurons are critical for 
maintaining energy homeostasis and that non-vagal sensory neurons are sufficient to mediate 
ghrelin’s effects on gastric motility, but whether or not this seemingly redundant mechanism 
exists in the NTS or DMV is unknown.  Our novel AGKO mouse model is an important step 
towards understanding how peripheral sensory neurons regulate metabolic homeostasis, but 
because it inherently deletes GHSRs on all sensory neurons (i.e. both DRG and vagal) it is 
unable to differentiate the discrete role of these pathways.  Moreover, we are presently unable to 
comment on any changes in hindbrain NTS/DMV crosstalk or downstream changes that could 
account for our observed phenotype.   
In sum, our work presented here will serve as a foundation from which future studies can 
build upon to fully elucidate ghrelin’s role in metabolic control.  The diverse behavioral and 
physiological effects of ghrelin make it an attractive target for obesity reversal and prevention.  
By identifying the mechanism through which ghrelin drives acute and long-term changes in 
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appetitive and consummatory behaviors as well as how it regulates metabolism through 
peripheral signaling pathways, we have provided clinically relevant information that can be used 
to progress drug or behavioral therapies.   
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